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Summary 
 
Molecular chaperones of the Hsp70 and Hsp90 family are central components in protein 
folding processes in the cell. In addition to their general chaperone function in protein quality 
control, Hsp70 and Hsp90 cooperate in the control of stability and activity of some 200 
natively folded clients including receptors, protein kinases and transcription factors, many of 
which are key regulators in essential signal transduction pathways. Both chaperones are 
multi-domain proteins that use ATP-controlled cycles for substrate binding and release which 
are regulated by co-chaperones. The aim of this thesis was to elucidate the allosteric 
mechanism of Hsp70 and Hsp90 chaperones and their interactions with the co-chaperone 
CHIP by investigating their conformational changes and dynamics in solution. These 
conformational studies were performed primarily using amide hydrogen exchange (HX) 
combined with high-resolution mass spectrometry (MS) and fluorescence spectroscopy.  
 HX-MS experiments with the E. coli Hsp70 homologue DnaK revealed specific ATP-
induced conformational changes. Upon ATP binding, the nucleotide-binding domain was 
more compact, while the substrate binding domain was more flexible. The exposed 
interdomain linker became completely protected from solvent upon ATP binding. 
Comparison of the dynamics of the full-length protein with the dynamics of the isolated 
domains demonstrated a mutual stabilization of both domains. Substrate binding to DnaK in 
the ATP-bound state reverses the ATP-induced conformational changes in the linker and 
selected parts of the NBD. The HX-MS data outline a pathway for allosteric interdomain 
communication which mediates ATP-induced opening of the substrate binding pocket and the 
substrate-induced stimulation of ATP hydrolysis.      
 Continuous-labeling and pulse-labeling HX-MS experiments with the dimeric E. coli 
Hsp90 homologue HtpG demonstrate drastic ATP-induced conformational changes 
throughout the protein that do not occur simultaneously but progress slowly like a wave from 
the nucleotide binding site towards the N-terminus and the middle domain. A conformation-
sensitive fluorescent probe allowed the elucidation of the kinetics of the ATPase cycle of 
HtpG. Conversion into a compact conformational state was shown to be rate-limiting for ATP 
hydrolysis and the nucleotide-coordinating residue Glu34 was important for the rate of 
conversion.           
 Analysis of the conformational dynamics of the eukaryotic Hsp90 homologues from yeast 
and human, Hsc82 and Hsp90β, by HX-MS revealed a significant higher flexibility as 
compared to the prokaryotic HtpG. Segments with higher dynamics were located 
predominantly in the middle and the dimerization domains. Nucleotide binding had long-
range effects on the conformation of all domains, but these were more subtle compared to 
HtpG. Consistent with the hypothesis that conformational dynamics of Hsp90 is linked to 
regulation by co-chaperones, it could be shown by fluorescence resonance energy transfer 
experiments with fluorescent Hsp90β that the binding of the co-chaperone p23 in presence of 
ATP leads to movement of the N-terminal Hsp90 domains towards each other. Two Hsp90 
inhibitors competitive for nucleotide affected the conformational dynamics of Hsp90β 
differently from nucleotides and from each other.      
 The human E3-ubiquitin ligase CHIP exhibited an extraordinary flexibility with an almost 
completely unfolded N-terminal TPR domain as measured by HX-MS. Complex formation 
with intact Hsp70 and Hsp90 or their respective C-terminal octapeptides induced folding of 
the TPR domain to a defined, stabilized structure. Interaction of CHIP with two different E2 
ubiquitin-conjugating enzymes, UbcH5a and Ubc13, resulted in distinct effects on the 
conformational dynamics of CHIP suggesting different roles of the CHIP-E2 interaction for 
the ubiquitination of substrates. 
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Zusammenfassung 
 
Molekulare Chaperone der Hsp70 und Hsp90 Familie sind an einer Vielzahl von zellulären 
Proteinfaltungsprozessen beteiligt. Neben der allgemeinen Chaperon-Funktion in der 
Proteinqualitätskontrolle spielen Hsp70 und Hsp90 eine wichtige Rolle in der Kontrolle der 
Stabilität und Aktivität von über 200 nativ gefalteten Substraten, darunter Rezeptoren, 
Proteinkinasen und Transkriptionsfaktoren, von denen viele Schlüsselproteine wichtiger 
Signaltransduktionswege sind. Beide Chaperone sind Multi-Domänproteine, die ihre 
Substrate in ATP-kontrollierten Reaktionszyklen binden und wieder freisetzen, und dabei 
zusätzlich durch Co-Chaperone reguliert werden. Ziel dieser Arbeit war es, die allosterische 
Funktionsweise von Hsp70 und Hsp90 Chaperonen und deren Interaktion mit dem Co-
Chaperon CHIP durch die Untersuchung ihrer Konformationsdynamik und ihrer 
Konformationsänderungen in Lösung aufzuklären. Diese strukturellen Untersuchungen 
wurden hauptsächlich mit Wasserstoff-H/D-Austausch (HX) in Verbindung mit 
hochauflösender Massenspektrometrie (MS) sowie Fluoreszenzspektroskopie durchgeführt. 
Durch HX-MS Experimente mit Hsp70 aus Escherichia coli, DnaK, konnten spezifische 
ATP-abhängige Konformationsänderungen in beiden funktionellen Domänen des Proteins 
nachgewiesen werden: die Nukleotidbindedomäne wird durch ATP-Bindung kompakter, 
während es in der Substratbindedomäne zu einer Öffnung kommt. Der exponierte Linker 
zwischen beiden Domänen wird in Gegenwart von ATP stark von der austauschenden 
Umgebung geschützt. Durch den Vergleich der Konformationsdynamik des 
Volllängenproteins mit den isolierten Domänen konnte eine wechselseitige Stabilisierung der 
Domänen gezeigt werden. Die Bindung von Substratpeptid an ein DnaK im ATP gebundenen 
Zustand führt zu einer Umkehrung der ATP-induzierten Konformationsänderungen im Linker 
und in Segmenten der Nukleotid-bindedomäne. Die gewonnenen Ergebnisse zeigen somit die 
Signalwege der allosterischen Domänen-Kommunikation von Hsp70, durch die einerseits die 
ATP induzierte Öffnung der Substratbindetasche bewirkt wird und andererseits die ATP-
Hydrolyse durch Substratbindung stimuliert wird.  
Mithilfe kontinuierlicher und gepulster HX-MS Messungen mit dem dimeren Hsp90 
Homolog aus Escherichia coli, HtpG, konnten starke ATP-induzierte 
Konformationsänderungen im gesamten Protein beobachtet werden, die allerdings nicht 
konzertiert ablaufen, sondern sich langsam und schrittweise wie eine Welle von der 
unmittelbaren Nukleotidbindestelle zum N-terminalen Ende und zur Mitteldomäne des 
Proteins ausbreiten. Ein konformationsempfindlicher Fluorophor gekoppelt an HtpG konnte 
zur Bestimmung der Kinetiken des gesamten ATP-Reaktionszyklus verwendet werden. Es 
konnte gezeigt werden, dass der Übergang zu einer stabilisierten Konformation 
geschwindigkeitsbestimmend für die ATP Hydrolyse ist und dass dabei die Aminosäure Glu34 
wichtig für diesen Konformationsübergang ist.  
Die Analyse der Konformationsdynamik der eukaryotischen Hsp90 Homologen, dem 
Hsp90β des Menschen und Hsc82 aus Hefe, zeigte eine signifikant höhere Flexibilität im 
Vergleich zum prokaryotischen HtpG. Die meisten Bereiche mit höherer Dynamik befanden 
sich in der Mitteldomäne und in der Dimerisierungsdomäne. Nukleotidbindung führte in allen 
Hsp90-Domänen zu Konformationseffekten, die allerdings erheblich schwächer waren als in 
HtpG. Mithilfe von Fluoreszenz-Resonanz-Energie-Transfer-Messungen konnte indes gezeigt 
werden, dass die Bindung des Co-Chaperons p23 an fluoreszenzmarkiertem Hsp90 in 
Gegenwart von ATP zu einer Bewegung der N-terminalen Domänen zueinander führt. Die 
 X
Bindung von zwei mit ATP kompetitiven Hsp90-Inhibitoren beeinflusste die Dynamik von 
Hsp90β in einer von Nukleotiden verschiedenen Weise.   
HX-MS Experimente mit der E3-Ubiquitin-Ligase CHIP zeigten, dass das Protein eine 
außerordentlich hohe Dynamik mit stark entfalteten Bereichen in der N-terminalen TPR 
Domäne aufweist. Durch Komplexbildung mit intaktem Hsp70 und Hsp90 oder deren 
C-terminalen Oktapeptiden konnte die Faltung der TPR-Domäne zu einer stabilisierten 
Konformation induziert werden. Die Interaktion mit zwei E2-Ubiquitin-verknüpfenden 
Enzymen, UbcH5a und Ubc13, führte zu unterschiedlichen Effekten auf die 
Konformationsdynamik von CHIP und weist damit auf eine spezifische Rolle der E2-CHIP 
Interaktion für die Ubiquitinierung von Substraten hin. 
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 1
1 Introduction 
 
1.1 Protein Folding and Dynamics  
 
Newly synthesized proteins must fold into a native three-dimensional structure to become 
functionally active. The complexity of the protein folding process can be illustrated as 
follows: given a protein of 100 amino acids and assuming only two different conformational 
states for each amino acid (e.g. cis and trans conformation of the peptide bond), the 
polypeptide can adopt 2100 = 1.3 x 1030 conformational states. It would take longer than the 
age of the universe to find the native structure if protein folding proceeds via random search 
of all possible conformations even at the highest sampling rate possible. This conclusion is in 
contrast to the experimental finding that many proteins fold within milliseconds to seconds; 
this dilemma is known as “Levinthal’s paradox” (Levinthal, 1968). 
This folding paradox is elegantly solved within the framework of the energy landscape 
description of directed folding pathways (Dinner et al., 2000; Onuchic et al., 2000). In this 
description, the folding process is interpreted in terms of conformational ensembles that 
undergo a biased diffusion on a multi-dimensional free-energy surface. The native state of a 
protein corresponds the global free-energy minimum on the conformational energy landscape, 
thus resulting in a “folding funnel”. The denatured state, on the other hand, is represented by a 
large ensemble of conformations with high internal energy and flexibility. On the way to its 
native state a protein can follow trajectories from the unfolded state over different partially 
folded states and intermediates. Many proteins form an intermediate during early folding 
termed “molten globule” which describes a fairly compact folding state with pronounced 
secondary structure but few ordered tertiary structure elements. 
The protein structure under native conditions is with very few exceptions not a static 
crystalline state as analyzed in X-ray crystallography, but a rather dynamic ensemble 
involving local unfolding and refolding; proteins “breathe”. For many proteins, dynamics are 
essential to function. Protein motions can be categorized in three classes, local, rigid, or large-
scale motion. These identified motions cover a wide range of timescales (10-15 to 103 s), 
amplitudes (0.01 to 100 Å) and energies (1 to 400 kJ/mol) (Brooks et al., 1990). Such 
conformational changes can include local fluctuations affecting only few atoms within the 
secondary structure as well as global fluctuations altering the whole protein structure. Many 
of these conformational alterations are induced by binding of ligands or other proteins by an 
Introduction 
 2
”induced fit” mechanism (Koshland, 1958; Koshland, 1998). A large variety of proteins use 
dynamics as a means of communication between different domains. This process of allostery 
is best shown for haemoglobin conformations changing upon oxygen binding (Perutz, 1972; 
Perutz et al., 1998). Another important protein class demonstrating the importance of 
conformational dynamics is the group of “intrinsically unstructured proteins” that contain 
large segments of disorder under native conditions, and seem to have a large variety of 
regulatory functions in vivo (Dyson and Wright, 2005). 
Conformational properties of proteins can be monitored on the global level by conventional 
biophysical and analytical methods, including far-UV circular dichroism (CD) (Pelton and 
McLean, 2000), tryptophane fluorescence and infrared spectroscopy (Barth, 2000). In 
addition, small-angle X-ray scattering and cryo-electron microscopy can reveal changes in the 
conformational shape and assembly of proteins (Koch et al., 2003).  
In terms of detailed amino acid resolution, few techniques can compete with X-ray 
crystallography which is capable of determining structure from a highly ordered crystallized 
protein with a resolution in the range of 1-2 Å (Moffat, 2001). Newly developed “time 
resolved” crystallographic methods have shown some promise in determining dynamic 
information, but need large amounts of pure protein and the formation of crystals (Moffat, 
2001; Schlichting et al., 2000). Multi-dimensional nuclear magnetic resonance (NMR) 
spectroscopy has been used for many years to monitor protein dynamics in solution under 
steady-state conditions and on multiple time scales at the amino acid level (Dyson and 
Wright, 2004). NMR experiments have traditionally been limited to small, soluble proteins up 
to 35 kDa. However, new spectrometer technology (such as high magnetic fields and 
cryoprobes) and new NMR pulse sequences have pushed the size limit upward to 100 kDa 
and even the size of the ribosome, depending on the system and biological question (Henzler-
Wildman and Kern, 2007).  
Hydrogen exchange (HX) methods, which can be analysed by either mass spectrometry or 
NMR spectroscopy, provide a powerful tool to detect global or local unfolding on timescales 
of milliseconds and longer. Since this technique was extensively used in this work to 
investigate conformational changes in chaperone proteins, the details will be discussed in a 
later section.  
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1.2 Molecular Chaperones  
 
 
Protein folding in the cell is a much more complex process than it is in vitro. The conditions 
in a living cell seem to be not beneficial for effective folding, mainly because of high 
temperature and high concentration of proteins in the cell (ca. 200 mg/ml). This molecular 
crowding effect leads to strong competition between productive folding processes and 
aggregation or misfolding. Protein aggregation is fatal for the cell as it can interfere in 
important cellular processes and is the cause of many neurodegenerative diseases like 
Alzheimer’s disease, Parkinson’s disease or prion diseases (Chiti and Dobson, 2006).  
Cells harbour a set of proteins called molecular chaperones which assist folding and prevent 
the aggregation of misfolded proteins during de novo protein synthesis as well as under stress 
conditions such as high temperature (Young et al., 2004). The fact that the level of many 
chaperones is elevated under heat shock conditions led to the term “heat shock protein” (Hsp) 
(Ellis, 1987). Hsp proteins exist in several evolutionary conserved families, which are named 
according to the apparent molecular weight of a typical member, e.g. Hsp110, Hsp100, 
Hsp90, Hsp70, Hsp60 or Hsp40 and the small Hsps. 
The characteristic feature of chaperone action is the transient and stoichiometric binding to 
their substrate proteins. The Hsps can be grouped into three functional categories: holder 
chaperones, folder chaperones and disaggregases. The “holders” prevent unfolded proteins 
from interacting with each other by binding to them and, hence, counteract protein 
aggregation. Typical examples for this functional group are the small heat shock proteins (e.g. 
E. coli IbpA and IbpB, human Hsp26), members of the Hsp40 family (e.g. E. coli DnaJ, 
human Hdj-2, S. cerevisiae Ydj1) and Trigger factor. 
The folder chaperones have the unique feature to actively assist folding processes. Members 
of this group typically possess an ATPase domain because this function requires energy. Two 
well studied examples are the Hsp60 chaperones, also called chaperonins (e.g. E. coli GroEL, 
human TRiC), and the Hsp70 protein family (e.g. E. coli DnaK, human Hsp70) (Bukau and 
Horwich, 1998). 
The proteins with disaggregating activity are able to dissolve already formed protein 
aggregates to release polypeptide chains for refolding or degradation. Examples for this 
protein group are the Hsp100 family members E. coli ClpB and S. cerevisiae Hsp104. They 
are able to resolubilize protein aggregates in cooperation with members from the Hsp70 
family (Glover and Lindquist, 1998; Mogk et al., 1999). 
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1.2.1 The Hsp70 chaperone machinery 
1.2.1.1 Cellular functions of Hsp70 
 
The 70-kDa heat shock proteins (Hsp70) constitute the central part of a ubiquitous chaperone 
system that is present in most compartments of eukaryotic cells, in eubacteria and in many 
archaea. They assist an extraordinarily broad spectrum of folding processes within the entire 
life span of proteins (Fig. 1.1) (Mayer et al., 2001; Mayer and Bukau, 2005). These processes 
include the folding of newly synthesized and misfolded proteins and the prevention or 
reversion of protein aggregation (Deuerling et al., 1999; Goloubinoff et al., 1999; Mogk et al., 
1999; Teter et al., 1999). Such quality control functions, mostly in cooperation with co-
chaperones and chaperones of other families, play an essential role in stress situations like 
heat shock or harsh environmental conditions.  
 
Fig. 1.1 Functions of Hsp70 chaperones in the cell 
 
All of these activities appear to be driven by the basic property of Hsp70s to interact with 
short hydrophobic peptide segments of protein substrates in an ATP-dependent fashion. 
Hsp70 chaperones also have important housekeeping functions in the cell under normal 
conditions, e.g. the disassembly of protein complexes such as clathrin coats (Chappell et al., 
1987; Ungewickell, 1985), the import of proteins into the endoplasmic reticulum (ER) lumen 
(Lyman and Schekman, 1997; Matlack et al., 1999) and the mitochondrial matrix (Voisine et 
al., 1999), the regulation of the heat-shock response and the control of regulatory proteins in 
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cooperation with the Hsp90 system. The main Hsp70 chaperone of E. coli is DnaK which is 
highly expressed under all conditions but even more expressed under heat shock conditions, 
being regulated by the heat-shock transcription factor σ32. In higher eukaryotes there are 
Hsp70 isoforms that are either constitutively expressed (e.g. the human Hsc70) or stress-
inducible (e.g. the human Hsp70) under the control of the heat-shock response. 
 
1.2.1.2 Hsp70 structure 
 
The structure of Hsp70 proteins is highly conserved and consists of an N-terminal 44-kDa 
nucleotide binding domain (NBD) and a C-terminal substrate-binding domain (SBD) of at 
about 25 kDa, which are connected by a conserved short hydrophobic linker (Bukau and 
Horwich, 1998). At the beginning of this work, no high resolution structure of a full-length 
Hsp70 molecule was available, but the individual domains were characterized extensively by 
X-ray crystallography and NMR spectroscopy.  
The nucleotide-binding domain of Hsp70s is structurally homologous to actin, hexokinase and 
glycerokinase. It consists of two equal-sized lobes forming a V-like shaped domain with a 
deep cleft. Each lobe can be further divided into two subdomains IA, IB and IIA, IIB (Fig. 
1.2b). The binding pocket for nucleotide and the required Mg2+ and K+ ions is formed at the 
bottom of the cleft by all four subdomains and the cross-connecting helices, contacting the 
adenosine nucleotide with two β- and γ-binding loops (Flaherty et al., 1990). The many 
available X-ray structures of the ATPase domain of bovine, human and bacterial Hsp70 
indicate that there are only subtle conformational changes in response to nucleotide binding or 
hydrolysis (Flaherty et al., 1994; Harrison et al., 1997; Sondermann et al., 2001). NMR data 
revealed a high degree of flexibility in the NBD with a shearing and tilting motion of the 
different subdomains relative to each other, leading to an opening and closing of the 
nucleotide binding cleft (Zhang and Zuiderweg, 2004). The opening frequency seems to be 
highest in the order nucleotide-free>ADP>ATP (Gassler et al., 2001).  
Most structural information on the substrate-binding domain of Hsp70 exist for E. coli DnaK. 
The X-ray structure of the SBD (residues 389-607) was solved in complex with a heptameric 
peptide NRLLLTG by Hendrickson and co-workers (Zhu et al., 1996) (Fig. 1.2b). Additional 
studies in solution were performed in presence or absence of substrate by NMR spectroscopy 
(Bertelsen et al., 1999; Morshauser et al., 1999; Pellecchia et al., 2000; Stevens et al., 2003). 
The peptide binding domain forms a sandwich of two fourstranded β-sheets with four 
upwards protruding loops (two inner and two outer loops) and two helices A and B which are 
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packed against the inner loops. The peptide binding site lies in between the loops L1,2 and L3,4 
which form the direct hydrogen bond interactions with the peptide substrate backbone. Helix 
B constitutes a lid which closes the cavity through a salt bridge and two hydrogen bonds to 
the outer loops L3,4 and L5,6. The distal part of helix B together with 3 additional helices C, D 
and E forms a subdomain of unknown function. The very C-terminus of DnaK is highly 
flexible and could not be structurally resolved (Bertelsen et al., 1999), while a crystal 
structure for a C-terminal construct of  C. elegans Hsp70 is reported showing a multimeric 
assembly of α-helices (Worrall and Walkinshaw, 2007). 
 
Fig. 1.2 Domain architecture and structure of Hsp70. (a) Domain organisation of DnaK with nucleotide-
binding domain (NBD) and substrate binding domain (SBD) (b) Secondary structure representation of the SBD 
and the NBD of Hsp70. Left, secondary structure representation of the E. coli DnaK SBD (393-607, PDB code 
1DKZ) with bound heptameric substrate peptide  NRLLLTG (yellow) (Zhu et al., 1996). Right, standard 
representation of the NBD of bovine Hsc70 (PDB code 1HPM) in complex with ADP+Pi with lobes I and II, 
formed by subdomains A and B respectively.  
 
Five central residues of the substrate peptide NRLLLTG show important interactions with the 
DnaK SBD: hydrogen bonding between the peptide backbone and the loops L1,2 and L3,4 and 
van-der-Waals interactions of the hydrophobic peptide side chains with the hydrophobic 
cavity of the SBD and the arch (formed by Met404 and Ala429) bridging over the peptide 
backbone. The principal preference of DnaK for hydrophobic peptides was investigated by 
peptide library screening. The experimentally determined binding motif for DnaK consists of 
five consecutive residues enriched in hydrophobic amino acids and flanking regions enriched 
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in basic amino acids (Rudiger et al., 1997a; Rudiger et al., 1997b). Such binding sequences 
occur frequently within protein sequences, approximately one DnaK binding site every 36 
residues and are typically buried within the hydrophobic core of the folded proteins.  
Cytosolic eukaryotic Hsp70 proteins have an entirely conserved motif (EEVD) at the very C-
terminus, which is unstructured and, therefore, flexible and accessible for interaction partners. 
The EEVD-motif facilitates binding of proteins with a tetratricopeptide binding motif (TPR) 
to Hsp70 proteins (Scheufler et al., 2000). Examples for interacting TPR-proteins are the 
Hsp70/Hsp90 organizing protein (Hop/Sti1) or the mammalian E3 ligase CHIP (Nikolay et 
al., 2004; Odunuga et al., 2003) which will be introduced later in this chapter.   
It was unclear for long time, how both SBD and NBD are oriented to each other in the fully 
functional two-domain molecule. Residual dipolar coupling in NMR was used to align both 
domains in a DnaK two-domain construct of Thermus thermophilus (Revington et al., 2005). 
Recently, the first structure of an intact bovine Hsc70 two-domain construct in the high-
affinity state was reported (Jiang et al., 2005). This structure and other new structural data 
will be discussed on the basis of the data of this thesis in the results section. 
1.2.1.3 Hsp70 functional cycle 
 
The basic principle of Hsp70-mediated folding processes relies on the transient interaction 
with unfolded polypeptide stretches within the SBD which is controlled by the nucleotide 
status of the NBD in an allosteric manner. ATP binding and hydrolysis is absolutely essential 
for the chaperone activity. Hsp70 chaperones seem to assist folding by repeated cycles of 
substrate binding and release between two nucleotide states (Bukau and Horwich, 1998; Hartl 
and Hayer-Hartl, 2002) (Fig. 1.3). In the ATP bound state, the affinity for substrates is low, 
but the association and dissociation rates of the substrate are high (low-affinity state). In 
contrast, the ADP bound state resembles the high-affinity state for substrates, but has low 
association and dissociation rates.  
Hsp70 proteins have a higher affinity for ATP (~1 nM) than for ADP/Pi (~ 10 nM) implying 
that at most conditions in vivo (3 mM ATP), they are in the ATP bound state. However, the 
basal ATP hydrolysis rate for DnaK (6 · 10-4 s-1, half-life τ = 19 min) is too low to be 
physiologically relevant (Flynn et al., 1989; Gao et al., 1993; Ha and McKay, 1994; Jordan 
and McMacken, 1995; Karzai and McMacken, 1996; McCarty et al., 1995; Theyssen et al., 
1996). Therefore, Hsp70 proteins interact in vivo with members of the Hsp40 protein family 
(J-domain proteins JDP), which accelerate the ATP hydrolysis reaction (Gamer et al., 1996). 
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Substrate binding to the SBD in synergism with the J-protein triggers the ATP hydrolysis in 
the NBD of Hsp70. Substrate and the J-domain protein DnaJ can stimulate the ATPase 
activity of DnaK synergistically more than 1000-fold (Laufen et al., 1999). Since JDPs can 
bind itself substrates, they are proposed to be targeting factors for Hsp70 substrates which 
bind the substrates first and allow efficient transfer to Hsp70 by enhancing the coupling of 
ATP hydrolysis and substrate binding. Cells usually encode a broad spectrum of JDPs which 
differ in their domain composition and cellular functions (Kelley, 1998; Mayer and Bukau, 
1998). The number of different J-proteins is much higher than the number of Hsp70 homologs 
in the cell (e.g. 6 JDP in E. coli, 20 in S. cerevisiae, 44 in human cells), some of which 
display a restricted substrate specificity. 
 
Fig. 1.3 Functional ATPase cycle of Hsp70.  The cycle involves the high-substrate-affinity ADP state and the 
low-affinity ATP state. ATP hydrolysis is catalyzed by the synergistic action of J-domain-proteins (JDP) of the 
Hsp40 family and the substrate. Nucleotide-exchange factors (NEF) accelerate nucleotide release and the 
subsequent ATP binding leads to substrate release. 
 
The next step in the Hsp70 functional cycle is the release of ADP and inorganic phosphate. 
Subsequent rapid association of a new ATP molecule triggers the release of the bound 
substrate and returns the Hsp70 machinery back to its low-affinity state. With stimulation of 
the Hsp70 ATPase rate by Hsp40 proteins, release of the product ADP becomes the rate-
limiting step. A number of Hsp70 proteins interact in vivo with co-factors, which accelerate 
the nucleotide exchange. 
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Bacterial and eukaryotic organellar Hsp70 homologues are bound by the GrpE family 
members (Dekker and Pfanner, 1997; Liberek et al., 1991a; Miao et al., 1997), which lower 
the affinity for ADP and increase the nucleotide exchange rate by a factor 5000 (Brehmer et 
al., 2004; Packschies et al., 1997). The crystal structure of a GrpE dimer in complex with 
nucleotide-free ATPase domain of DnaK gave some insight into how GrpE decreases the 
affinity of DnaK for nucleotides (Harrison et al., 1997). In the functional model, GrpE inserts 
a helical bundle into the ATP binding cleft, actively widening the groove and accelerating the 
dissociation of bound ADP. Eukaryotic cytosolic and ER-resided Hsp70 homologues interact 
with members of the HspBP1/Fes1 or the Bag family, which bind in a completely different 
manner than GrpE to the ATPase domain (Bimston et al., 1998; Gassler et al., 2001; Kabani 
et al., 2002a; Kabani et al., 2002b; Sondermann et al., 2001). Recently, a member of the yeast 
Hsp70 family, the Hsp110 protein Sse1 was shown to bind itself to cytosolic Hsp70s and to 
act as nucleotide exchange factor (Raviol et al., 2006). The binding and exchange mechanism 
of Sse1 onto Hsp70 is still unclear but seems to be activated in a nucleotide-driven process 
(Andreasson et al., 2008). 
Allosteric communication between both the NBD and SBD of Hsp70 is critical for the 
regulated interaction between chaperone and its substrate polypeptide. This process is 
strongly coupled in a nucleotide-/substrate controlled manner: ATP binding in the NBD 
induces conformational changes in the SBD leading to the transition from the high affinity to 
an open low affinity state. Conversely, substrate binding to the SBD in synergism with the 
JDP triggers ATP hydrolysis in the NBD, leading to a closing of SBD which traps the 
substrate. The mechanism by which this allosteric communication works on the structural 
level is still poorly understood. Biochemical studies including fluorescence, limited 
proteolysis, CD spectroscopy and small angle X-ray scattering (SAXS) of Hsp70 have given 
more insights into the coupling mechanism.  
SAXS measurements determined that ATP binding induces a significant reduction in the 
radius of gyration of both a bovine Hsc70 fragment (1-554) (Wilbanks et al., 1995) and full-
length DnaK (Shi et al., 1996). Further evidence is demonstrated by proteolysis studies, where 
ADP and ATP-bound states distinctly showed different cleavage patterns (Buchberger et al., 
1995; Liberek et al., 1991b).  
An important part of the interdomain communication mechanism is the hydrophobic linker 
between the ATPase domain and the β-sheets of the substrate-binding domain. Mutations of 
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the linker motif VLLL in DnaK abolish the substrate/Hsp40 induced stimulation of ATP 
hydrolysis and ATP-induced substrate release (Laufen et al., 1999).  
It is still enigmatic, how Hsp70 proteins interact with substrates in order to assist protein 
folding. There are at least two alternative modes of action possible (Mayer and Bukau, 2005). 
In the first mechanism, Hsp70s play a rather passive role. Through repetitive substrate 
binding and release cycles they keep the free concentration of the substrate low to prevent 
aggregation, while allowing free molecules to fold to the native state (kinetic partitioning). In 
the second mechanism, binding and release cycles induce local unfolding in the substrate 
which helps the substrate polypeptide to overcome kinetic barriers for native folding.  
 
1.2.2 The Hsp90 chaperone machinery 
 
The homodimeric 90 kDa heat shock proteins (Hsp90) are essential chaperones in all 
eukaryotic cells. They belong to the most abundant proteins making up about 1 – 2% of all 
cellular proteins under normal growth conditions and even more under heat shock conditions. 
The Hsp90 family of proteins is also evolutionary highly conserved with 60% sequence 
identity between yeast and human and 40% between E. coli and human members. Eukaryotic 
Hsp90 chaperones are global players in the signal transduction networks of the cell, 
interacting with numerous client substrates in a complex system together with Hsp70 
chaperones and a large number of co-chaperones. In yeast and human two cytosolic Hsp90 
proteins with 99% sequence identity are found, one of which is constitutively at high levels 
present (yeast Hsc82, human Hsp90β) and the second is produced under heat shock conditions 
(yeast Hsp82, human Hsp90α) under the control of the heat-shock transcription factor HSF-1. 
Other compartmentalized Hsp90 chaperones include the ER-resident Grp94 in higher 
eukaryotes or the mitochondrial TRAP1 which is a descendent of the bacterial Hsp90 protein 
HtpG. Hsp90 is essential for the survival of all eukaryotes tested, whereas HtpG knockouts 
results in no detectable phenotype. 
1.2.2.1 Cellular functions of Hsp90 
 
Although Hsp90 chaperones can bind misfolded proteins (Jakob et al., 1995), their main and 
essential function is to interact with native or near native proteins, so-called clients, most of 
them are regulatory components of signal transduction pathways such as steroid hormone 
receptors, protein kinases and transcription factors, controlling stability and activity of these 
proteins. Hsp90 chaperones are therefore involved in the regulation of cell homeostasis, cell 
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cycle, proliferation, differentiation, and programmed cell death. Up to now, more than 200 of 
such Hsp90 client substrates have been identified (see Tab. 1 for selected substrates) in 
interaction studies. Since the activity of many of those client proteins is important in 
hallmarks of cancer growth and survival, Hsp90 has become a central target for anti-cancer 
drug development.  
A recent genome-wide chemical-genetic screen in baker’s yeast combined with 
bioinformatics identified unknown functions of Hsp90 in cellular transport and the secretory 
pathway under normal conditions (McClellan et al., 2007). 
Tab. 1  Hsp90 substrate proteins  
 Protein 
Steroid hormone receptors (AR, ER, GR, MR, PR) 
HSF-1 
p53 
Transcription factors 
v-erbA 
Protein kinases Cdk2, Cdk3, Cdk4,Cdk9 
 ErbB2 
 Raf family kinases (v-Raf, c-Raf, B-Raf) 
 v-Src, c-Src 
 Aurora B 
 eIF-2α 
 Wee1 
 Hck, Lck 
Others Telomerase 
 Apaf-1 
 CFTR 
 Histones H1, H2A, H2B, H3, H4 
 Tubulin 
 Myosin 
 DNA-polymerase α 
Viral proteins SV40 large T antigen 
 Hepatitis B virus reverse transcriptase 
 AdV-CP 
 λP 
 HPV-E7 
See www.picard.ch/downloads/hsp90interactors.pdf for full list and references 
 
Apart from the function in various regulatory cellular processes, Hsp90s have been implicated 
as capacitors in morphogenic evolution allowing the phenotypically neutral accumulation of 
mutations by buffering their effects until stressful environmental conditions expose them to 
the forces of selection (Queitsch et al., 2002; Sangster et al., 2004). 
In addition to these functions, the cellular Hsp90 chaperone system seems to play an 
important role in the assembly and maturation of viral proteins in the host cell. Hsp90 
inhibitors have been shown to reduce the replication of several viruses in vitro (Geller et al., 
2007; Okamoto et al., 2006). 
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The bacterial Hsp90 protein HtpG (High temperature protein G) is, though structurally highly 
homologous to its eukaryotic family members, poorly characterized in terms of function and 
interaction to substrates. HtpG is already an abundant protein under normal conditions (0.35% 
of total protein) and becomes highly induced under heat shock conditions, being under control 
of the heat shock transcription factor σ32 (Heitzer et al., 1990). Deletion of the HtpG gene 
causes no detectable phenotype. Solely HtpG knockouts in cyanobacteria resulted in slightly 
impaired thermotolerance and intolerance against oxidative stress (Hossain and Nakamoto, 
2003; Tanaka and Nakamoto, 1999). In addition, no client substrates and co-factors of HtpG 
could be identified so far. 
1.2.2.2 Hsp90 structure 
 
The dimeric Hsp90 consists of three highly conserved domains: an N-terminal nucleotide 
binding domain (NBD), a middle domain (MD) and a C-terminal dimerization domain (DD) 
(Fig. 1.4a). In eukaryotes, a charged unstructured linker region of 50 to 60 residues inserts 
between the N- and M-domain, being poorly conserved and biologically dispensible (Pearl 
and Prodromou, 2006). In contrast to the prokaryotic HtpG, eukaryotic Hsp90 contain a C-
terminal EEVD motif which serves as the binding site for cytosolic co-chaperones containing 
TPR domains.  Structural information exists for the NBD of yeast and human Hsp90 in 
complex with different nucleotides and inhibitors, the MD of yeast Hsp90, the two domain 
construct of NBD plus MD of the E. coli homologue HtpG  and the DD of HtpG (Harris et al., 
2004; Huai et al., 2005; Prodromou et al., 1997a; Stebbins et al., 1997). Recently, an almost 
full-length construct of yeast Hsp90 in complex with the cochaperone Sba1/p23, a full-length 
structure of E. coli HtpG and a full-length structure of Grp94 were published (Ali et al., 2006; 
Dollins et al., 2007; Shiau et al., 2006).   
The first crystal structure of the N-terminal ATPase domain (NBD) of yeast Hsp82 was 
solved in 1997 and revealed a new type of binding site for ATP and for the inhibitor 
geldanamycin (Stebbins et al., 1997). The NBD contains an unusual adenine nucleotide-
binding pocket known as the “Bergerat” fold (Dutta and Inouye, 2000). The nucleotide is 
bound in a cleft formed by α-helices on top of an eight-stranded β-sheet (Fig. 1.4c). Binding 
induces a special kinked conformation of the nucleotide with the γ-phosphate being 
completely surface exposed. This fold and orientation shares homology with the superfamily 
of the GHKL-ATPases, including DNA-modifying proteins GyraseB, MutL and the histidine 
kinases CheA and EnvZ. All these related proteins contain a flexible structural element, the 
ATP ‘lid’, a loop consisting of two α-helices that claps over the nucleotide-binding pocket 
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when ATP is bound and forms a closed conformation. This lid seems to be one important 
conformational switch for the ATP hydrolysis function of Hsp90 and is also the binding site 
for co-chaperones like p23/Sba and Cdc37 (Ali et al., 2006; Roe et al., 2004; Zhang et al., 
2004).  The middle domain (MD) consists of a large and a small α-β-α-domain connected by 
a helical coil. The yeast Hsp82 MD could be crystallized in complex with the co-chaperone 
Aha1 (Meyer et al., 2004). In analogy to the GHKL-ATPases MutL and GyrB, the middle 
domain contains a catalytic loop with an arginine (Arg380 in yeast Hsp82) that interacts with 
the γ-phosphate of ATP bound in the N-terminal domain and promotes ATP hydrolysis. Two 
elements in the middle domain were further implicated in binding to client proteins, an 
exposed hydrophobic patch surrounding Trp300 and an amphipathic loop (residues 329–339). 
Mutations in this loop region showed severe effect in the maturation of v-Src kinase (Meyer 
et al., 2003). 
 
Fig. 1.4 (a) Domain structure representation of Hsp90 homologs.  Eukaryotic Hsp90 proteins contain a 
charged flexible linker between the N-terminal nucleotide binding domain (NBD) and the middle domain (MD), 
and a dimerization domain (DD) which harbours the C-terminal MEEVD motif for binding TPR co-chaperones. 
The charged linker is absent in the prokaryotic HtpG (b) Crystal structure of the yeast Hsp82 in complex with 
the non-hydrolysable ATP analogue AMPPNP and p23/Sba1 (PDB 2CG9).  One protomer of the dimer is 
shown in color reflecting the domains specified in (a), Sba1 was omitted for clarity. The N-terminal strand 
exchanges via hydrogen bonding with the other protomer, forming a N-terminal closed conformation  (c) 
Secondary structure representation of yeast Hsp82 nucleotide binding domain in complex with ADP (PDB 
1AM1). Shown in blue is the conformation of the lid that closes over the nucleotide binding pocket upon ATP 
binding. 
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The C-terminal domain is essential for the dimerization of a functional Hsp90 molecule 
(Minami et al., 1994). The crystallized HtpG C-terminal structure is a dimer of mixed α/β 
domain (Harris et al., 2004). The dimer interface is formed by a pair of helices at the C-
terminal end of the domain packing together to create a four-helix bundle. An exposed and 
flexible amphipathic helix (HtpG residues 549-558) was suggested to play a role in client 
protein binding (Harris et al., 2004). Several reports provided evidence for a second putative 
ATP-binding site in the C-terminal domain of Hsp90 which is also the suggested binding site 
for the drugs novobiocin and cis-platin (Garnier et al., 2002; Marcu et al., 2000; Soti et al., 
2002). All available structures cannot resolve the last 30 amino acids including the C-terminal 
MEEVD TPR domain-binding sequence in eukaryotic Hsp90s, because this region is largely 
disordered. 
The chaperone function of Hsp90 is closely coupled to its ATPase activity. In the yeast 
Hsp90, the two N-terminal domains undergo conformational changes to become closely 
associated in the ATP bound state, but not in the apo or ADP-bound state. Together with the 
constitutive C-terminal dimerization, the Hsp90 dimer forms then a closed “molecular clamp” 
which is supposed to entrap client substrates (Prodromou et al., 2000).  
The first view of the ATP-bound conformation of a full-length Hsp90 came from the co-
crystal structure of yeast Hsp82 with the co-chaperone p23/Sba and the non-hydrolysable 
ATP analogue AMPPNP (Ali et al., 2006) (Fig. 1.4b). This closed structure could only be 
obtained when the charged flexible linker between N-and M-domain was deleted. The two 
molecules in the Hsp90 dimer twist around each other, interacting via a constitutive dimer 
interface at the C-terminus and a transient N-terminal dimerization via a strand-swap of the 
most N-terminal strand to the other protomer. This conformation is only possible by a large 
rearrangement of the ATP lid in the nucleotide binding pocket. As a second “switch”, the 
catalytic loop of the MD remodels to form direct contacts between the catalytic Arg380 with 
the γ-phosphate of the bound nucleotide in the NBD to promote hydrolysis. Interestingly, the 
co-chaperone p23/Sba binds to both of these switches, the exposed surface of the lid and the 
catalytic residues of the middle domain, and thus stabilize the closed conformation and slows 
down the ATP hydrolysis.  
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Fig. 1.5 Conformation of  currently available full-length structures of Hsp90 and homologues. The closed 
N-terminally dimerized state is only observed in the ATP-bound conformation of yeast Hsp90 (PDB code 
2CG9). GRP94 forms a open V-shaped dimer in either ADP or the ATP bound state (PDB code 2O1U). The 
prokaryotic Hsp90 homologue HtpG could be resolved in a flexible open apo-state (PDB code 2IOQ) and a 
compact ADP-state (PDB code 2IOP).  
 
Crystal structures and negative stain electron micrographs of the intact E. coli HtpG reveal 
dramatic conformational changes upon nucleotide binding (Shiau et al., 2006). The apo HtpG 
structure has high conformational flexibility and forms an open V-shaped dimer (Fig. 1.5). In 
contrast, the ADP bound state appears to be more compact and is proposed to undergo large 
rigid body movements of the domains around two hinges to form a more twisted dimer with 
the N-terminal regions approached to each other. However, these conformations are strongly 
influenced by crystal lattice contacts (Fig. 1.5). The asymmetric unit of the ADP bound HtpG 
crystal contains a tetramer of two interlocked, inverted dimers and the biological relevance of 
this state is questionable. Recent full-length structures of the ER-resident Grp94 in complex 
with ADP or the ATP analogue AMPPNP revealed almost identical open twisted V-shaped 
conformations (Dollins et al., 2007) (Fig. 1.5).  In contrast to the yeast Hsp90, the ATP-bound 
state seems to populate the more open N-terminal state which is reflected in a slower 
uncoupled ATP hydrolysis rate. The existence of the fixed closed conformation in the ATP-
bound state may also be dependent on the presence of co-chaperones and the presence of the 
flexible charged linker which is deleted in all crystallized constructs.  
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1.2.2.3 Hsp90 chaperone cycle  
 
Hsp90 function in client activation and maturation is highly dependent on binding and 
hydrolysis of ATP (Obermann et al., 1998; Panaretou et al., 1998) which drives a dynamic 
conformational cycle that involves interactions with the Hsp70 system and an increasing 
number of co-chaperones (Fig. 1.6). 
 
 
Fig. 1.6 Hsp70/Hsp90 chaperone cycle postulated for steroid hormone receptor (SHR) as a client. SHR first 
interacts with Hsp40 and Hsp70 in an early complex and is then transferred via the adaptor co-chaperone Hop to 
Hsp90 to form an intermediate complex. As a next step, the co-chaperones p23 and immunophilins lead to 
dissociation of Hop and Hsp70 and build the mature Hsp90 complex. Upon ATP hydrolysis of Hsp90, SHR 
becomes competent for hormone binding and is than able to activate gene transcription in the nucleus. 
Unproductive folding or maturation of the client leads to re-entering in the cycle or to substrate ubiquitination 
mediated by the E3 ligase CHIP and targeting to the ubiquitin-proteasome pathway. Competitive Hsp90 
inhibitors like geldanamycin (GA) block the formation of the mature complex and cause degradation of the 
client controlled by CHIP. 
 
 
Hsp90 cooperates in its chaperone cycle with co-chaperones including Cdc37, p23, Aha1, and 
the TPR containing proteins Hop (Hsp70-Hsp90-organizing protein), the phosphatase PP5, 
and the immunophilins FKBP51, FKBP52 and Cyp40. Some of these cochaperones like 
Cdc37 and Hop are important for client binding to Hsp90 respectively transfer from Hsp70 to 
Hsp90. Others like Aha1 and p23 regulate the ATPase cycle of Hsp90. The TPR containing 
proteins compete for binding to the C-terminal EEVD motif of Hsp90 thereby influencing 
progression through the chaperone cycle (Mayer et al., 2002; Pearl and Prodromou, 2001; 
Pratt and Toft, 2003). 
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Mostly through studies using steroid hormone receptors (SHR) as clients a progressive 
chaperone cycle for Hsp90 was established (Pratt and Toft, 1997; Smith, 2000). The 
unliganded hormone receptor first interacts with the Hsp70 chaperone and its J-domain 
cochaperone in an ATP hydrolysis dependent step (Hernandez et al., 2002). Coordinated by 
the TPR protein Hop, which binds to the C-termini of Hsp70 and Hsp90 at the same time, an 
intermediate Hsp90-Hsp70-client complex is formed. Hop and Hsp70 are replaced by p23 and 
immunophilins to form the mature complex. This step depends on ATP binding to Hsp90. The 
mature complex leads to an active SHR which is competent for hormone binding. Hormone 
binding results in the release of the SHR and transcriptional activation of target genes in the 
nucleus. In the absence of hormone, the mature complex decays with a half-life of about 5 
min (Smith and Toft, 1993) in an ATP hydrolysis dependent step (Young and Hartl, 2000). 
The released client reenters the cycle by binding to Hsp70. Other clients of the Hsp90 system 
depend on additional cochaperones like Cdc37, which is important for protein kinases.  If 
maturation of client substrates cannot proceed through the chaperone cycle due to misfolding 
or blockage of Hsp90 by inhibitors, the client accumulates in the intermediate complex and is 
targeted to degradation via the ubiquitin-proteasome pathway by the E3-ubiquitin ligase 
CHIP. 
The kinetics of the ATPase cycle of yeast Hsp90, human Hsp90, Grp94 and TRAP1 has been 
analyzed in more detail in biochemical and structural studies (Frey et al., 2007; Leskovar et 
al., 2008; McLaughlin et al., 2002; Weikl et al., 2000). Based on the structurally related 
GHKL-ATPases DNA gyrase B and MutL the ATPase cycle of Hsp90 is proposed to involve 
several conformational changes including ATP-dependent docking of NBD and MD of the 
same monomer and a dimerization of the two NBDs in the Hsp90 dimer resulting in a ring-
shaped “closed” structure (Fig. 1.5) (Ali et al., 2006; Pearl and Prodromou, 2001). Evidence 
for such conformational changes was also found in the kinetics of ATP hydrolysis of wild-
type and mutant proteins in yeast Hsp90 but is still disputed for the human homologue 
(McLaughlin et al., 2004; Richter et al., 2001). NMR studies of wild-type and truncated 
NBDs in the absence and presence of different nucleotides and inhibitors suggested ligand-
induced conformational changes in this domain and changes linked to the ATPase cycle 
(Dehner et al., 2003; Richter et al., 2006).  The slow hydrolysis rate of Hsp90 (1 ATP/min for 
yeast Hsp90 and 0.05 ATP/min for human Hsp90) suggest the slow formation of the dimeric 
state of N-terminal domains prior to hydrolysis, presenting the rate-limiting step in the cycle. 
The Hsp90 ATPase activity is further regulated by the transient association with the various 
co-chaperones. The co-chaperone p23/Sba1 inhibits the ATPase activity, arresting the Hsp90 
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cycle to trap client proteins (McLaughlin et al., 2006; Richter et al., 2004; Siligardi et al., 
2002), while the partner protein Aha1 strongly stimulates the ATPase activity (Panaretou et 
al., 2002).  
How the coordinated ATPase cycle of Hsp90 is coupled to client activation or processing is 
poorly understood. Client binding seems to stimulate the Hsp90 ATPase activity significantly, 
as shown for the ligand binding domain of the glucocorticoid receptor (McLaughlin et al., 
2002). However, the binding sites and the effects of the Hsp90 interaction to client proteins 
remain unknown. The first glimpse of Hsp90 in a complex with a client protein delivered an 
EM structure of Hsp90 bound to the protein kinase Cdk4 together with the kinase-specific 
cochaperone Cdc37 (Vaughan et al., 2006). An electron-micrographic reconstruction of this 
complex revealed an interaction of the Cdk4 lobes to the NBD and the MD of only one Hsp90 
protomer.  
1.2.2.4 Hsp90 inhibitors and cancer treatment 
 
The importance of ATP hydrolysis in Hsp90 became evident by the discovery of the 
ansamycin antibiotic geldanamycin (Whitesell et al., 1994) and the macrolide radicicol 
(Schulte et al., 1998) (Fig. 1.7). Challenging cells with these natural product inhibitors 
resulted in a variety of phenotypes caused by the impaired cellular maturation of various 
Hsp90 clients. Crystal structures demonstrated clearly that geldanamycin (GA) and radicicol 
are competitive inhibitors that act by selectively docking in the N-terminal nucleotide binding 
site (Roe et al., 1999; Stebbins et al., 1997) of Hsp90, thereby inhibiting the intrinsic ATPase 
activity and thus blocking the formation of the mature client complex. These client proteins 
are then targeted for ubiqitination and proteasomal degradation. The finding of Hsp90 
inhibitors led to an explosion of discoveries in the Hsp90 pathway which identified many 
client proteins and co-chaperones. Many of these client proteins are involved in oncogenic 
processes including all hallmarks of cancer (Neckers, 2007), making Hsp90 a potential drug 
target for anti-cancer treatment (Whitesell and Lindquist, 2005). Clinical trials with 
derivatives of GA and newly developed small-molecule inhibitors are ongoing.  
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Fig. 1.7 Examples of the three main classes of Hsp90 inhibitors. Geldanamycin derivatives 17-AAG and 17-
DMAG have entered clinical trials. GA and the water-soluble purine-scaffold inhibitor PU-H71 were used in this 
study. 
 
Geldanamycin (GA) as a benzoquinone ansamycin binds to the human Hsp90 nucleotide 
binding pocket in an unusual C-shaped conformation via strong hydrophobic van-der-Waals 
interactions and via a direct hydrogen bond between the Asp93 (in yeast Asp79) and the 
carbamate group of geldanamycin (Stebbins et al., 1997) and indirect hydrogen bonding to 
water molecules. Although GA has an affinity in vitro in the low micromolar range, it was 
found that GA preferentially accumulates in cancer cells (Chiosis et al., 2003a; Kamal et al., 
2003), exhibiting low nanomolar anti-proliferative activity in vivo. The explanation for these 
differences is still under debate. One explanation for the preferential binding of GA to Hsp90 
in cancer cells is that more Hsp90 is engaged in active multi-chaperone complexes which 
might have a higher affinity for GA than un-complexed Hsp90 in normal cells (Kamal et al., 
2003). Recent data suggest two alternative mechanisms for the in vivo efficiency of 
geldanamycin. The first suggests a reducing event of the quinone moiety in vivo which 
increases the binding affinity of GA (Maroney et al., 2006). In the second mechanism, Hsp90 
was suggested to undergo a slow conformational change upon binding to GA, leading to an 
increased affinity for tumour-specific Hsp90 (Gooljarsingh et al., 2006). While geldanamycin 
has limitations for clinical development including limited oral bioavailability, low solubility 
and liver toxicity, the semisynthetic analogue 17-allylaminogeldanamycin (17-AAG) and the 
more soluble 17-dimethylaminoethylamino-demethoxygeldanamycin (17-DMAG) have 
displayed promising activity in clinical trials (Pearl et al., 2008). 
Structure-function based design led to development of a series of synthetic small-molecule 
Hsp90 inhibitors with markedly improved drug-like properties.  The first of these were the 
purin-scaffold inhibitors designed by Chiosis and co-workers (Chiosis et al., 2003b; Solit and 
Chiosis, 2008) which combine the structure of the adenine moiety of ADP and the C-shaped 
conformation of the natural inhibitors geldanamycin. Co-crystal structures with the first 
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generation purin-scaffold inhibitor PU3 showed binding like ADP, but the compounds 
induced a conformational change in the ATP binding site, opening a lipophilic pocket in a 
unpredicted way (Wright et al., 2004). Subsequent studies led to the design of a range of 
potent and soluble purine-scaffold inhibitors (e.g. PU-H71) with good activities in animal 
models (He et al., 2006; Zhang et al., 2006)(Fig. 1.7). 
Workman and colleagues used a high-throughput screen based on inhibition of Hsp90 ATPase 
activity to identify 3,4-diarylpyrazoles as a novel class of Hsp90 inhibitors (Cheung et al., 
2005; Dymock et al., 2005). The bacterial gyrase antibiotic novobiocin, a member of the 
coumeromycin family, and cis-platin have been shown to be potent Hsp90 inhibitors, however 
differently acting by binding to the C-terminus of Hsp90 (Marcu et al., 2000). The 
biochemical basis for the inhibitory effect of novobiocin is unclear. 
1.2.3 TPR Co-chaperones 
 
The majority of Hsp90 co-chaperones interact with the Hsp90 C-terminus through 
tetratricopeptide (TPR) repeat motifs (Smith, 2004). TPR repeats are degenerated sequence 
motifs of 34 amino acids that often occur repetitively and mediate protein-protein interactions 
found in all kingdoms of life (D'Andrea and Regan, 2003). Most of the investigated TPR 
domains contain 3.5 tetratricopeptide repeats each forming a conserved helix-turn-helix motif 
(Das et al., 1998).  The best characterized TPR co-chaperones are the Hsp70/Hsp90 adaptor 
protein Hop, the proline isomerases FKBP51 and FKBP52, protein phosphatase 5 (PP5) and 
the E3 ubiquitin ligase CHIP. The structure and function of two TPR containing chaperones, 
Hop and CHIP, will be described below. 
1.2.3.1 Hsp70/Hsp90 organizing protein (Hop) 
 
The dimeric co-chaperone Hop (Sti1p in yeast) has been identified by specific interaction 
with Hsp90-containing steroid hormone receptor complexes (Smith and Toft, 1993). The 
60 kDa protein consists of three TPR domains with three tandem repeats each, and two 
domains which are enriched in aspartate-proline repeats (DP1 and DP2) (Fig. 1.8a). Based on 
structural and genetic data it is known that the N-terminal TPR1 domain binds specifically the 
Hsp70 C-terminus, and TPR2a binds to Hsp90 but needs the cooperation with TPR2b 
(Brinker et al., 2002; Scheufler et al., 2000) (Fig. 1.8b). The function of the DP regions is not 
clear yet. The ability to bind both the chaperones simultaneously enables Hop to function as 
an adaptor connecting Hsp70-client complexes with Hsp90 and mediate the transfer of 
substrates on Hsp90 to form an intermediate complex (Pratt and Toft, 2003; Wegele et al., 
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2006). In addition to binding to their C-termini, Hop/Sti1 can influence the ATPase activity of 
the chaperones, by inhibiting the ATPase activity of yeast Hsp90 (Prodromou et al., 1999; 
Richter et al., 2003) but stimulating the ATPase of yeast Hsp70 protein Ssa1 (Wegele et al., 
2003). None of these effects are observed for the human Hsp90 system indicating that the 
regulation of the Hsp90 system underwent evolutionary changes. The cellular localization of 
the mainly cytosolic Hop is posttranslationally controlled by phoshorylation in vivo. 
Phosphorylation promotes nuclear localization whereas dephosphorylation mediates 
cytoplasmic retention (Daniel et al., 2008; Longshaw et al., 2004). 
 
 
 
 
Fig. 1.8 Domain organization and cystal structures of the TPR-containing co-chaperones Hop/Sti1 and 
CHIP.  (a) 60 kDa adaptor protein Hop contains three TPR domains with three TPR repeats each, TPR1 binds 
exclusively Hsp70, while TPR2a/b bind Hsp90. 35 kDa protein CHIP has an N-terminal TPR domain that binds 
both Hsp70 and Hsp90, and a C-terminal U-box domain that cooperates with E2 ligases in substrate 
ubiquitylation. (b) Crystal structure of the middle TPR domain 2a of Hop in complex with the Hsp90-
pentapeptide MEEVD shown in stick representation (PDB code 1ELR). One TPR repeat consists of a helix-turn-
helix motif. (c) Crystal structures of CHIP showing different homodimeric assemblies. Mouse CHIP dimer (PDB 
code 2C2L, left) complexed to MEEVD-peptide was found to form an asymmetric dimer, zebrafish CHIP 
lacking the TPR domain (PDB code 2F42, right) crystallized as a symmetric dimer. 
 
1.2.3.2 The E3 ubiquitin-ligase CHIP 
 
The C-terminus of Hsc70-interacting protein (CHIP) is a co-chaperone that links Hsc/Hsp70 
and Hsp90 to protein degradation as a complementary function to protein stabilization and 
refolding in protein quality control (Arndt et al., 2007). CHIP is a multidomain protein 
composed of an N-terminal TPR domain, a middle domain and a U-box domain which is 
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typical for a RING-finger type E3 ligase involved in the ubiquitination cascade (Pickart, 
2001) (Fig. 1.8a). Unlike the HECT domain E3 ligases which play an active role in 
ubiquitination, E3’s containing RING domains (zinc-finger really new interesting gene) 
enable the direct transfer of ubiquitin chains from the E2 ubiquitin-conjugating enzyme to the 
substrate lysine side chain, serving as a scaffold. The U-box of CHIP selectively cooperates 
with members of the UbcH4 and UbcH5 family that are stress-activated (Demand et al., 2001; 
Jentsch et al., 1990; Jiang et al., 2001; Murata et al., 2001) and possess a conserved Ser-Pro-
Ala sequence that is required for interaction with CHIP. These canonical ubiquitin-
conjugating enzymes link polyubiquitin chains via the Lys48 to the mono-ubiquitinated 
substrate to form a typical proteasomal degradation signal. Recently, the heterodimeric E2 
complex Ubc13-Uev1a was found to interact to CHIP and could be crystallized as a complex 
(Zhang et al., 2005). Ubc13-Uev1a forms an E2-conjugating enzyme that facilitates non-
canonical Lys63 polyubiquitination which seems not to play a role as protein degradation 
signal but rather modifies the activity of substrates. 
Full-length mouse CHIP (23-303) could be crystallized in complex with a C-terminal Hsp90 
peptide and revealed a dimeric assembly with an asymmetric arrangement, showing one 
protomer with an elongated helix and the other protomer with a partially unfolded helical 
hairpin within the middle domain (Zhang et al., 2005) (Fig. 1.8c). The middle domain 
harbours the most critical interfaces for dimerization which was shown to be important for 
CHIP’s function in ubiquitination (Nikolay et al., 2004). In contrast to Hop/Sti1, CHIP binds 
both C-termini of the chaperones unselectively to the same TPR. The crystal structure of the 
CHIP-peptide complex revealed that the peptide is bound in a curled conformation in which 
only the common (M/I)EEVD sequence is in contact with the TPR domain, allowing to bind 
different types of chaperones.  A recent crystal structure of zebrafish CHIP lacking the TPR 
domain differs substantially from the mouse CHIP structure, showing a symmetric dimer 
assembly with elongated helices in the middle domains (Xu et al., 2006). 
Overproduction of CHIP in vivo targets a diverse group of different chaperone clients for 
degradation (Arndt et al., 2007). These include members of the steroid hormone receptor 
family, protein kinases (e.g. the oncogenic receptor tyrosine kinase ErbB2) and members of 
the Smad family of TGF-β signal transducers and the tumour suppressor protein p53. Another 
important class of substrates are aggregation-prone proteins implicated in various 
neurodegenerative diseases and pathologies that are recognized by chaperones during protein 
quality control. Among these substrates are the cystic fibrosis transmembrane-conductance 
regulator (CFTR), hyperphosphorylated tau protein (Alzheimer’s disease), α-synuclein 
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(Parkinson’s disease) and the polyglutamine-repeat protein huntingtin. Overexpression of 
CHIP has a significant protective effect on the formation of aggregates and promotes the 
clearance of aggregates. 
Nevertheless, how CHIP’s decision making process between chaperone folding and targeting 
to proteasomal degradation is regulated is still unclear. 
 
1.3 Biomolecular Mass Spectrometry 
 
 
Mass spectrometry (MS) has become an indispensable analytical tool in many areas of 
science and technology. In mass spectrometric analyses, the mass-to-charge ratios (m/z) of 
gas-phase ions are determined. The technique was first introduced in the pioneering work of 
Thomson (Thomson, 1913), and has since then been an important tool for the discovery of 
elements and isotopes, the exact determination of atomic and molecular weights and the 
investigation of chemical reaction mechanisms. By definition, a mass spectrometer consists of 
three main parts: (1) an ion source which volatizes and ionizes the analyte into the gas-phase, 
(2) a mass analyzer and (3) an ion detector that registers the number of ions at each m/z value. 
 
Fig. 1.9 Principal components of a mass spectrometer. Elements shown in gray are used in tandem MS 
measurements to generate fragment ion spectra. 
 
With the introduction of “soft ionization” techniques of matrix-assisted laser desorption/ 
ionization (MALDI) and electrospray ionization (ESI), mass spectrometry has become a 
powerful tool for the study of intact biomolecules, especially in protein and peptide analysis, 
but also in lipid, sugar and oligonucleotide analytics. 
For MALDI-MS analysis, the analyte is co-crystallized with an UV-absorbing compound, 
referred to as the ‘matrix’ (e.g. 4-hydroxy-α-cyanocinnamic acid, HCCA), and applied to a 
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target plate (Kussmann and Roepstorff, 2000). Ionization and vaporization of the embedded 
analyte is achieved by a pulse of a UV laser under vacuum. This results in the formation of 
predominantely singly charged protonated molecular ions (MH+) by mechanisms which are 
still poorly understood (Karas and Kruger, 2003; Zenobi and Knochenmuss, 1999). Laser 
desorption is an efficient process for producing gaseous ions and tolerates varying levels of 
contaminants, e.g. salts. MALDI-MS has the advantage of easy and fast sample preparation, 
which allows automation and a high sensitivity, but can have the problem of non-
reproducibility of matrix conditions and the limited possibility of separating different 
analytes. 
In the electrospray ionization (ESI) process, the polar analyte in a volatile solvent is delivered 
through a small capillary which is held under a high electric potential. The voltage applied to 
the tip generates an aerosol of charged analyte-containing droplets. Solvent evaporation leads 
to formation of smaller droplets driven by repulsive Coulombic forces between charged 
molecules until free ions are present and extracted to the high-vaccum of the mass analyzer. 
The exact mechanism of ion formation, whether it be by ion evaporation (ion-evaporation 
model) (Iribarne and Thomson, 1976; Thomson and Iribarne, 1979) or by complete solvent 
removal (charge-residue model) (Dole et al., 1968; Schmelzeisen-Redeker et al., 1989) from 
the charged droplet is under debate. 
In contrast to MALDI, electrospray generates ions at atmospheric pressure and results in the 
formation of multiple charged analyte ions and thus can produce more complicated spectra. 
Since ESI is a continuous process, it can be coupled easily to high-performance liquid-
chromatography (HPLC) systems. ESI is a concentration- rather than a mass-dependent 
process and improved sensitivity can be obtained for high-concentration samples with low-
volume. This led to the development of Micro- (100-1 µl/min) and Nano-flow (100-1 nl/min) 
systems with excellent sensitivity which are often used for biomolecular MS (Wilm and 
Mann, 1996). 
Mass analyzers are the central part of the MS technology. Four basic types of mass analyzers 
are common in biological MS: ion trap, time-of-flight (TOF), quadrupole and Fourier 
transform ion cyclotron (FT-MS) analyzers. All these analyzers are different in design and 
performance in terms of the key parameters sensitivity, resolution, mass accuracy and the 
ability to generate fragment spectra (tandem MS or MS/MS) (Aebersold and Mann, 2003).  
The mass spectrometer mainly used in this work was an ESI-quadrupole-TOF instrument 
(Fig. 1.10). In this setup, the ions are first selected in a quadrupole mass filter by applying a 
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particular sinusoidal potential (a combination of DC voltages and radiofrequency RF 
voltages) on four diagonally connected electrodes. The ions which are transmitted on a stable 
trajectory pass into a second quadrupole, the collision cell, and can herein be fragmented into 
smaller ions by collision-induced dissociation (CID) with an inert collision gas (argon or 
nitrogen). The mass of the ions generated in such an MS/MS experiment is then measured by 
the combined orthogonal time-of-flight (TOF) analyser. In the TOF instrument, the ions of 
different m/z are dispersed in time during their flight along a field-free drift path of known 
length. An electrostatic reflector acts as an ion mirror that focuses ions of different kinetic 
energies in time and improves the mass resolution (Mamyrin et al., 1973).  
 
Fig. 1.10 Setup of a ESI-quadrupol-TOF (Q-TOF) hybrid mass spectrometer coupled to LC-electrospray 
source.  Ions generated in the electrospray process are transmitted and filtered through are quadrupole (Q1) into 
a collision cell (q2) which can fragment the parent ion by CID (MS/MS). The parent and fragment ions are then 
analyzed in an orthogonal time-of-flight (TOF) analyzer and detected by a electron multiplier. 
 
The ion detector is usually a secondary electron multiplier (SEM) consisting of metal 
dynodes. In TOF type instruments the ion beam is not as focused and several miniaturized 
electron multipliers, so-called microchannel plates, are used to improve the detection. 
A key application of ESI and MALDI mass spectrometry is the protein identification and 
quantification for proteome research. Mass spectrometric protein identification usually 
involves the analysis of peptides produced by digesting the protein mixture of interest or a gel 
band with a proteolytic enzyme, e.g. trypsin (Steen and Mann, 2004). These peptides are 
introduced into a one-dimensonal (LC) or multi-dimensional (LC/LC) liquid-chromatography 
system and eluted into an ESI tandem mass spectrometer. After generating a mass spectrum 
of the eluting peptides, parent peptide ions are isolated and then fragmented by CID in the 
collision cell. The mass-to-charge ratios of the resultant fragments produce a MS/MS 
spectrum of the parent peptide ion which can reveal the amino acid sequence of the precursor 
ion. Low-energy CID usually leads to the fragmentation of peptides on the amide backbone, 
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resulting mainly in ions called b-ions when the charge is retained by the N-terminus or y-ions 
when the charge is retained by the carboxy-terminus (Biemann, 1992; Roepstorff and 
Fohlman, 1984).  
The final step of a proteomic MS experiment is the data analysis of the obtained mass spectra. 
One approach for identifying the protein is the peptide mass fingerprint (PMF) which 
compares specifically proteolytic cleaved peptides masses with in silico calculated masses of 
the theoretical digests of protein sequences in databases (Henzel et al., 2003). Two different 
methods using MS/MS data from peptides are currently applied for protein identification. One 
approach uses experimental tandem mass spectra and compares the data obtained by MS/MS 
with in silico generated product ion spectra of theoretical proteolytic peptides of all the 
proteins contained in a database. In these cases, the significance of the protein identification is 
either based on autocorrelation (SEQUEST algorithm, (Eng et al., 1994)) or on probability-
based matching (MASCOT, (Perkins et al., 1999)). The other approach is the peptide 
sequence tag algorithm which makes use of a short partial sequence information, the total 
mass of the peptide and the protease specificity (Mann and Wilm, 1994). 
Mass spectrometry has become the dominant method for proteomics research including the 
study of protein function, protein-protein interactions, posttranslational modifications and the 
quantification of proteins and peptides in complex samples (Aebersold and Mann, 2003; 
Cravatt et al., 2007; Domon and Aebersold, 2006). In addition, MS has developed to an 
important technique to investigate protein structure and conformation. It can be used to 
determine the stoichiometry, the assembly and the dynamics of macromolecular complexes 
(Hernandez and Robinson, 2007; Sharon and Robinson, 2007) or to identify protein-protein 
interaction sites after chemical crosslinking and proteolytic digestion (Vasilescu and Figeys, 
2006). In this study, mass spectrometry was used to probe protein conformation and dynamics 
in combination with amide hydrogen exchange experiments. 
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1.4 Amide Hydrogen Exchange 
 
1.4.1 Hydrogen exchange mechanism 
 
Amide hydrogen exchange (HX) has become a valuable tool for understanding protein 
dynamics and structure. Although conventionally used with NMR spectroscopy, mass 
spectrometry has developed as an important technique to monitor hydrogen exchange in 
proteins. Hydrogen atoms in proteins in NH-, OH- and SH- groups are “labile” and in 
continuous exchange with the solvent. These protons can be exchanged with deuterium (2H) 
under suitable conditions (Fig. 1.11a). Amide hydrogens of the polypeptide linkages are of 
particular importance because they exchange in a measureable kinetics (100 ms-10 s) at 
pD 7.0 while the hydrogens attached to functional groups in side chains and on the ends of the 
protein exchange too rapidly to be measured. An amide proton can only undergo exchange if 
it is (1) accessible to the solvent and (2) if it is not involved in hydrogen bonding. Thus, the 
rate at which backbone amide hydrogens exchange with solvent deuterons is highly dependent 
on the protein conformation and secondary structure.  
 
Fig. 1.11 Mechanism of intrinsic hydrogen exchange. (a) Principal reaction of deuterium transfer from D2O to 
an amide with the intrinsical chemical exchange rate (kint) (b) term that describes the pH dependence of the 
intrinsical exchange rate constant kint (c) rate constants for amide hydrogen exchange in an unstructured peptide 
as a function of pH. Results were calculated for polyalanine at 25°C using equation in (b) and values of kOH-, 
kH3O+, kH2O taken from (Bai et al., 1993)  
 
The intrinsical exchange rate constant kint describes the exchange rate for an amide proton in 
an unfolded, freely exposed peptide (Fig. 1.11b). Since the deuterium exchange is a base- and 
acid-catalyzed process, kint is dependent on the pH. Fig. 1.11c illustrates the relationship 
between the exchange rate constants and the pH for a given peptide. For each change in pH 
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unit kint changes one order of magnitude. The minimum exchange rate is at pH 2.5 to 3. At 
physiological pH, the exchange is predominantely base-catalyzed. The hydrogen exchange 
rate is also a temperature-dependent process following the Arrhenius equation. As a 
consequence, the rate of base-catalyzed hydrogen exchange can be further decreased by one 
order of magnitude when the temperature is lowered from 25°C to 0°C. In addition to their pH 
and temperature sensitivity, amide proton exchange rates are also affected by steric and 
inductive effects of the amino acid neighbours. Using model peptides, Bai et al. could 
quantitatively assess the neighbouring side-chain effects on the exchange rate. This NMR 
study enabled the calculation of intrinsic exchange rates in peptides based on the amino acid 
sequence. 
In folded proteins, amide protons are protected due to hydrogen bonding or burial in the 
native structure and thus have much slower exchange rates than unfolded polypeptides. In a 
fully folded, native protein, amide hydrogen exchange rates (kex) may be eight orders of 
magnitudes smaller than the rates in the unfolded, random structure (Englander and 
Kallenbach, 1983). Hydrogens may exchange directly from solvent at unprotected amides or 
by reversible protein unfolding (Kaltashov and Eyles, 2002). As a result, the observed 
exchange rate kex is determined by both reactions. In a commonly accepted model, 
Linderstrøm-Lang proposed a two-state situation in which protected amide hydrogens can 
only exchange after a closed-to-open transition (Hvidt and Nielsen, 1966; Linderstrøm-Lang, 
1956). 
 
Fig. 1.12 Model of hydrogen exchange in proteins according to Linderstrøm-Lang. 
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Here, kop and kcl are the kinetic rate constants for the unfolding (opening) and refolding 
(closing) reactions, respectively. Exchange takes place only after opening, which breaks 
intramolecular hydrogen bonds, thereby exposing amide hydrogens to D2O in the medium. 
This step is irreversible due to a high excess of solvent D2O and its rate is identical with the 
intrinsical chemical exchange rate kint from unstructured peptides which can be calculated 
(Bai et al., 1993).   
Under steady-state conditions, the experimentally measured exchange rate constant kex can be 
defined as: 
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The simplication is based on the assumption that the refolding for native proteins is much 
faster than the opening (kcl>>kop).  
There are two limiting cases for this equation. Under EX2 (bimolecular exchange) conditions, 
the closing reaction is much faster than the intrinsic chemical exchange (kcl >> kint) and most 
sites must visit many times the open conformation before they undergo exchange. The overall 
exchange rate is given by 
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where Kop is the equilibrium constant for the unfolding (opening) reaction.  The free energy of 
stabilization of the unfolding process can then be calculated as 
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Under EX1 conditions (monomolecular exchange), the closing rate is much slower than the 
intrinsical chemical exchange rate (kcl << kint) and the experimental exchange rate correlates 
with the opening rate as follows 
(EX1)     opex kk =  
As a result, the EX1 exchange rate is a direct measure of the rate of protein unfolding and is 
often referred as correlated exchange (Hvidt and Nielsen, 1966).  While most protein amides 
exchange under physiological conditions via the EX2 mechanism, EX1 is usually observed 
under destabilizing conditions like in the presence of chemical denaturants or extreme pH. 
Some proteins may contain regions that undergo EX1 and EX2 kinetics simultaneously. 
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1.4.2 Amide hydrogen exchange and mass spectrometry (HX-MS) 
 
Traditionally, HX has been measured with multidimensional NMR spectroscopy to study 
protein dynamics (Bougault et al., 2004; Dempsey, 2001). In NMR experiments, the exchange 
rates of individual amides can be studied, but the method requires high concentrations of 
sample protein and is usually limited to proteins smaller than approximately 30 kDa. HX 
coupled to MS has become a powerful new tool to monitor protein dynamics and 
conformational changes (Hoofnagle et al., 2003; Kaltashov and Eyles, 2002; Konermann and 
Simmons, 2003; Wales and Engen, 2006). Since the mass difference between the isotopes 
hydrogen (1H) and deuterium (2H) is 1 Da, changes in deuteron incorporation in a protein can 
be detected by mass differences in MS. In contrast to NMR, MS data are not averaged over all 
molecules in the sample and allows the monitoring of the HX behaviour of co-existing 
species. Further advantages of the HX-MS technique over NMR are the low limits of 
detection, small sample requirement, the limitless mass range for larger proteins and the 
ability to monitor individual peptides and proteins in a mixture. ESI-MS has become the most 
commonly used ionization method in HX studies because of its coupling to HPLC, but there 
is also an increasing number of reports using MALDI for amide hydrogen exchange 
experiments (Nazabal et al., 2003). 
In a typical HX experiment, undeuterated proteins can be labelled with deuterium by dilution 
in a D2O buffer, or vice versa. There are two ways of HX labelling methods: continuous 
labelling and pulse-labelling (Deng et al., 1999).  
In continuous labelling experiments, the protein is incubated for different time intervals in 
D2O and the isotope exchange is monitored as a function of exchange time providing 
information on the conformational dynamics of a protein under equilibrium conditions. In a 
native continuous labelling protocols established by Smith and coworkers (Zhang and Smith, 
1993), the exchange reaction is performed at physiological conditions for certain amount of 
time and subsequently quenched by lowering the pH to 2.5 and the temperature to 0 °C, which 
decreases HX rates at the peptide amide linkages by up to five orders of magnitude. Under 
these quench conditions, the half-life for amide hydrogen exchange is 30-120 min, giving 
enough time to analyze the sample by a reversed-phase HPLC coupled to ESI-MS without 
substantial loss of deuterons on the amides. The exchange behaviour of a protein can thus be 
measured on a global level by determining deuteron incorporation to the full-length mass. 
Information on the slow or fast exchanging regions in the protein can be obtained by 
proteolytic digestion of the deuterated protein and MS analysis of the resulting peptides. 
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Pepsin is the most commonly used acidic protease providing peptides with a spatial resolution 
of 4-15 amino acids. One weakness of the procedure is a continuous loss of deuterium during 
HPLC analysis in aqueous buffers, known as “back-exchange” which can be reduced by fast 
sample processing and low temperatures (Feng et al., 2006).  
In isotopic pulse-labelling experiments, a population of protein molecules is induced to 
undergo a conformational change by addition of a pertubing agent or a ligand and is then 
exposed to deuterium for a very short time (pulse). The resulting deuterium levels indicate the 
population of folded and unfolded molecules and thus can reveal protein folding mechanisms. 
 
 
Fig. 1.13 Experimental setup of an amide hydrogen exchange experiment combined with mass 
spectrometry. The protein is equilibrated under physiological conditions and then diluted into D2O buffer for 
certain time intervals (tHX). After a quench at low pH and low temperature, the deuterated protein is injected to 
an HPLC for desalting and subjected to ESI-MS. Measurement of the deuteron incorporation in full-length 
protein mass spectra results in information about global exchange kinetics. In addition, the deuterated protein can 
be digested during the HPLC step by pepsin and the deuteration kinetics of the peptic peptides (i.e. shifts of the 
isotopic cluster to higher m/z by deuteration time) provides information about slow and fast exchanging regions 
in the protein. 
 
HX-MS has been successfully used for numerous studies of protein dynamics, protein 
assemblies and conformational changes in proteins (Bai, 2006; Wales and Engen, 2006). It 
can also be used for monitoring complex formation and binding sites of ligands; and even to 
analyze interfaces of protein-protein interactions.  
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1.5 Aims of this thesis 
 
The aim of the thesis was to elucidate the molecular mechanism of the Hsp70-Hsp90 
chaperone machinery by studying their conformational dynamics and conformational 
changes.  In order to study conformational properties of the chaperones, this work employed 
mainly the technique of amide hydrogen exchange combined with mass spectrometry (HX-
MS) and fluorescence spectroscopy. 
The conformational dynamics within three central proteins of the cellular chaperone 
machinery should be investigated: Hsp70, Hsp90 and the co-chaperone CHIP that can bind 
both Hsp70 and Hsp90 and links chaperone substrates to ubiquitination and proteasomal 
degradation. 
Hsp70:  The structural dynamics of Hsp70 chaperones should be analyzed by HX-MS for the 
E. coli Hsp70 DnaK to understand conformational changes transmitting allostery within the 
chaperone upon nucleotide binding. At the beginning of this work, no full-length two domain 
structure of an Hsp70 was known. The aim was to identify regions in the protein that transmit 
the ATP binding signal in interdomain communication to the substrate binding domain. In 
addition, the orientation and influence of the two functional domains on each other should be 
analyzed. The interaction of DnaK with high affinity substrate peptides should also be 
studied. 
Hsp90:  The conformational dynamics of Hsp90 should be investigated by HX-MS and 
fluorescence spectroscopy to elucidate the effects of nucleotides and inhibitors on the 
mechanism of the Hsp90 ATPase cycle. Moreover, this study should compare the 
conformational properties of different Hsp90 family members (human Hsp90, yeast Hsp90 
and the bacterial HtpG) that were proposed to have mechanistic differences. The results 
should than be transferred to interaction studies of Hsp90 in complex with co-chaperones and 
client proteins.  
CHIP: HX-MS should be used to investigate conformational properties of human E3 ligase 
CHIP and its interaction with Hsp70 and Hsp90 chaperones or E2 ligases. The dynamics of 
CHIP might provide insights into its function in the decision making process between 
chaperone folding and ubiquitination. 
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2 Results and Discussion 
 
2.1 Conformational studies of the Hsp70 chaperone allostery  
 
To analyze the conformational dynamics in Hsp70 proteins that allow substrate binding in the 
high-affinity state and the nucleotide-dependent conformational changes we used native state 
amide hydrogen exchange (HX) technology in combination with mass spectrometry (MS) and 
mapped the solvent accessibility of the backbone amides in Escherichia coli DnaK in 
dependence of bound nucleotide.  
2.1.1 Conformational flexibility of the E. coli Hsp70 DnaK 
 
We initially measured deuteron incorporation into wild-type DnaK in the absence of 
nucleotides or substrates to analyze the overall kinetics of the HX reaction. We therefore 
incubated DnaK for different time intervals in D2O, quenched the reaction by lowering the pH 
to 2.2 and the temperature to 0°C, and subsequently analyzed the reaction on an HPLC-
electrospray ionization tandem mass spectrometry setup (Rist et al., 2003; Rist et al., 2005b). 
Deuterons incorporated into full-length DnaK with apparent triple exponential kinetics 
leaving approximately 40% of amide protons unexchanged after one hour (Fig. 2.2). A 
protected core of 40 to 50% of all amide protons under such conditions is typical for a well-
folded native protein.  
To localize fast and slow exchanging regions in DnaK and to elucidate the flexible parts in the 
SBD, which allow substrate binding in the high-affinity state, we performed the analysis of 
the HX reaction on our HPLC-MS setup including two columns with immobilized pepsin and 
Aspergillus saitoi protease XIII, both of which are active under quench conditions at 0°C, to 
generate on-the-fly peptide fragments of DnaK. The average peptide size was around 
17 residues and the overall sequence coverage with peptides that could be detected in every 
run was about 80% (Fig. 2.1a). Sample spectra are shown in Fig. 2.1b and in Fig. 2.1c 
secondary structure representations of the NBD and SBD of DnaK are shown color-coded 
according to the relative deuteron incorporation after 10 s, 60 s, 10 min and 60 min.  
Overall there is good agreement between crystallographic data and the protection against HX. 
Well-folded secondary structure elements incorporate deuterons to a lower degree than coil 
regions or less well defined helices and sheets. After 10 s incubation in D2O only the C-
terminal region of the SBD exchanged its amide protons almost completely for deuterons. 
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Fig. 2.1 Conformational flexibility of E. coli DnaK. (a), Amino acid sequence of DnaK and peptic peptides 
used for the analysis (underlined). Sequence coverage was ca. 80%. The gray line indicates the peptide that was 
only visible using specific elution conditions for the reversed-phase HPLC column. (b),(c) Time-dependent 
deuteron incorporation into DnaK. (b) Example spectra of the peptic peptide amino acids 49 to 65 in H2O and 
after 10 s, 60 s, 10 min and 60 min in D2O as indicated. Control spectrum of the same peptide of a fully 
deuterated DnaK sample (top).(c), Secondary structure representation of DnaK NBD (residues 4-386 modelled 
on bovine Hsc70 NBD 1HKM using Swiss-Model (Guex and Peitsch, 1997; Peitsch, 1996)) and SBD (residues 
393 to 607, 1DKX; (Zhu et al., 1996)) colored according to deuteron incorporation as indicated in the middle 
after 10 s, 60 s, 10 min and 60 min. The missing 6 residues between NBD and SBD are symbolized as dotted line 
colored accordingly. The images were created in PyMOL (http://www.pymol.org). 
 
This is not surprising since the corresponding peptide includes most of the 30 C-terminal 
residues not contained in the crystal structure and therefore not visible in Fig. 2.1c, which 
were shown by NMR to be unstructured (Bertelsen et al., 1999). The outer loops (L3,4 and 
L5,4) of the β-sheet subdomain of the SBD exchange amide protons faster than the inner loops 
(L1,2 and L4,5), which are packed against helices αA and αB. Interestingly, helix αB 
incorporates deuterons surprisingly fast with 20 of the 32 amide protons (62%) exchanged 
after 10 min and 26 (81%) after 60 min leaving only 12 and 6 amide protons protected 
corresponding to three and one and a half helix turns, respectively. These data indicate 
significant flexibility of this helix with transient opening of hydrogen bonds. 
The NBD subdomain IA appears to incorporate deuterons more rapidly than other parts of the 
NBD. However, since the resolution of our method is limited by the size of the peptides 
analyzed, close inspection of the data showed that most of the deuteron incorporation into 
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subdomain IA can be accounted for by the unstructured coil regions. For example, the 
peptide, which includes the C-terminal helix of the NBD and the N-terminal part of the SBD, 
residues 371-391 (yellow in the 60 s time point in Fig. 2.1c), incorporates 11 deuterons within 
60 s leaving 9 amide protons unexchanged. Even after one hour 7 amide protons remain 
protected from exchange, corresponding to two helix turns, which is exactly the number of 
turns of the C-terminal helix of the NBD that is included in the peptide. It is therefore likely 
that this helix is very stable and that the part, which links the NBD to the SBD (indicated as 
dotted line in Fig. 2.1c), is almost completely solvent accessible consistent with the recent 
crystal structure of the two-domain construct of Hsc70 (Jiang et al., 2005) (Fig. 2.7a) 
 
2.1.2 Nucleotide-dependent solvent accessibility changes in full-length 
DnaK 
 
To assess the effects of nucleotides on the solvent accessibility of amide protons of DnaK we 
first determined the overall kinetics of nucleotide-induced changes in HX. To analyze HX in 
DnaK in the presence of ATP over longer incubation times without interference with ATP 
hydrolysis, we used the DnaK-T199A mutant protein that is deficient in ATP hydrolysis but 
still proficient in ATP binding and undergoes ATP-induced conformational changes in the 
SBD like the wild-type protein (Barthel et al., 2001). This protein was incubated in D2O in the 
nucleotide-free or ATP-bound state and analyzed after different time intervals by our HPLC-
MS setup excluding the columns with immobilized proteases. As for wild-type DnaK 
deuteron incorporation into DnaK-T199A occurred with apparent triple exponential kinetics 
(half lives τ1 = 2.5 s; τ2 = 110 s; τ3 = 1430 s) leading to the exchange of 354 (58%) of a total 
of 613 amide protons after 60 min (Fig. 2.2a). HX in the ATP-bound state occurred with 
similar kinetics (τ1 = 2.0 s; τ2 = 73 s; τ3 = 1670 s), but, surprisingly, leveled of at a 
significantly lower number of total incorporated deuterons (327) as compared to the 
nucleotide-free state (Fig. 2.2a). Since biochemical evidence, including substrate association 
and dissociation measurements and partial tryptic digestion, clearly demonstrated that ATP 
binding induces an opening of the SBD, we hypothesized that ATP-induced increase in 
solvent accessibility in the SBD may be counteracted by a decrease in solvent accessibility in 
other parts of the protein. We therefore repeated the experiment adding ATP at a later time 
point (20 min, > 10 τ2) when most of the rapidly exchanging amids in nucleotide-free DnaK 
were already deuterated. Under these conditions addition of ATP led to the incorporation of 7 
additional deuterons as compared to the control without addition of ATP (Fig. 2.2b). These 
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data show that ATP binding to the NBD leads to an increased solvent accessibility in some 
parts of the proteins that is counterbalanced by a decreased solvent accessibility in other parts. 
 
Fig. 2.2 Nucleotide-dependent incorporation of deuterons into full-length DnaK-T199A. (a) Time-
dependent mass increase of full-length DnaK-T199A in the absence of nucleotide (open circles) and in the 
presence of ATP (filled circles). (b) Time-dependent incorporation of deuterons into DnaK-T199A in the 
absence of nucleotide. After 20 min the reaction was split into two aliquots and ATP was added to one aliquot. 
The inset shows an enlargement of the time between 20 min and 60 min. 
 
Calculation of the observed protection factors of the DnaK in absence and presence of ATP 
resulted in a global stabilization energy of ΔG = 160 kJ/mol upon ATP binding. 
 
2.1.3 Localization of nucleotide-induced conformational alterations 
 
To localize the regions within DnaK with increased and decreased solvent accessibility we 
repeated the analysis using the HPLC-MS setup with included protease columns (Fig. 2.3). 24 
of 29 analyzed segments of DnaK incorporated less deuterons in the presence of ATP as 
compared to the nucleotide-free state coherent with our data on the full-length protein. The β-
sheet subdomain of the SBD (fragments 413-437 to 486-511) exchanged amide protons more 
rapidly in the ATP-bound state as compared to the nucleotide-free state. In contrast, helix αB 
and the C-terminal part of the SBD exchanged amide protons more slowly (Fig. 2.3a, b). Most 
segments of the NBD incorporated deuterons more slowly in the ATP-bound state as 
compared to the nucleotide-free state indicating a tightening of the NBD conformation (Fig. 
2.3a, b). Although the differences are small they are highly reproducible and well reflected in 
the kinetics of deuteron incorporation as shown for selected segments in Fig. 2.3c. Most 
prominent is the difference between nucleotide-free and ATP-bound states in the linker region 
(segments 372-391 and 389-392 Fig. 2.3a and b). In the nucleotide-free state segment 389-
392 exchanges all exchangeable amide hydrogens within 10 s indicating complete exposure to 
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solvent consistent with the recent crystal structure (Jiang et al., 2005) (Fig. 2.3b). In contrast, 
in the ATP bound state this segment does not exchange its amide hydrogens indicating 
complete protection. The overlapping segment 372-391 shows a similar behavior, high 
solvent accessibility in the nucleotide-free state and almost complete protection in the ATP 
bound state (Fig. 2.3a and b). 
 
Fig. 2.3 Localization and kinetics of nucleotide-dependent deuteron incorporation into DnaK. Difference of 
deuteron incorporation into (a) wild-type DnaK and (d) DnaK-R151A in the presence of ATP minus deuteron 
incorporation in the absence of nucleotide after 1 min incubation in D2O. Numbers at the right indicate the 
corresponding protein segments (= amino acids of the peptic peptide minus the N-terminal residue). (b) Mass 
spectra of representative peptic peptides (residues 138-163, 371-391, 389-392, 438-457, 601-628) of DnaK-
T199A incubated in H2O (0%) or for 10 s in D2O in the nucleotide-free state (K – ATP) and in the presence of 
ATP (K + ATP). The spectra of the same peptides from a 100% deuterated control (100% D) are shown at the 
top. (c), Kinetics of deuteron incorporation into selected segments of DnaK-T199A in the absence (open circles) 
and presence of ATP (black circles). The segments are indicated in black in the secondary structure 
representation of NBD and SBD in the middle. 
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As comparison we analyzed the DnaK-R151A variant, which we recently identified as 
completely devoid in interdomain communication (Vogel et al., 2006a) (Fig. 2.3d). ATP-
induced changes in deuteron incorporation into the NBD during a 1-min incubation in D2O 
were similar in this variant protein as compared to the wild-type protein (compare Fig. 2.3a 
and d segments 3-15 to 358-370). However, ATP-induced changes in deuteron incorporation 
into the SBD were strongly reduced (compare Fig. 2.3a and d segments 401-408, 413-437, 
486-511, 602-628). Most notable was the difference in segment 372-391. Upon ATP binding, 
6 amide protons were protected from exchange in the wild-type protein but only 1 was 
protected in the DnaK-R151A variant.  
Together these data demonstrate that ATP binding leads to pronounced changes in solvent 
accessibility in the NBD and in the substrate enclosing loops in the SBD. If communication 
between the two domains of DnaK is compromised by a mutational replacement in 
subdomain IA of the NBD the changes in the SBD are not anymore observed. HX analysis 
thus allows to monitor the conformational changes occurring in DnaK during ATP-dependent 
interdomain communication. 
In the presence of ATP four additional segments (segments 139-163, 164-177, 338-356, 372-
382) exhibit slower deuteron incorporation in the full-length protein as compared to the 
isolated NBD (Fig. 2.4a, c). These four segments represent two regions of the NBD, the 
subdomain IA and parts of subdomains IIA and IIB that are located on the opposite face of the 
NBD as compared to the region in subdomain IA. 
The comparison of the deuteron incorporation into the isolated SBD (DnaK(389-638)), with 
the incorporation into full-length DnaK also revealed surprising results (Fig. 2.4b). Overall, 
the isolated SBD exchanged in five of the eight segments investigated more amide protons 
than the full-length protein in the nucleotide-free state (Fig. 2.4b white bars). This is most 
pronounced in segment 486-511, comprising half of β-strand 7, β-strand 8 and the first turn of 
helix αA, which exchanges on average 6.6 of the 26 amide protons in the full-length protein 
but 13.9 amide protons in the isolated SBD. 
 
Since helix αA of the SBD contains the major contact sites with the NBD in the recent crystal 
structure of the two-domain construct of Hsc70 we were eager to see whether these contacts 
would be measurable in solvent accessibility of this helix. Using an altered solvent gradient of 
the reversed-phase column we were able to analyze a peptic peptide that contained the C-
terminal part of helix αA and the N-terminal half of helix αB (512-532; Fig. 2.4d). This 
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peptide showed one deuteron difference when incubating the isolated SBD as compared to 
full-length DnaK in the nucleotide-free state suggesting only a slight stabilizing influence of 
the NBD on this region. 
 
Fig. 2.4 Comparison of deuteron incorporation into wild-type DnaK and isolated NBD and SBD (a) 
Difference of deuteron incorporation into DnaK(2-638) minus deuteron incorporation into the NBD (DnaK(2-
385)) in the nucleotide-free state (white bars) or the presence of ATP (black bars) after 1 min of incubation in 
D2O. (b), Difference of deuteron incorporation into DnaK(2-638) minus deuteron incorporation into the SBD 
(DnaK(389-638)) in the nucleotide-free state (white bars) or the presence of ATP (black bars) after 1 min of 
incubation in D2O. (c), Secondary structure representation of the SBD (left) and the NBD (right) with specific 
segments in black and residue positions indicated. (d), mass spectra of the peptic peptide residues 512-532 
(representing the C-terminal part of helix αA and the N-terminal part of αB; m/z = 821.74, z = 3) of wild-type 
DnaK in the nucleotide-free state (K-ATP) or the presence of ATP (K+ATP) and of the same peptide from the 
SBD after 1 min incubation in D2O. The undeuterated peptide is shown for comparison at the bottom. The 
spectra were obtained using specific conditions for eluting the peptides from the reversed-phase column. Spectra 
for the fully deuterated peptide could not be obtained. 
 
When the isolated SBD is compared to full-length DnaK in the ATP-bound state significant 
differences are still observed (Fig. 2.4b black bars). The four C-terminal segments of the SBD 
still incorporate less deuterons in the full-length protein as compared to the isolated SBD and 
only two segments (413-437 and 439-457) exchanged more in the full-length protein 
demonstrating the ATP-induced opening of the substrate-binding pocket. Similarly, the region 
512-532 incorporates at least 4 deuterons more in the full-length protein in the presence of 
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ATP than in the isolated domain, indicating that ATP-induced conformational changes also 
lead to an increased solvent accessibility of the amides of helices αA and αB (Fig. 2.4d). 
Taken together our comparison of HX into the isolated domains of DnaK with HX of full-
length DnaK indicate that the two domains stabilize each other, an effect that is much more 
pronounced in the SBD than in the NBD. 
 
2.1.4 Substrate-induced conformational alterations in DnaK 
 
To analyze possible substrate-induced conformational changes in the SBD and the NBD we 
compared the HX of full-length DnaK in the absence and presence of the peptide σ32-M195-
N207, which was identified earlier to be a high-affinity substrate for DnaK (McCarty et al., 
1996), and in the absence and presence of ATP. In the absence of ATP overall little changes 
in deuteron incorporation were observed except for the segments that form the substrate-
enclosing loops L1,2 and L3,4. The HX kinetics of these two segments is shown in Fig. 2.5. The 
segment representing the inner loop L1,2 (residues 401-408) incorporates one to two deuterons 
very rapidly and a third over a period of about 1 h in the absence of the substrate peptide, 
while in the presence one of the three amide protons is completely protected from exchange 
(Fig. 2.5a). This result is consistent with the crystal structure which shows one amide proton 
completely free, one in a loose internal hydrogen bond (distance between amide N and 
carbonyl O 3.4 Å), and one forming a hydrogen bond to the backbone of the substrate peptide 
(Zhu et al., 1996). The HX kinetics of the segment representing the outer substrate enclosing 
loop L3,4 (residues 413-437) changed in a more surprising way upon substrate binding. In the 
absence of the substrate peptide about 6 deuterons were incorporated within the shortest time 
interval measured (10 s). Consistent with the X-ray structure which shows 6 of the 23 amide 
protons directly coordinated to water (PDB entry code 1DKX). Deuteron incorporation 
continued more slowly to arrive at 15 after 1 h, leaving 8 amide protons protected consistent 
with the number of strong hydrogen bonds (O-N distance below 3Å) within this segment in 
the x-ray structure. In the presence of a substrate deuteron incorporation was much slower. 
Only three amide protons exchanged within the first 10 s, and after 1 h deuteron incorporation 
approached 10 leaving 13 amide protons completely protected within this time frame. Since 
only two hydrogen bonds are formed with the substrate in the crystal structure it must be 
concluded that parts of the segment represented by the analyzed peptide are stabilized upon 
substrate binding. 
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Fig. 2.5  Substrate dependence of deuteron incorporation into DnaK. Kinetics of deuteron incorporation into 
two segments of the SBD (residues 401-408 (a) and 413-437 (b)) in the absence (white diamonds) or presence  
(blue diamonds) of the substrate peptide σ32-M195-N207 (MAPVLYLQDKSSN;(McCarty et al., 1996)). Insets 
show same data with a logarithmic time scale. (c) ATP and substrate induced conformational changes. 
Nucleotide-free DnaK-T199A was incubated in the absence (white) and presence of ATP (red), in presence of 
peptide σ32-M195-N207 (blue) and presence of both peptide and ATP (purple) for 1 min in D2O. Shown is the 
deuteron incorporation into selected segments as indicated. Numbers in parenthesis give the number of 
exchangeable amide hydrogens in the segments. (d), deuteron incorporation into the linker segment 372-391 
after 1 min and 3 min in D2O in the absence or presence of ATP or peptide. pep?ATP (bright purple), 
incubation of nucleotide-free DnaK-T199A in the presence of peptide for 1 min in D2O, then addition of ATP 
and incubation for additional 2 min. ATP?pep (dark purple), incubation of ATP-bound DnaK-T199A for 1 min 
in D2O, then addition of peptide and incubation for additional 2 min. 
 
To analyze the allosteric mechanism by which substrates induce ATP hydrolysis we wanted to 
measure HX in the presence of peptide and ATP. To circumvent the problem of ATP 
hydrolysis during the incubation in D2O we made use of the DnaK-T199A variant. None of 
the resulting mass spectra showed indications for a bimodal distribution of the isotopic peaks 
indicating that all DnaK molecules were in the same conformation. Fig. 2.5c shows the 
comparison of deuteron incorporation after 1 min in D2O into selected segments of 
nucleotide-free DnaK-T199A in the absence or presence of the peptide σ32-M195-N207 and 
in the absence or presence of ATP. Three different situations can be distinguished. First, the 
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effects of ATP are dominant over the effects of peptide (segments 17-41, 401-408) indicating 
that ATP was not hydrolyzed during the incubation time. Second, the effects of peptide are 
dominant over the effects of ATP (segments 139-163, 165-177, 372-391) suggesting 
conformational changes that could be linked to allosteric control (discussed in detail below). 
Third, the effects of ATP and peptide seem independent and additive (segment 413-437) 
suggesting that this segment consists of parts that react independently one according to the 
first and one according to the second situation. To analyze the ATP and peptide effects more 
closely we performed order-of-addition experiments. We incubated nucleotide-free DnaK-
T199A in the presence or absence of ATP or peptide for 1 min in D2O and than added peptide 
to the ATP-containing sample or ATP to the peptide-containing sample and continued 
incubation for an additional 2 min and compared the deuteron incubation with samples to 
which nothing was added. The outcome was principally the same as in the previous 
experiment, shown exemplarily for the linker segment in Fig. 2.5d. Peptide overrides the 
effect of ATP on this segment of DnaK and leads to an exposure of the linker to solvent. 
Taken together these data clearly indicate that ATP-induced conformational changes in some 
parts of the NBD and the linker are reversed by peptide binding suggesting a mechanism for 
the mutual allosteric control of the two domains. 
 
2.1.5 Discussion of the conformational changes within Hsp70 
 
This study revealed several new insights into the structural dynamics of Hsp70 proteins and 
the ATP-dependent communication between the nucleotide and substrate-binding domains, 
which mediates the allosteric regulation of this class of chaperones. Nucleotide-dependent 
changes in deuteron incorporation demonstrate an overall tighter folding of the NBD and an 
increased solvent exposure of several regions in the SBD visualizing the conformational 
changes accompanying the opening of the substrate-binding pocket. Comparison of the 
isolated domains with the full-length protein indicates a stabilizing effect of the domains onto 
each other, which is specifically pronounced in the lower β-sheet of the substrate-binding 
domain. The observation that the linker is completely accessible to solvent in the absence of 
nucleotides and solvent protected in the presence of ATP reveals nucleotide-dependent 
conformational changes of the linker, which may be part of the mechanics by which the two 
domains communicate with each other. 
The time-dependent incorporation of deuterons into DnaK in the nucleotide-free state allows 
three conclusions. First, the NBD shows significant flexibility consistent with a shearing 
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movement of the four subdomains relative to each other that was recently proposed based on 
dipolar coupling NMR data (Zhang and Zuiderweg, 2004). Second, the lid forming helix αB 
in the SBD exchanges much more rapidly than expected for a well-folded helix, leaving the 
hydrogen bonds of only 3 and 1.5 helix turns intact over a period of 10 and 60 min, 
respectively. This is consistent with local unfolding that accompanies the opening movement, 
which allows substrate binding and release even in the absence of ATP. Such a movement 
was proposed by Hendrickson and coworkers on the basis of a second crystal form in which 
helix αB was bent upward by 11° (Zhu et al., 1996). This flexibility of helix αB would not be 
necessary in other models, which propose that the opening of the lid occurs either by a 
pivoting movement of the entire lid around helix αA or by an upward movement of the entire 
helix αB without helix melting and with a hinge between helix αA and αB (Mayer et al., 
2000; Wang et al., 1998). Our data are also consistent with the NMR and x-ray structures of 
truncated versions of the SBD of DnaK and Hsc70, which show a helical secondary structure 
only up to residue 535 (Jiang et al., 2005; Morshauser et al., 1999; Wang et al., 1998). The 
estimated half-life of the HX in this helix (ca. 10 min) is similar to the half-life of the DnaK-
peptide complex (ca. 15 min). Consistently, the substrate enclosing outer loops L3,4 and L5,6 
and β-strand 3 incorporate deuterons with similar kinetics. Third, the C-terminal part of the 
NBD and the linker that connects NBD and SBD are highly solvent exposed in the nucleotide-
free state, in agreement with data from partial tryptic digestion, which shows an exposed 
cleavage site N-terminal of the linker, and the recent crystal structure of a two-domain 
construct of bovine Hsc70 (Buchberger et al., 1995; Jiang et al., 2005) (Fig. 2.7a). Taken 
together, Hsp70 proteins show a high degree of flexibility in both, NBD and SBD. 
The comparison of deuteron incorporation into full-length DnaK with the incorporation into 
DnaK(2-385) in the absence of nucleotide revealed small changes throughout the NBD. These 
data are consistent with a recent NMR study, which compared chemical shifts of the residues 
in the NBD in a Thermus thermophilus DnaK two-domain construct with the isolated NBD 
(Revington et al., 2005). It was found that chemical shift perturbations caused by the presence 
of the SBD are scattered throughout the NBD. The absence of a defined area, which is 
protected by the presence of the SBD, is surprising. It should be noted, however, that mere 
side chain interactions, which do not affect the backbone amide hydrogen accessibility, would 
not be detected by this method. The differences in HX observed in the presence of ATP as 
compared to the nucleotide-free state revealed three regions of the NBD, the major part of 
subdomain IA and small parts of subdomains IB and IIA, both of which are located on the 
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opposite face of the NBD as compared to the region in subdomain IA. The slight stabilizing 
effect exerted by the SBD on the NBD is therefore enhanced by ATP binding to the NBD 
indicating a more tightly coupled state. These data provide a structural basis for earlier 
observations with small X-ray scattering and partial tryptic proteolysis (Buchberger et al., 
1995; Wilbanks et al., 1995). Both investigations show that the NBD and SBD are more 
tightly coupled with each other in the ATP-bound state as compared to the nucleotide-free 
state with a smaller radius of gyration of the full-length protein and the linker connecting both 
domains not accessible for proteolytic cleavage.  
The comparison of amide hydrogen exchange of full-length DnaK in the presence and 
absence of ATP as well as with the isolated NBD at the peptide level provides insights into 
the allosteric regulatory mechanism by which ATP binding induces the opening of the 
substrate-binding pocket and by which substrate binding stimulates the ATPase activity. In 
the NBD the segments with the largest nucleotide-dependent changes in HX kinetics of full-
length DnaK cluster in subdomain IA (Fig. 2.3b, c), as do the changes between full-length 
DnaK and DnaK(2-385) in the presence of ATP (Fig. 2.4a, c). The nucleotide-dependent 
alterations of HX are explained easily for the segments 3-15 and 165-177. The former 
contains residues Asp8, Thr11, Thr12, Tyr13 and Cys15 corresponding to Asp10, Thr13, Thr14, 
Tyr15 and Cys17 of bovine Hsc70, which contact the β- and γ-phosphate of the bound ATP in 
the crystal structure, and nucleotide binding may therefore stabilize this loop (Flaherty et al., 
1990; O'Brien et al., 1996). The latter segment (165-177) contains Glu171 corresponding to 
Glu175 in Hsc70 that is involved in the coordination of Mg2+ and may therefore also be 
stabilized by ATP binding (Flaherty et al., 1994). The segments 139-163 and 372-391 do not 
have such an obvious connection to nucleotide binding. The first region, however, contains 
Pro143 that was recently shown to constitute the molecular switch, which stabilizes the two 
alternating conformations of Hsp70 proteins, and Arg151, which relays the proline switch 
position and therefore ATP binding to the SBD and substrate and DnaJ binding to the NBD 
(Vogel et al., 2006a). The second region contains the linker that connects NBD and SBD. 
Alterations in the HX behaviour in this region are particularly interesting because it also has 
implications on the allosteric interdomain control mechanism. Since the residues in this region 
are highly conserved we propose that these conformational changes are intimately linked to 
allosteric interdomain control. Consistent with this hypothesis are the earlier observations that 
replacement of the hydrophobic residues 389 to 392 with alanine (Laufen et al., 1999) blocks 
completely ATP-induced stimulation of substrate release and substrate and DnaJ-mediated 
triggering of ATP hydrolysis. The linker which is exposed in the nucleotide-free state and 
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becomes protected upon ATP binding, therefore seems responsible for triggering the 
conformational change in the NBD that is necessary for the induction of ATP hydrolysis. 
Consistent with this hypothesis is the fact that a NBD construct including the linker (DnaK(2-
393)) has a strongly increased ATPase activity similar to full-length DnaK in the presence of 
DnaJ and a substrate protein (Swain et al., 2007; Vogel et al., 2006b). 
When the mutual allosteric control between the NBD and the SBD is abolished by the Arg151 
to Ala replacement (Vogel et al., 2006a) most nucleotide-dependent changes in the HX 
kinetics in the NBD are still observed but not the changes in the linker or the SBD (Fig. 2.3d). 
Together these data clearly demonstrate that the HX kinetics reveal segments in Hsp70 
proteins that are involved in nucleotide-dependent allosteric control. In particular the linker 
region seems to play a pivotal role in this mechanism. 
Our comparison of HX into the isolated SBD with the HX of full-length DnaK indicated a 
strong stabilizing effect of the NBD on the SBD, which may be part of the linker-mediated 
allosteric control. The largest difference in deuteron incorporation between full-length DnaK 
and the SBD was observed in segment 486-511 (Fig. 2.4b and d). In the isolated SBD we 
observed an exchange of around 14 of the 26 amide protons within a time span of 1 min 
demonstrating an unexpectedly high degree of flexibility in this region. The protection of 
more than 6 amide protons observed by us for the full-length protein indicates that the NBD 
stabilizes this region significantly. The recent crystal structure of an Hsp70 protein in the 
nucleotide-free state that contains the NBD and parts of the SBD shows the helix αA of the 
SBD docked onto subdomain IA of the NBD  (Jiang et al., 2005) (Fig. 2.7a). Since in this 
structure no additional hydrogen bonds are observed between the NBD and the region 486-
511 the stabilizing effect must be transduced through helix αA and the entire β-sheet. 
The ATP-induced changes in deuteron incorporation into the SBD lead to increased HX in 
four segments (residues 413-437, 439-457, 459-473, 486-511) representing the β-sheet 
subdomain and a decreased HX in helix αB and the C-terminus (Fig. 2.3a and c and Fig. 2.4). 
This demonstrates that the ATP-induced opening of the SBD involves mainly the β-sheet 
subdomain and not helix αB consistent with earlier biochemical data (Mayer et al., 2000) but 
incompatible with a mechanism that proposes melting of helix αB as the first step for SBD 
opening (Zhu et al., 1996). 
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Fig. 2.6 Proposed model of the Hsp70 chaperone cycle based on HX-MS data and biochemical analysis. 
ATP binding to DnaK leads to conformational changes in the hydrogen bonding network around Pro143 (P) and 
the linker (shown in black), as measured by the protection of hydrogens in these segments. P143 undergoes trans-
cis isomerization (P*) and this signal is transmitted through the linker to the SBD. This conformational change 
leads to an opening of the SBD and to substrate release (low-affinity state). Substrate binding reverts these 
conformational changes and stimulates in cooperation with DnaJ ATP hydrolysis which converts the chaperone 
into the high-affinity state. The cycle restarts after nucleotide release. 
 
Increase in deuteron incorporation into β-sheet 3 and the outer substrate inclosing loops L3,4 
(residues 413-437) and L5,6 (residues 458-473) are obvious requirements for the opening of 
the substrate-binding pocket. The increase in HX kinetics of the inner loop L4,5 (residues 439-
457) is surprising since the inner loops together with the framing helices αA and αB appear to 
constitute a stable entity in the crystal structure. However, Hendrickson and coworkers 
pointed out the unexpected high number of charged residues in this region (Zhu et al., 1996). 
The increased deuteron incorporation may be linked to the interdomain communication and 
the mechanism through which ATP effects the opening of the SBD. Interestingly, residue 
Lys414, which is essential for interdomain communication, is close to the base of this loop 
(Montgomery et al., 1999). In addition, segment 512-532, comprising the C-terminal part of 
helix αA and proximal half of helix αB, incorporates at least 4 deuterons more in the ATP 
bound state as compared to the nucleotide-free state. There are two alternative explanations 
for this observation. Either the proximal part of helix αB or the C-terminal part of helix αA 
becomes more flexible. In the first case this would indicate a local unfolding that accompanies 
the opening of the lid, which together with the absence of large changes in solvent 
accessibility of the distal half of helix αB suggests the proximal part of the helix as hinge 
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region for the ATP-induced lid opening: this scenario is consistent with the increased solvent 
accessibility of the inner loop L4,5. In the second case this could indicate a detachment of the 
upper part of helix αA from the NBD as part of the ATP-induced movement of both domains 
relative to each other, which would lead to a burial of the linker region consistent with the 
loss of solvent accessibility of the linker. In consideration of all available data it seems that a 
combination of both models is most likely. 
Substrate binding to nucleotide-free DnaK reduced solvent accessibility in two segments of 
the SBD by one and six amide hydrogens, respectively. While the protection observed in 
segment 401-408 comprising parts of β-sheets 1 and 2 and loop L1,2 corresponds exactly to 
the hydrogen bond between this part of the SBD and the substrate peptide suggested by the x-
ray structure, the protection in segment 413-437 comprising the loop between β-sheets 2 and 
3, β-sheet 3, and loop L3,4 exceeds the expected reduction of solvent accessibility through 
hydrogen bonds with the substrate peptide by 4 amide hydrogens. Although an exact 
localization of the stabilized position is not possible due to the low spatial resolution of our 
MS analysis in this part of the SBD, it is likely that conformational changes in the loop 
between β-sheets 2 and 3 contributes at least in part to this loss of solvent accessibility, since 
this part contains Lys414 implicated in interdomain communication (Montgomery et al., 1999). 
This hypothesis is supported by the results in the presence of ATP (Fig. 2.5c) showing the 
protection of exactly two amide hydrogens after 1 min in D2O presumably corresponding to 
the two hydrogen bonds formed with the peptide substrate, while the overall deuteron 
incorporation increased. 
The ATP-induced changes in solvent accessibility was affected or even totally reversed by the 
peptide substrate in four segments (139-163, 165-177, 372-391, 413-437). These results have 
two important implications: first, they show the protein segments involved in transmitting the 
substrate-binding signal to the catalytic center; second, they suggest that substrate triggers 
ATP hydrolysis by reverting certain ATP-induced conformational changes and converting 
certain parts of the protein into an ADP-like state. These results are consistent but go well 
beyond earlier observations that peptide binding leads to an increase of intrinsic tryptophane 
fluorescence that precedes ATP hydrolysis (Slepenkov and Witt, 1998). Especially interesting 
is the substrate-triggered reversion of the ATP-induced conformational change in segment 
139-163, which is fully consistent with the recently proposed proline switch (Vogel et al., 
2006a). We showed in this publication that Pro143 in the NBD undergoes a conformational 
change, possibly a trans to cis isomerization upon ATP binding. This conformational change 
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is relayed to the SBD through Arg151. Substrate was proposed to trigger ATP hydrolysis by 
inducing the reversion, cis to trans, of this conformational change. The changes observed in 
segment 165-177 most likely also contribute to the stimulation of ATP hydrolysis since the 
Mg2+-coordinating Glu171 is in this segment. The two other segments with significant effects 
of peptide on the ATP-induced conformational change seem to mark the pathway by which 
peptide triggers ATP hydrolysis. 
Taken together, our data suggest the following mechanism of allosteric interdomain control 
(Fig. 2.6): ATP binding to the NBD induces a conformational change in segment 139-163 and 
165-177 most likely in Pro143 (trans-cis isomerization), Arg151 and Glu171. This leads to a 
conformational change in the linker region (segment 372-391), which becomes protected from 
solvent and is transduced from there to segment 413-437 most likely onto the loop between β-
sheet 2 and 3 of the SBD around Lys414, resulting in an opening of the substrate binding 
pocket with increased solvent accessibility of segment 439-457. Substrate binding reverts all 
of these conformational changes in particular in Pro143 (cis-trans isomerization) and Glu171 
thereby bringing the catalytic Lys70 with its coordinated water molecule into the ideal position 
for γ-phosphate cleavage. 
This work provided for the first time local structural information of the ATP coupling 
mechanism of Hsp70 in peptide resolution. However, there is still a need for high-resolution 
structures of the chaperone showing the interdomain docking sites that transmit the ATP 
signal. Two recent papers have described a docked conformation of the two Hsp70 domains, 
but surprisingly the interdomain docking site and the relative orientation of the domains differ 
between the two. Zuiderweg and co-workers used NMR chemical shift mapping and residual 
dipolar couplings to orient the two domains of a truncated version of a bacterial Hsp70, DnaK 
from Thermus thermophilus, in the ADP-bound state (Revington et al., 2005).  In this model, 
the region of the β subdomain near the entry point of the interdomain linker interacts with a 
cleft in the ATPase domain on the outside of the hinge between the two lobes. The new 
crystal structure of a truncated version of the bovine Hsp70 family member Hsc70 in the 
absence of nucleotide shows a different packing arrangement, in which a portion of the helical 
lid of the SBD (which is missing in the T. thermophilus DnaK construct) interacts with the 
same ATPase domain cleft, but at an adjacent site (Jiang et al., 2005). However, both studies 
reveal some inconsistency with previously published data. On the one hand, the T. 
thermophilus DnaK construct used contained mutations that might impair allosteric function. 
On the other hand, the central involvement of a portion of the SBD helical lid at the 
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interdomain interface in the Hsc70 crystal structure is inconsistent with the fact that a 
truncated E. coli DnaK lacking the entire helical lid is allosterically functional (Pellecchia et 
al., 2000). In particular, the exact positioning of the hydrophobic linker in the ATP bound 
state in the context of allosteric coupling remains enigmatic.  
 
 
Fig. 2.7 Recent crystal structures of Hsp70 homologs and comparison with DnaK HX-MS data. (a) 
Secondary structure representation of bovine Hsc70 two-domain construct (2-554) in nucleotide-free state (PDB 
code 1YUW). NBD is shown in blue, the SBD is colored green (β-sheet part) and red (helical part). The linker 
(magenta) is solvent-exposed. (b) Yeast Hsp110 (Sse1) in ATP bound state (PDB 2QXL). (c) and (d) Same 
representations are colored with homologous segments from DnaK that were shown by HX-MS to be important 
in interdomain communication. Blue segments were protected, red segments became more flexible upon ATP 
binding. Only in the Hsp110·ATP structure, these segments are in close proximity to each other, suggesting that 
this model represents the correct conformation of the coupled ATP bound state of Hsp70. 
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New insights into the conformation of the low-substrate-affinity ATP state of Hsp70s were 
reported by NMR studies of DnaK and Hsc70 constructs. By performing NMR of the NBD 
construct of DnaK including the linker (1-392), Gierasch and coworkers could localize 
docking sites of the linker to residues Leu177 and Ile373, which are located between the 
“crossing helices” of subdomains IA and IIA of the NBD (Swain et al., 2007) and may 
activate the ATPase. Using a fully functional truncated E. coli DnaK, they also demonstrate 
that docking of the two domains occurs only when ATP is bound (Swain et al., 2007). This is 
in contrast to recent NMR data from the mammalian Hsc70, which also revealed interdomain 
interactions in the ADP state (Jiang et al., 2007).  
New structural information about the low-affinity conformation of a full-length Hsp70 
homologue revealed a recent crystal structure of the Hsp110 Sse1 dimer in complex with ATP 
(Liu and Hendrickson, 2007) (Fig. 2.7b). This crystal structure identified interdomain contacts 
between the SBD β-sheet region and the backside of NBD at the IA/IIA interface with the 
linker residues (Asp396) bound to the NBD via hydrogen bonds to Thr176, Asn173 and Arg154 
and hydrophobic contacts. Interestingly, the proximal helix αB of the SBD packs between 
NBD subdomains IA/IIA, too. The hydrogen network of the NBD-linker-SBD shown in this 
structure is consistent with the regions identified by our HX-MS data that are important for 
allosteric coupling (Fig. 2.7d) 
Though Hsp110 itself lacks interdomain communication, all current biochemical and 
genetical data (Liu and Hendrickson, 2007) and our HX data on DnaK demonstrate indeed 
that the Sse1 structure represents the correct model for an ATP bound conformation of Hsp70. 
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2.2 Conformational dynamics of the bacterial Hsp90 HtpG 
 
 
 
To analyze the conformational dynamics of Hsp90 during progression through the ATPase 
cycle we employed HX-MS and fluorescence spectroscopy. The study focused first on the 
bacterial Hsp90 homologue HtpG because it is the most simple representative of the Hsp90 
family and is not regulated by co-chaperones. In this study we resolved the changes in 
conformational dynamics in space and time. We demonstrate that ATP binding induces a 
series of conformational changes in order to attain a compact pre-hydrolysis state.  
 
 
2.2.1 Deuteron incorporation into full-length HtpG 
 
In order to analyze the conformational flexibility of HtpG we performed HX-MS experiments 
as described previously (Rist et al., 2006; Rist et al., 2003). Apo-HtpG exchanged about 38% 
of its exchangeable amide hydrogens within 10 s and around 60% within one hour. These 
exchange kinetics are consistent with a well-folded native protein with globular domains (Fig. 
2.8a). Addition of ADP induced a small protection (ca. 7 amide hydrogens). A much larger 
protection was observed in the presence of ATP. During the first 60 s almost 50 amide 
hydrogens were protected. This protection decreased to the level of the ADP state by 1200 s 
(Fig. 2.8a). These data indicate that the most compact state of HtpG can only be reached 
through addition of ATP and not ADP, which seems to be at odds with a structural study on 
HtpG (Shiau et al., 2006). However, our experiments do not exclude that the compact ATP-
induced state is a post-hydrolysis conformation. We considered this possibility because the 
generation of the ATP-induced protection required a pre-incubation of HtpG with ATP that 
was much longer than we had expected for a protein with high nucleotide association rates 
(see below). 
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Fig. 2.8 HX kinetics of the full-length HtpG and localization of fast and slow exchanging regions. (a) 
Deuteron incorporation into full-length E. coli HtpG in the absence of nucleotides (black circles) and in the 
presence of ADP (blue diamonds), ATP (red triangles), and AMPPNP (cyan squares). The solid lines are fits of a 
tri-exponential equation to the data. (b) Deuteron incorporation into full-length HtpG-E34A variant in the 
absence of nucleotides (open black circles) and in the presence of ATP (open red triangles). (c) Sequence 
coverage of peptic peptides of HtpG. The amino acid sequence of E. coli HtpG is shown with the secondary 
structure elements as found in the crystal structure of nucleotide-free HtpG (PDB entry code 2IOQ) above the 
sequence (dashed lines are not resolved in the crystal structure). The black lines below the sequence indicate the 
peptic peptides that were found consistently in our HX-MS experiments. The colored bars show deuteron 
incorporation of the respective segment (i.e. the peptic peptide minus the N-terminal amino acid, which lost any 
incorporated deuteron during peptic cleavage) after 10 s and 10 min in D2O as specified at the bottom of the 
figure. 
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2.2.2 The ATPase cycle of HtpG 
 
The issue, whether the highly protected state was an ATP-bound state or a post-hydrolysis 
state, could be resolved by determining the rate-limiting step of the ATPase cycle. To this end 
we measured the ATPase rate of HtpG under steady state and single turnover conditions. The 
ATPase rate of HtpG increased with increasing ATP concentrations according to normal 
Michaelis-Menten kinetics with a kcat of 0.011 ± 0.001 s-1 (τ = 90 s) and a KM of 250 ± 82 µM 
at 30°C (Fig. 2.9). Under single turnover conditions the amount of ATP decreased with single 
exponential kinetics resulting in a hydrolysis rate khyd of 0.0077 ± 0.0003 s-1, which is smaller 
but close to the steady state ATPase rate. These results demonstrate that product release is not 
rate-liming in the ATPase cycle of HtpG. Therefore, in the presence of high concentrations of 
ATP the majority of HtpG molecules is in the ATP-bound state. 
 
Fig. 2.9 Michaelis-Menten kinetics of the ATPase activity of HtpG. The observed steady-state ATPase rate is 
plotted against the ATP concentration. Error bars represent the standard error of means of at least 3 independent 
determinations. The solid line shows a non-linear regression fit of the Michaelis-Menten equation to the data. 
The inset shows a Lineweaver-Burk representation of the data and the fit. 
 
As an independent confirmation of these results, we repeated the HX experiments in the 
presence of the non-hydrolysable ATP analogue AMPPNP, which was devoid of any 
detectable amounts of ATP (Fig. 2.8a). Here we also observed a strong protection of about 35 
amide hydrogens as compared to 7 in the presence of ADP and 47 in the presence of ATP. 
Strikingly, in the presence of AMPPNP we observed the same protection throughout the 
entire kinetics up to 3600 s incubation time, which contrasts the loss of protection observed 
after 1200 s in the presence of ATP. We made the same observation when using an HtpG 
variant with Glu34 replaced by Ala (HtpG-E34A; constructed in analogy to the hydrolysis-
deficient yeast Hsp82-E33A (Obermann et al., 1998; Panaretou et al., 1998), which in our 
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hands hydrolyses ATP about 10-times more slowly (τ = 1071 s) at 30°C (Fig. 2.8b). These 
data indicate that the loss of protection in the presence of ATP is linked to ATP hydrolysis. 
Taken together, our results demonstrate that (1) ATP hydrolysis is the rate-limiting step in the 
ATPase cycle of HtpG, (2) the ATP-bound state is the most compact state with least solvent 
accessible amide hydrogens, and (3) the ADP state shows only little protection as compared to 
the nucleotide-free state suggesting similar conformations. The most compact ATP-bound 
state we will call henceforth the tensed (T) state and the nucleotide-free the relaxed (R) state. 
 
2.2.3 Localization of fast and slow exchanging regions in nucleotide-free 
HtpG 
 
In order to localize the regions within HtpG that contain slow and fast exchanging amide 
hydrogens we digested the protein after the HX reaction under quench conditions using a 
column with immobilized pepsin in our HPLC setup as described previously (Rist et al., 
2003). The regularly observed peptic peptides of HtpG had an average length of 14.5 residues 
and covered 88% of HtpG’s sequence. Fig. 2.8c shows the deuteration level of the analyzed 
peptic fragments when the protein was incubated for 10 s or 10 min in D2O. Our HX data of 
HtpG free in solution are in good agreement with the published crystal structure of HtpG in 
the apo state (PDB entry code 2IOQ). Two regions of the NBD, the very N-terminus (residues 
1-31) and the so-called ATP-lid (residues 90-127), exhibited a high degree of solvent 
accessibility with almost complete deuteration within 10 s despite the fact that the crystal 
structure indicates secondary structure with a significant number of hydrogen bonds. 
However, these regions have a relatively high b-factor denoting high degrees of positional 
variation consistent with our data. 
 
2.2.4 Localization of nucleotide-induced changes in HtpG 
 
Recently, it was proposed that HtpG undergoes conformational changes as rigid body 
movements (Shiau et al., 2006). If this is the case, nucleotide-induced changes in solvent 
accessibility should be located primarily at hinge regions. To localize nucleotide-induced 
conformational changes, we compared deuteron incorporation into different segments of 
HtpG in the absence of nucleotide and presence of ADP, ATP, and AMPPNP (Fig. 2.10). 
Addition of ADP only had small effects on the incorporation of deuterons. For example, 
amide hydrogens were protected in the nucleotide-binding site (residues 90-98) and in the N-
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terminal segment (residues 2-19). In addition, a small but significant deprotection was 
detected in specific segments in the NBD (residues 108-119), the MD (residues 279-299, 401-
416 and 437-449) and almost the entire C-terminal DD. 
 
 
Fig. 2.10 Nucleotide-dependent changes in HtpG. Difference plots of deuterons incorporated in the presence 
of ADP (left panel), ATP (middle panel) and AMPPNP (right panel) minus deuterons incorporated in the 
absence of nucleotides into HtpG after 30 s in D2O. The domain structure of HtpG and numbers of the 
corresponding segments are given at the left of the panels. The data are the average of three independent 
experiments. The gray area indicates the average standard error and bars within the gray area are not 
significantly different from zero.  
 
In the presence of ATP, we observed in seven segments a large protection (up to 7 amide 
hydrogens) compared to the nucleotide-free state (Fig. 2.10 middle panel and Fig. 2.11 dark 
blue segments): the N-terminal segments 2-19 and 21-31, the ATP-lid segments 90-98 and 
121-127, the last helix of the NBD (residues 192-206), and the loop in the MD that contains 
the catalytic arginine (residues 319-334 and 336-359). We detected a small but significant 
protection in additional segments scattered throughout the entire protein (Fig. 3 cyan 
segments). A few segments in the C-terminal region exhibited slightly more exchange in the 
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presence of ATP than in the nucleotide-free state (Fig. 2.11, orange segments). Thus, our data 
demonstrate that ATP induces large conformational changes not only in the NBD but 
throughout the HtpG protein leading to a significant loss of conformational dynamics. 
 
 
Fig. 2.11 Nucleotide-dependent HX kinetics of selected segments of HtpG. Secondary structure 
representation of the crystal structure of full-length E. coli HtpG in complex with ADP (PDB ID code 2IOP; 
only one dimer shown with one monomer in gray and the other in pale green). Segments with more than 1.5 
amide hydrogens protected in the presence of ATP at time point 30 s are colored in dark blue and the HX 
kinetics for these segments in the absence of nucleotides (black circles) and the presence of ADP (open squares) 
and ATP (black triangles) and for HtpG-E34A in the presence of ATP (open triangles) are shown. The solid lines 
are fits of a bi-exponential equation to the data to guide the eye. Segments with one to two amide hydrogens 
protected at 30 s are colored in cyan. Segments deprotected upon ATP binding are colored in orange. 
 
The kinetics of deuteron incorporation in all of the highly protected segments in the presence 
of ATP was nearly identical with an average rate of 0.0038±0.0005 s-1 (Fig. 2.11). This is 
very unusual, since different segments of a protein usually exchange with different kinetics 
(see Fig. 2.11). These findings could be explained by the hypothesis that a process different 
from protein unfolding and folding, explicitly ATP hydrolysis, is rate-limiting for HX in the 
ATP-bound state. Indeed, the mutant protein HtpG-E34A exhibited a similar protection in the 
presence of ATP and this protection was observed over a much longer time interval, which 
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demonstrates that the HX reaction follows different kinetics in HtpG-E34A. These data 
suggest that ATP hydrolysis is rate-limiting for HX. Consistent with this hypothesis is the 
observation of a bimodal distribution of the isotope peaks in several peptides (Fig. 2.12). 
Bimodal isotopic peak distributions are indicative of the coexistance of two different 
conformational states. These two conformational states are the ATP-bound T state, in which 
the segments are largely protected from HX, and the ADP-bound and nucleotide-free R state 
with higher HX rates. 
 
 
Fig. 2.12 Effects of ATP on deuteron incorporation into selected segments of HtpG. Mass spectra of two 
peptic peptides (120-127, 191-206) of HtpG in the absence of nucleotides and the presence of ATP after 30 s, 
5 min, 10 min, and 30 min incubation in D2O as indicated at the left. The spectra of the peptic peptides in the 
undeuterated (0% D; bottom) and the fully deuterated (100% D; top) state are shown for comparison. The 
spectra of the samples in the presence of ATP exhibit a bimodal distribution of the isotope peaks indicative of 
coexisting conformations. 
 
In the presence of AMPPNP, the same changes in deuteron incorporation occurred as in the 
ATP-bound state, which confirms that the T state is the pre-hydrolysis state (Fig. 2.10). The 
magnitude of the observed protection was slightly reduced compared to the ATP-bound state 
consistent with our HX data for full-length HtpG. 
Taken together, significant nucleotide-dependent changes of the conformational dynamics of 
HtpG were observed which were not localized to hinge regions but to all three globular 
domains of the protein. Our data not only demonstrate the existence of an R and a T state but 
show which structural elements of the protein are more tightly folded in the T state. 
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2.2.5 Kinetics of R to T transition 
 
In order to investigate whether γ-phosphate cleavage or preceding conformational changes are 
rate-limiting for the ATPase cycle of HtpG we determined the rate of R to T transition using 
pulse-labeling HX experiments. HtpG and HtpG-E34A were incubated for different time 
intervals with ATP and then pulse-labeled for 10 s with D2O. Since the HX reaction times 
were always identical, changes in the numbers of incorporated deuterons are due to the ATP-
induced transition from the R to the T state. In the absence of ATP or at the shortest time-
point after addition of ATP only one mass peak is observed Fig. 2.13a and b). 
 
 
Fig. 2.13 Kinetics of the ATP-induced R to T transition of HtpG. Deconvoluted mass spectra of wild type 
HtpG (a) and HtpG-E34A (b) before incubation in D2O (bottom curve), after 10 s in D2O in the absence of 
nucleotides (apo; R state) or after different pre-incubation times in the presence of ATP (as indicated to the left) 
followed by pulse-labeling for 10 s in D2O. Dashed gray lines indicate the maximum of the mass peaks after 10 s 
preincubation in the presence of ATP (I state) and after 600 and 3600 s preincubation in ATP (T state) as 
designated. (c) Relative amount of T state versus the pre-incubation time in ATP. A first order rate equation was 
fitted to the data (solid line) to give the I to T conversion rates of 0.01 s-1 and 0.0006 s-1 for wild type HtpG and 
HtpG-E34A, respectively. 
 
However, the mass of pulse-labeled HtpG after the shortest incubation with ATP was already 
smaller than the mass of pulse-labeled apo-HtpG indicating a conformational transition that 
happens within 10 s. At later time points a second species with a still lower mass appeared 
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and became dominant. These data strongly suggest a two-phase transition: a rapid transition 
between the fast exchanging R state to a slightly protected intermediate (I) state and a 
subsequent slow transition to the fully protected T state. The second transition is much slower 
in HtpG-E34A. We fitted an equation for two Gaussian peaks with different means and areas 
but similar width to the data and determined the percentage of I and T states. The average I to 
T conversion rates for wild type HtpG and mutant HtpG-E34A were 0.01 s-1 and 0.0006 s-1, 
which are within the error of the experiment identical to the ATP hydrolysis rates 
demonstrating that the conformational changes are rate-limiting for ATP hydrolysis. 
2.2.6 Spatial resolution of the R to T transition 
 
Our peptide data revealed ATP-dependent conformational changes in regions close to the 
nucleotide-binding site but also in regions far distant in space. This raises the question of 
whether all ATP-induced conformational changes occur simultaneously in a concerted fashion 
or whether they occur in an ordered succession of events. In the first scenario, the protein 
would oscillate continuously between an open and a closed state with ATP-binding trapping 
the closed state. In the second scenario ATP would bind to the open state and trigger local 
conformational changes that are subsequently propagated throughout the protein. To 
distinguish between these two scenarios, we performed spatially resolved pulse-labeling HX 
experiments by including peptic digestion under quench conditions after pulse-labeling. 
The comparison of the mass spectra of selected peptic peptides of HtpG in the nucleotide-free 
state with 10 s of incubation with ATP already revealed a significant shift of the center of the 
isotopic peak distribution towards lower m/z values most notably in peptides 89-98 and 
120-127 but also in peptides 1-19 and 335-359 (Fig. 2.14a). These data locate the 
conformational changes that lead to the I state. At subsequent time points the isotope peaks in 
most spectra formed a clear bimodal distribution, which demonstrates the simultaneous 
presence of two HtpG states with different solvent accessibility. The more accessible state 
slowly converts into a more protected state. From the intensities of the highest peaks in the 
two states we determined the rates for the I to T transition for each of the peptides analyzed. 
Interestingly, the rate of  I to T conversion was different in the analyzed segments (Fig. 
2.14b). The transition rate was highest in the ATP-lid (segments 90-98 and 121-127) and 
decreased towards the N-terminal segment 2-19 and the MD segments 320-334 and 336-359, 
which contains the catalytic Arg336 (homologous to Arg380 in yeast Hsp82). For the HtpG-
E34A variant protein, we observed the same phenomenon, albeit with overall much lower 
rates (Fig. 2.14c). These data confirm that the R to T transition occurs in two phases: a fast 
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phase, which cannot be resolved by HX, and a slow phase. Since the first phase not only 
affects the ATP-lid region but also the N-terminus and segments in the MD, it is a global 
transition to an intermediate state (I) that may happen in a concerted fashion. The major 
second phase, the transition from the I state to the T state, does not occur in all segments 
simultaneously but in sequential steps. The I to T conversion in the MD segments has the 
same rate as the single turnover ATPase rate indicating that this conformational change is 
rate-limiting for γ-phosphate cleavage. 
 
Fig. 2.14 Spatially resolved kinetics of R to T transition. (a) Representative mass spectra (m/z scale) of 
selected peptic peptides of wild type HtpG before incubation in D2O (bottom curve; monoisotopic mass and 
charge state are given), after 10 s in D2O in the absence of nucleotides (apo) or after pre-incubation for 10 to 300 
s in the presence of ATP (as indicated to the left) followed by pulse-labeling for 10 s in D2O. The residue 
numbers of the peptides are given above the spectra. Dotted gray lines indicate the highest peak after 10 s pre-
incubation in ATP followed by 10 s HX (I state, black circle) and the highest peak after 300 s pre-incubation in 
ATP followed by 10 s HX (T state, black square). (b) I to T transition rates for selected peptides of wildtype 
HtpG calculated as described in Materials and Methods. The bars represent the mean of 3 independent 
determinations and standard error of mean. (c) I to T transition rates for selected peptides of HtpG-E34A. 
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2.2.7 Conformational changes in HtpG followed by fluorescence 
 
We wished to extend our study to the analysis of global domain movements. To this end, we 
introduced fluorescent labels at position 12 in HtpG in order to perform fluorescence 
resonance energy transfer (FRET) experiments. Prodromou and coworkers previously used 
the homologous position in yeast Hsp82 for pyrene excimer fluorescence (Prodromou et al., 
2000). HtpG-E12C was labeled with Hilyte Fluor™ 488 (HtpGFL) as donor and the quantum 
dot QXL520 as fluorescence quencher (HtpGQ). Upon mixing of HtpGFL and HtpGQ, donor 
fluorescence decreased significantly, which indicates that heterodimers formed and that the 
two fluorescent dyes were within the Förster distance of each other. Addition of ATP but not 
ADP induced a time-dependent decrease in fluorescence. However, a similar ATP-dependent 
decrease in fluorescence was also observed in the absence of HtpGQ (Fig. 2.15a) 
demonstrating that the decrease in donor fluorescence was caused by a change in the 
environment of the donor fluorophor. The same fluorescence decrease was observed for the 
HtpG-E34A variant albeit with slower kinetics (Fig. 2.15b). Addition of a large excess of 
ADP to reactions of HtpGFL already equilibrated with ATP led to an increase in fluorescence 
(Fig. 6c). Close inspection of the fluorescence traces after addition of ATP revealed that the 
fluorescence emission first increased rapidly before it decreased again (Fig. 2.15a and c). We 
determined the kinetics of the first phase in dependence of the ATP concentration using 
stopped-flow measurements (Fig. 2.15d and e). The observed rate increased with increasing 
ATP concentrations according to a hyperbolic relationship, which indicates a two-step process 
with a fast equilibrium as first step and a subsequent isomerization. The equilibrium constant 
for the first step was determined to 3.6 ± 0.6 mM and the forward and back reaction rates for 
the isomerization step to 227 ± 12 s-1 and 30 ± 5 s-1. The isomerization step was followed by a 
much slower conformational change, which caused a decrease in fluorescence. The rate for 
this step was determined to 0.0089 ± 0.0003 s-1, which is very close to the conversion rate of 
segment 2-19 as determined by HX-MS (Fig. 2.14b). The reversion of the fluorescence 
decrease upon addition of a large excess of ADP to the equilibrated reaction of HtpGFL with 
ATP occurs with a rate of 0.0062 ± 0.0003 s-1, which is similar to the ATP hydrolysis rate at 
the HtpG and ATP concentrations used. This argues that ATP hydrolysis is rate-limiting for 
the fluorescence change and that ATP dissociation from this stage occurs at a rate of 
≤ 0.0062 s-1. These data suggest that once the ATPase cycle has reached this point ATP is 
committed to catalysis.  
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Fig. 2.15 Kinetics of nucleotide-induced conformational changes followed by fluorescence. (a) Fluorescence 
trace of HtpG-E12C-Hilyte Fluor™ 488 (HtpGFL; 300 nM) in the absence or presence of HtpG-E12C-QXL-520 
(HtpGQ; 600 nM) after addition of ADP (20 mM) or ATP (20 mM) as indicated (excitation 475 nm; emission 
525 nm). For better visibility the curves were shifted in y-axis direction. (b) Fluorescence trace of HtpG-
E12C,E34A-Hilyte Fluor™ 488 (HtpG-E34AFL; 300 nM) in the presence of HtpG-E12C,E34A-QXL-520 
(HtpG-E34AQ; 600 nM) after addition of ATP. (c) Fluorescence trace of HtpGFL (300 nM) after addition of ATP 
(20 mM) and subsequent addition of ADP (60 mM) as indicated by the arrows. (d) Fluorescence traces of 
HtpGFL (150 nM final concentration) after mixing 1:1 with 0.15 to 7.5 mM ATP (final concentrations) 
(excitation 488 nm; cut-off filter 530 nm). (e) Plot of the observed rates of fluorescence increase versus the ATP 
concentration. The solid line represents the non-linear regression fit of a hyperbolic equation giving a KD1 of 3.6 
± 0.6 mM, k2 of 227 ± 12 s-1 and k-2 of 30 ± 5 s-1 (means of two independent determinations). (f) Single-turnover 
ATPase assay to determine the degree of commitment to catalysis of bound ATP. HtpG (50 µM) was mixed with 
[α-32P]ATP (40 µM; 3.7 kBq) and ATP hydrolysis followed by thin layer chromatography and phosphoimaging. 
The ratio of ATP divided by ATP plus ADP is potted versus incubation time. At the indicated time point 5 mM 
unlabeled ATP was added to the samples with filled symbols (3 independent experiments shown); open circle, 
control sample. The solid lines are non-linear regression fits of a single exponential decay function to the data. 
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In order to test this hypothesis, we performed single turnover ATPase assays using [α-
32P]ATP and adding an excess of unlabeled ATP 60 s after the start of the reaction (Fig. 
2.15f). After addition of unlabeled ATP conversion of [α-32P]ATP into ADP did not stop 
immediately but continued with essentially the same rate but the total amount of ATP that was 
converted decreased to 13 % of the control sample. These data indicate that 13% of the ATP 
could not be replaced by cold ATP and was therefore committed to catalysis. Approximately 
the same fraction of HtpG molecules is converted into the T state under these conditions. 
 
Upon addition of ADP to HtpGFL we also observed a rapid increase in fluorescence but no 
subsequent slow decrease. (Fig. 2.16, Fig. 2.15a). These data are consistent with our HX-MS 
experiments, which revealed a small protection in segment 2-19 in the presence of ADP but 
not the large conformational change observed in the presence of ATP. 
 
 
Fig. 2.16 Association of ADP to HtpG followed by fluorescence spectroscopy. (a) Fluorescence traces of 
HtpGFL (150 nM final concentration) after mixing 1:1 with 0.15 to 3 mM ADP (final concentrations) (excitation 
488 nm; cut-off filter 530 nm). (b) Plot of the observed rates of fluorescence increase versus the ADP 
concentration. Linear regression analysis resulted in association and dissociation rate constants of 70,000 ± 2,000 
M-1 s-1 and 5.4 ± 1.6 s-1, respectively, from which a KD of 78 ± 23 µM could be calculated. 
 
Taken together, our fluorescence experiments allowed us to dissect the ATPase cycle of HtpG 
Fig. 2.18a). The fluorescent probe monitored a series of nucleotide-dependent conformational 
changes in the segment 2-19, which are fully consistent with our HX-MS experiments. These 
data also demonstrate that the last slow conformational change after addition of ATP leads to 
the trapping of ATP and commitment to catalysis. 
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2.2.8 Distances between the two NBDs in the HtpG dimer 
 
Our FRET experiments could not detect nucleotide-dependent changes in the distance 
between the two NBDs of the HtpG dimer. We therefore used site-specific crosslinking to 
detect domain movements. First, we tried to form disulfide bonds between the two NBDs of 
the HtpG-E12C dimer. To this end, nucleotide-free HtpG was completely reduced and then 
treated with diamide in the absence or presence of ADP or ATP. Subsequently, iodoacetamide 
was added to block any free thiols and the samples were analyzed by non-reducing SDS-
polyacrylamide gelelectrophoresis (Fig. 2.17a). Disulfides formed only in the absence of 
nucleotides and the presence of ADP but not in the presence of ATP indicating that the 
cysteines in position 12 come within 4 Å in the nucleotide-free and the ADP-bound state. 
 
 
Fig. 2.17  Determination of the proximity of position 
12 in the two NBD of the HtpG dimer. (a) Disulfide 
bond formation. SDS-polyacrylamide gel of reduced 
HtpG-E12C pre-incubated with the indicated 
nucleotide for at least 10 min, treated with diamide for 
10 min (where indicated) and subsequently with 
iodoacetamide. Gel was run under non-reducing 
conditions and stained with Coomassie Brillant Blue. 
Molecular weights are given at the left, the disulfide 
linked HtpG-dimer is indidated at the right.  
(b) Crosslinking of HtpG-E12C with 
bis(maleimido)ethane (BMOE) and 
bis(maleimido)hexane (BMH) in the absence of 
nucleotide or the presence of ADP or ATP as 
indicated. SDS-polyacrylamide gels were run under 
reducing conditions and stained with Coomassie 
Billant Blue. The HtpG and crosslink (XL) bands are 
designated. 
 
 
 
 
To obtain information on the distance of the thiol groups of Cys12 in the HtpG dimer in the 
presence of ATP we added the homobifunctional thiol-specific crosslinker 
bismaleimidoethane (BMOE) and bismaleimidohexane (BMH) with a length of 8 and 13 Å, 
respectively (Fig. 2.17b). As expected, both crosslinker were able to crosslink the HtpG dimer 
in the absence of nucleotides and in the presence of ADP. In the presence of ATP a 
crosslinking product only formed when BMH was used but not with BMOE suggesting that 
the thiol groups of Cys12 have a distance of more than 8 Å and less than 13 Å in the presence 
of ATP. These data are consistent with the formation of a strand exchange between the two 
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NBDs of the HtpG dimer since the distance of the Cβ and Cγ atoms of the two Glu12 in the 
dimeric homology model of HtpG on the Hsp82 dimer structure is 12.2 and 11.3 Å, 
respectively. 
2.2.9 Discussion 
 
Our analysis of the conformational dynamics of the E. coli Hsp90 homologue HtpG yielded 
the following novel insights into the ATPase cycle of HtpG: (1) Nucleotide binding induces 
conformational changes in NBD, MD and C-terminal DD; (2) The ATP-bound state is the 
most compact state of HtpG with least backbone amide hydrogens solvent accessible; (3) The 
majority of the ATP-induced conformational changes happen surprisingly slow in a sequential 
fashion, starting with the nucleotide binding pocket and progressing like a wave to the very 
N-terminus and to the MD; (4) Glu34 is important for the rate of R to T conversion; (5) The 
slow conformational change leads to trapping of the ATP and to commitment to catalysis; this 
step is rate-limiting for ATP hydrolysis and therefore acts like a timer for the chaperone cycle 
of HtpG; (6) In the ATP-bound state the two NBDs of the HtpG dimer are within 13 Å of 
each other consistent with the strand exchange mechanism of yeast Hsp82. In addition our 
fluorescent probe allowed us to determine the kinetics of ATP-binding, which occurs in a 
multi-step process. 
Our data differ significantly from a recent HX-MS study on human Hsp90 (Phillips et al., 
2007). Jackson and coworkers analyzed in this study the influence of two inhibitors, which 
bind into the nucleotide-binding pocket, and of the cochaperone Cdc37 on the conformational 
flexibility of Hsp90. Although some of the inhibitor-induced changes in human Hsp90 
occurred in similar regions as the ATP-induced changes in HtpG, the magnitude was much 
smaller and it remains an open question whether inhibitors in general cause smaller changes 
than nucleotides or whether the human Hsp90 protein is less affected by ligand binding to the 
nucleotide binding pocket. 
A recent crystallographic and electronmicroscopic study provided evidence that HtpG 
performs dramatic conformational changes when progressing through the ATPase cycle 
(Shiau et al., 2006). In this study the ADP-bound state was proposed to be the most compact 
conformation within the ATPase cycle of HtpG. Our data demonstrate that the ATP-bound 
state and not the post-hydrolysis or the ADP-bound state is the least solvent accessible and 
most rigid state of HtpG. 
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Fig. 2.18 ATPase cycle of HtpG and model of conformational changes. (a) Steps of the ATPase cycle of 
HtpG with rate and equilibrium constants as determined by fluorescence spectroscopy and biochemical assays. 
ER, EI, and ET, HtpG in the relaxed, intermediate and tensed states. (b) Model of conformational changes of 
HtpG during the ATPase cycle. Secondary structure representations of the crystal structure of ADP-bound HtpG 
(PDB entry code 2IOP (Shiau et al., 2006); left panel) and of an homology model of HtpG on the crystal 
structure of yeast Hsp82 in complex with AMPPNP and Sba1 (PDB entry code 2CG9 (Ali et al., 2006; Guex and 
Peitsch, 1997; Peitsch, 1996)) as model for the ATP-bound structure of HtpG (right panel) colored according to 
the I to T transition rates with red (high rates) to blue (low rates). Residue Glu12 (E12), where the fluorescent dye 
was attached in the HtpG-E12C variant, is shown in magenta. Between the structural representations a model of 
the ATPase cycle is shown which includes the nucleotide-free R state, the first intermediate (I state) after ATP 
binding, the T state and the ADP-bound state, which is similar to the I state. The nucleotide-free and ADP-bound 
states can assume several conformations as indicated by the double arrows since the distance of E12 in the crystal 
structure is 38 Å but could be crosslinked with an 8 Å crosslinker or form disulfide bridges requiring a 4 Å 
proximity. 
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While the ADP-bound state may have a more compact shape as proposed by Agard and 
coworkers (Shiau et al., 2006), it is nonetheless almost as flexible as the nucleotide-free state, 
whereas the ATP-bound state has a much lower degree of conformational dynamics. 
Such flexibility of the nucleotide-free and ADP-bound states cannot be restricted to secondary 
structure but must also accompany domain movement. In neither the dimer structure of ADP-
bound HtpG (PDB entry code 2IOP) nor the dimeric model of the nucleotide-free structure of 
HtpG (PDB entry code 2IOQ) are the Glu12s of the two protomers within 30 Å of each other. 
These conformations would not allow crosslinking with BMH or BMOE nor disulfide bond 
formation. We conclude that the NBDs sample conformations that bring the two Glu12 within 
4 Å of each other. 
The reduced flexibility in the ATP-bound state could be important for high-affinity client 
binding. ATP hydrolysis might release the strain and therefore lower the affinity for clients. 
Such a model would be consistent with data for yeast Hsp90 demonstrating that ATP 
hydrolysis leads to client dissociation (Young and Hartl, 2000). Our results provide a 
thermodynamic explanation for this phenomenon: In the nucleotide-free state the 
conformational flexibility, and therefore the conformational entropy, is much higher than in 
the ATP-bound state. It is conceivable that client binding reduces the conformational entropy 
in the interacting parts of HtpG. Client release in the ADP-bound or nucleotide-free state 
would therefore be accompanied by an increase in conformational entropy, which would favor 
the dissociation reaction. In the ATP-bound state this increase in conformational entropy upon 
client dissociation would be much smaller due to the more rigid structure of HtpG. This 
would result in shifting the equilibrium to the bound form. The chaperone cycle of HtpG may 
start with client binding to the nucleotide-free state with relatively high conformational 
entropy. ATP binding leads to a tight binding of the client due to the conformational rigidity. 
Subsequent ATP hydrolysis relaxes HtpG, which favors client dissociation. The slow ATP-
induced conformational change in HtpG might impose a strain on the client protein 
performing mechanical work on their conformation.  
Our HX-MS and fluorescence data demonstrate that ATP binding induces a series of 
consecutive conformational states that are in equilibrium with each other (Fig. 2.18a). ATP 
associates with the R-state of HtpG to form an initial encounter complex that has a 
dissociation equilibrium constant of 3.6 mM. The encounter complex is converted rapidly 
with a rate of 227 s-1 into an intermediate state. This I state is characterized by reduced 
solvent accessibility of backbone amide hydrogens in several regions of the protein including 
the N-terminal segment 2-19 and segments in the middle domain and an increase in 
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fluorescence of a fluorophor at position 12. The transition to the I state occurs most likely in a 
concerted conformational change. ADP binding also induces a small protection in segment 2-
19 (Fig. 2.10) and a fluorescence increase of HtpGFL (data not shown). Thus, the ADP-bound 
state might be similar to the ATP-induced I state. However, the subsequent slow step to the T 
state only occurs upon binding of ATP and not ADP. This conversion involves a succession 
of conformational changes starting in the nucleotide-binding pocket, for which we measured 
the highest conversion rate, and progressing like a wave towards the N-terminus and the 
catalytic loop of the MD, which reach the T state conformation with lower rates. This is the 
first time that such stepwise changes in the conformation in an Hsp90 protein could be 
spatially and temporally resolved. 
Our data are consistent with the proposed ATPase cycle of yeast Hsp82 (Richter et al., 2001; 
Weikl et al., 2000). ATP associates rapidly with Hsp82 to form an encounter complex. Based 
on the observed cooperativity of ATP hydrolysis in the dimeric protein, it has been proposed 
that the encounter complex undergoes two sequential conformational changes: First, docking 
of the NBD with the MD; second, N-terminal dimerization with strand exchange, which is 
proposed to be very slow. In the present study, we provide direct evidence for these 
conformational changes. Our data suggest that N-terminal dimerization of HtpG occurs at the 
same time as or even precedes docking with the MD. Similar conformational changes were 
proposed based on crystal structure data and the structural similarity of Hsp90 with DNA 
gyrase B (Meyer et al., 2003; Prodromou et al., 2000). Evidence for a multi-step ATPase 
cycle with conformational changes was reported recently for the mitochondrial Hsp90 
homologue Trap1 (Leskovar et al., 2008). The ATPase cycle of human Hsp90 and the Hsp90 
homologue in the endoplasmic reticulum, Grp94, seem to be less complex and do not involve 
a slow isomerization step (Frey et al., 2007; McLaughlin et al., 2004). In all investigated 
Hsp90 proteins ATP hydrolysis was rate-limiting. Based on the correlation of the conversion 
rates with hydrolysis rate, we propose that the slow conformational change which leads to the 
docking of NBD and MD is rate-limiting rather than γ-phosphate cleavage itself. Our 
experiments with the HtpG-E34A variant, which has an ATPase activity of less than 10% of 
wild type HtpG and also a much lower conversion rate from the I to the T state (Fig. 2.14c) 
also support this mechanism. It is very unexpected that a single amino acid change would 
affect the conformational transition rates in distant parts of the protein. However, in the 
Hsp82 crystal structure, the homologous Glu33 is in a central position in the ATPase pocket. 
One of its carboxyl oxygens forms a hydrogen bond with the γ-phosphate of the AMPPNP, 
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and the other carboxyl oxygen is 3.6 Å away from one of the terminal nitrogens of Arg380 of 
the middle domain, which is essential for γ-phosphate cleavage. It is conceivable that Glu33 
guides Arg380 to the γ-phosphate, and therefore its replacement with alanine could slow down 
the formation of a hydrogen bond between Arg380 and the γ-phosphate, which would explain 
the reduced conversion rate of the middle domain segments from the I to the T state and the 
reduced ATPase activity. In addition, the interaction of this Glu with the ATP could stabilize 
helix 2 which may favor the formation of the strand exchange complex. 
Glu33 in Hsp82 was originally linked to catalysis of γ-phosphate cleavage due to the structural 
similarity to DNA gyrase B, in which the homologous Glu42 was shown to act as general base 
(Jackson and Maxwell, 1993; Obermann et al., 1998; Panaretou et al., 1998). Based on our 
data, we propose that Glu34 in HtpG has an additional role in coordinating the docking of the 
NBD with the MD and the NBD of the second protomer in the HtpG dimer by guiding Arg336 
to the γ-phosphate and by stabilizing helix 2, which favors strand exchange. 
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2.3 Comparative study on the dynamics of eukaryotic Hsp90 
chaperones 
 
 
 
The HX-MS study on the bacterial HtpG revealed dramatic compaction and stabilization of 
the protein upon ATP binding and provided insights in the sequential steps of conformational 
changes during the ATPase cycle. Based on this data we wondered if the dynamics of HtpG is 
similar to the eukaryotic Hsp90 homologues, the constitutively expressed yeast Hsc82 and 
human Hsp90β. In contrast to HtpG, eukaryotic Hsp90 chaperones are essential and co-
operate with various co-chaperones in order to function in client maturation and activation. 
However, the nucleotide-dependent dynamics and the binding sites of clients and co-
chaperones in eukaryotic Hsp90s are still poorly understood. A recent study performed amide 
hydrogen exchange and MS on human Hsp90 in complex with inhibitors or the co-chaperone 
Cdc37, but could only detect minor conformational changes which affected all domains 
throughout the protein (Phillips et al., 2007). We performed HX-MS experiments with 
yHsc82 and hHsp90β in absence or presence of nucleotides and inhibitors in order to 
elucidiate the effect of real ligands on the Hsp90 conformation. 
2.3.1 Global deuteron incorporation into human Hsp90β and yeast Hsc82 
 
 
Both hHsp90β and yHsc82 were purified from E. coli with the SUMO-strategy resulting in 
pure nucleotide-free proteins without any additional tag. The activity of the proteins was 
tested by measuring the steady-state ATPase activity at 30°C using an enzyme-coupled assay. 
Human Hsp90 was determined to have a low ATPase activity of 0.0915±0.004 min-1, while 
yeast Hsc82 displayed a higher activity of 0.73 ±0.054 min-1 at 5 mM ATP. The activities 
were slightly higher but close to published turnover numbers (McLaughlin et al., 2002; 
Panaretou et al., 1998; Weikl et al., 2000). 
To analyze the conformational flexibility of the full-length Hsp90 proteins we performed HX-
MS at 30°C and compared the results with the data acquired for E. coli HtpG. We found that 
the yeast and human Hsp90 proteins are extremely flexible at the secondary structure level 
exchanging in the nucleotide-free state close to 50% of their amide hydrogens within 10 s and 
more than 70% within one hour (Fig. 2.19a). Well folded proteins are expected to retain 40 to 
50% of their amide hydrogens during a 60 min time period. In contrast to the eukaryotic 
Hsp90 proteins, HtpG is more stable exchanging only 38% within 10 s and around 60% 
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within one hour. This difference in mobility is not due to the different length of the charged 
linker connecting nucleotide binding domain (NBD) and middle domain (MD) (see Fig. 
2.20a) and also apparent when the numbers of linker amide hydrogens are subtracted from the 
data (Fig. 2b). 
 
 
Fig. 2.19 Deuteration kinetics of the Hsp90 homologs. (a) HX kinetics in hHsp90β. The mass of hHsp90β and 
the percentage of hydrogen exchange, respectively, is plotted versus the incubation time in D2O. The data points 
are averages of up to four independent experiments and the error bars represent the standard error of mean. The 
solid line is a fit of a tri-exponential equation to the datapoints. The dashed line represents the theoretical 
exchange curve including the backexchange during the desalting process calculated for the completely unfolded 
Hsp90 protein using the HXPep program (courtesy of Z. Zhang). (b) Comparison of the HX kinetics of full-
length hHsp90β (black circles), yHsc82 (green squares), and E.coli HtpG (blue triangles). Relative percentage of 
exchange (amide hydrogens of the charged linker substracted, see  Fig. 2.20a ) is plotted versus the time in D2O. 
The inset shows the same data with a logarithmic time scale.  
 
2.3.2 Localization of slow and fast exchanging regions in the eukaryotic 
Hsp90s 
 
Online peptic digestion under quench conditions at 0°C allowed us to map fast and slow 
exchanging regions with a sequence coverage of 82% and 65% for the human and the yeast 
protein, respectively, including parts of the charged linker, which is absent in any crystal 
structure.  
High secondary structure stability was observed in the NBD except for the ATP-lid (residues 
99 to 133 in hHsp90β) which exchanged 60 to 78% of all amide hydrogens within 10 s and 
more than 90% after 10 min. 
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Fig. 2.20 Comparison of yHsc82 and hHsp90. (a) Domain organization (b) Clustal W alignment of the amino 
acid sequence of yeast Hsc82 and human Hsp90β. Secondary structure elements, α helices (α1-18), 310 helices (η 
1-8), and β strands (β1-20) are derived from the crystal structure of yHsp82 (PDB ID code 2CG9). The lines 
under each sequence indicate the peptic fragments covering the Hsp90 sequences that were analyzed in this HX-
MS study. 
 
 
The MD and the C-terminal dimerization domain (DD) are much more flexible than the NBD 
(Fig. 2.21c). Not surprisingly, the charged linker (residues 216-275 in hHsp90β), which 
connects NBD and MD and which is symbolized as dashed line in Fig. 2.21c, exchanged 
almost all of its amide hydrogen within 10 s. The catalytic loop in the MD (residues 382-402 
in hHsp90β) was observed in two peptides which exchanged 39 and 52% within 10 s, 
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respectively. Since the peptic fragments also covered adjacent secondary structure elements, 
which can account entirely with their hydrogen bonds for the degree of protection observed in 
the fragments, it is very likely that the catalytic loop exchanged all amide hydrogens within 
this time frame.  
 
Fig. 2.21 Comparision of deuteration levels within segments of all three Hsp90 homologues. Secondary 
structure representation of a homology model of human Hsp90 onto the structure of yeast Hsp82 (PDB ID code 
1CG9; 42; 43; 44; upper panels), the crystal structure of yeast Hsp82 (PDB ID code 1CG9; middle panels), and the 
crystal structure of E. coli HtpG (PDB code 2IOP; lower panels) colored according to the degree of deuteron 
incorporation after 10 s (left panels) and 10 min (right panels) as indicated. N, N terminus; C, C terminus; NBD, 
nucleotide binding domain; MD, middle domain; DD, dimerization domain; CL, charged linker; lid, ATP-lid; 
cat, loop containing the catalytic arginine; DI, dimerization interface. Elements implicated in substrate binding: 
W, loop containing Trp312 (human Hsp90; position 300 in yeast Hsp82; (Sato et al., 2000)); src, src-loop (Meyer 
et al., 2003);  α15 , helix 15 (numbering according to  Fig. 2.20b).  
 
 
A similar degree of flexibility exhibited three structural elements implicated in substrate 
binding: the loop, which contains Trp312 in hHsp90β (position 300 in yeast Hsp82; (Sato et al., 
2000)), the so-called Src-loop (residues 324-340 in yeast Hsp82 and not resolved in the 
structure; (Meyer et al., 2003)), and the α-helix 15. Even one or both of the helices involved 
in the dimer interface incorporated deuterons to a high degree within 10 min consistent with a 
fast dimer-monomer equilibrium (Fig. 2.21c right panels) (Richter et al., 2001). The 
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difference in stability between HtpG and the eukaryotic Hsp90 proteins resides clearly in the 
MD and DD. The NBD exhibited a similar degree of stability in the central β-sheet region but 
a higher degree of conformational dynamics within the very N-terminal part (residues 1-19) 
and the ATP-lid (residues 97-127). In the MD it is especially the first β-sheet and the α-helical 
coil that exchanges with slower kinetics in HtpG than in the eukaryotic proteins (compare 
right panels in Fig. 2.21c). The helices in the DD of HtpG also incorporate deuterons to a 
lower degree at 10 s and 10 min as compared to the yeast protein. In particular, the one of the 
helices involved in the dimer interface in HtpG is more stable than its counterpart in yeast or 
human Hsp90 suggesting a less dynamic dimer-monomer equilibrium. Taken together, the 
high degree of flexibility of the nucleotide-free eukaryotic Hsp90 proteins resides mainly in 
the MD and the DD and in the ATP-lid of the NBD. 
 
2.3.3 Nucleotide-dependent conformational changes in yHsc82 and 
hHsp90β 
 
To analyze the influence of nucleotides on the conformational dynamics we preincubated the 
Hsp90 proteins with a large excess of ADP and ATP for at least 10 min before the start of the 
exchange reaction as done with HtpG in the previous chapter. Deuteron incorporation into the 
proteins was significantly reduced in the presence of nucleotides (Fig. 2.22a, b). For human 
Hsp90β we found at the 10 s time-point an overall protection of around 16 and 19 amide 
hydrogens in the presence ATP and ADP, respectively. The degree of nucleotide-induced 
protection was observed throughout the exchange kinetics. For yeast Hsc82 the degree of 
protection observed in the presence of ADP and ATP was slightly lower (ca. 10 amide 
hydrogens). Interestingly, a large protection in presence of ATP as observed in the 
prokaryotic HtpG could not be found in both proteins. To localize the regions in the 
chaperones affected upon nucleotide-binding, we included peptic digestion in the HPLC-MS 
set-up. 
Mapping the nucleotide-induced differences onto the primary sequence of hHsp90β revealed 
that a stabilizing effect of ATP was observed in the ATP-lid (residues 100-114 and 127-133; 
Fig. 2.22c left panel, Fig. 2.23). 
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Fig. 2.22 Nucleotide-dependent conformational changes in hHsp90β and yHsc82.  
Global HX kinetics of (a) Hsp90 and (b) Hsc82 in absence or presence of ADP, ATP and AMPNP (colours as 
indicated). The data points are averages of at least two independent experiments. The solid lines are fits of a 
biexponential equation to the data. (c) Difference plots of deuterons incorporated in the presence of ATP (red 
bars) and ADP (orange bars) minus deuterons incorporated in the absence of nucleotides into human Hsp90β 
(left panel) and yeast Hsc82 (right panel) segments after 30 s in D2O. The numbers to the left of each panel 
indicate the corresponding segments in the proteins. The gray bar indicates the standard error of mean, defining 
the detection level of significant changes. 
 
 
A small stabilization was also observed throughout the entire protein down to the very C-
terminus. In particular the segment following the catalytic Arg-392 exhibited a significant 
stabilization in the presence of ATP suggesting a contact between the NBD and the MD upon 
ATP binding consistent with the currently favoured ATPase mechanism for Hsp90 proteins. 
The situation was similar but not as prominent in yeast Hsc82. Only parts of the ATP-lid 
(residues 91-105) were significantly protected in the presence of ATP (Fig. 2.22c right panel, 
Fig. 2.23). But the overall small protection of the MD and DD was also observed in the yeast 
protein. Unfortunately, we did not detect the peptic fragment, which contained the catalytic 
arginine for the yeast protein. One segment near the N-terminus (residues 9-15) and one 
segment of the MD of Hsc82 (residues 264-279) adjacent to the charged linker (residues 210-
260 in yHsc82) showed a small deprotection (Fig. 2.22c right panel). 
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Fig. 2.23 Kinetics of deuteron incorporation in selected segments of yHsc82 and hHsp90β. Secondary 
structure representations of the human Hsp90α NBD crystal structure in complex with ADP (PDB ID code 
1BYQ). Segments, residues 100-114 and 127-133, for which HX kinetics are shown in the left (for yeast Hsc82) 
and right panels (for human Hsp90β) are colored in blue (1BYQ). Symbols as indicated in the figure.  
 
 In the presence of ADP the situation is quite different for the human and bacterial Hsp90 
proteins. Though a protection of the ATP-lid was also observed in the two proteins in the 
presence of ADP, several segments of significant deprotection occurred throughout the 
proteins contrasting the protection in the presence of ATP (Fig. 2.22c, orange bars). In the 
human protein part of the charged linker (residues 217-256), the src-loop (residues 345-355), 
and the helical coiled-coil of the MD (residues 434-466) exhibited this deprotection. In 
contrast, yeast Hsc82 showed overall very similar changes in the presence of ADP as 
compared to the presence of ATP.  
We also analyzed the effect of the ATP analogue AMPPNP on the conformational dynamics 
of both proteins. Interestingly, the deuteration kinetics of full-length Hsc82 in presence of 
AMPPNP was similar to ATP after 30 s in D2O, but showed a much higher protection of 
amide protons after long deuteration intervals indicating reduced flexibility (Fig. 2.22b). HX-
MS on peptide level revealed that almost all regions in Hsc82 were significantly stabilized 
after 30 min in D2O in presence of AMPNP Fig. 2.24). 
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Fig. 2.24 Deuteron incorporation of Hsc82 segments in the apo state versus the AMPPNP bound state. 
Plots show the difference in numbers of deuterons incorporated in presence of AMPNP minus the number of 
deuterons incorporated in the absence of nucleotide for two different deuteration times, 30 s (white bars) and 30 
min (black bars) in D2O. 
 
 
Taken together, significant nucleotide-dependent changes of the conformational dynamics 
were observed in both eukaryotic Hsp90s ranging from the NBD to the MD and even the DD. 
The stabilization effects upon ligand binding, however, are minor compared to the dramatic 
effects in the bacterial HtpG. 
2.3.4 Differential effects of inhibitor binding on hHsp90β conformation  
 
Since human Hsp90 became a prime target for anti-cancer therapy in recent years we 
wondered how inhibitors change the conformational dynamics of Hsp90 while arresting the 
chaperone cycle. We tested two different inhibitors, the ansamycin inhibitor geldanamycin 
(GA) and the watersoluble purin-scaffold inhibitor PU-H71 (courtesy of G. Chiosis; (He et 
al., 2006)), both of which bind to the nucleotide binding pocket. We first analyzed the 
deuteron incorporation into full-length hHsp90β in the presence of the two inhibitors and 
compared the HX kinetics with the apo and the ATP bound Hsp90 (Fig. 2.25a). Surprisingly, 
the two inhibitors had different effects on the overall HX kinetics of Hsp90. While GA 
induced an overall protection that is similar to the effect of ATP, PU-H71 did not induce a 
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significant protection and the kinetics of deuteron incorporation were similar to the HX 
kinetics of the apo protein.  
 
Fig. 2.25 Effects of inhibitor binding on conformational dynamics of Hsp90 (a) Global deuteron 
incorporation kinetics of hHsp90β in absence or presence of ATP, geldanamycin (GA) and purin-scaffold 
inhibitor PU-H71. (b) Difference plot of deuteron incorporation in presence of inhibitors or ATP as indicated 
minus the deuteron incorporation in unliganded hHsp90β after 30s in D2O. Shown are selected segments 
throughout the entire protein. 
 
When comparing the HX behaviour of Hsp90 on the peptide level in presence of GA with the 
HX in presence of ATP, significant differences were observed.  One part of the ATP lid 
(segment 127-133) was much stronger protected in the presence of GA than in the ATP bound 
state while the other lid part was less protected (Fig. 2.25b, Fig. 2.23). GA also induced a 
significant protection in segments 33-39 and 156-165, which were barely affected by ATP, 
and in the very C-terminal segment 698-720, which was even deprotected in the presence of 
ATP. While the purin-scaffold inhibitor PU-H71 also induced a protection in the segment 
127-133, it induced a deprotection in segment 100-114 contrasting the effects of ATP and GA 
(Fig. 2.25b). Interestingly, the exchange behavior of this segment was very similar in the 
presence of PU-H71 as compared to GA except for the number of amide hydrogens that 
exchanged in the dead-time of the experiment, which was higher in the case of PU-H71 (Fig. 
2.23). Some segments adjacent to residues 100-114 and the very last segment, residues 
698-720, also showed a slight deprotection. Our data show that both inhibitors deviated in 
their effect on the conformational dynamics of Hsp90 from nucleotides and from each other. 
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2.3.5 Co-chaperone p23 binding stabilizes the N-terminal dimer 
conformation of hHsp90β 
 
HX data could not detect nucleotide-dependent effects in the N-terminal strand of hHsp90β 
that would implicate strand-exchange and hydrogen-bond formation during N-terminal 
dimerization as shown for yeast Hsp82. In order to investigate N-terminal dimerization and 
monitor nucleotide-dependent movements of the two NBD, we performed fluorescence 
resonance energy transfer (FRET) experiments. We designed and purified an hHsp90β mutant 
that was devoid of all other cysteines but contained an E20C mutation in analogy to the 
previously investigated HtpG-E12C mutant (2.2.7). The cysteine mutant was labelled with the 
fluorescent FRET probes Cy3 and Cy5 to completeness and mixed to form hetero-dimers. No 
increase in the acceptor fluorescence of Cy5 could be monitored by fluorescence spectroscopy 
in the mixed dimer solution, showing that the FRET-probes in the apo-hHsp90β dimer are not 
within the Förster distance. There was also no FRET observed upon addition of either ADP, 
ATP or AMPPNP to the solution.  
 
Fig. 2.26 Fluorescence resonance energy transfer (FRET) experiments with mixed fluorescently labelled 
hHsp90β dimers. hHsp90β-E12C was labelled with Cy3 as donor (D) or with Cy5 as acceptor (A). Shown are 
the emission spectra of the mixed heterodimers upon excitation at 520 nm. The inset shows a magnification of 
the Cy5 acceptor fluorescence spectrum. Only in presence of both ATP and the co-chaperone p23, there is an 
increase in acceptor  fluorescence observed indicating FRET. 
 
Next, we asked whether the co-chaperone p23 could influence N-terminal dimerization since 
the closed Hsp82 crystal structure could only obtained in complex with the protein p23/Sba1 
(Ali et al., 2006). Indeed, the Hsp90-Cy3/Cy5 FRET pair showed a small, but significant 
time-dependent increase in acceptor fluorescence when purified p23 was added in presence of 
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ATP, while the presence of ADP had no effect (Fig. 2.26). Thus, these data show that co-
chaperone p23 in presence of ATP modulates the dynamics within the NBD of the hHsp90β 
dimer and might be necessary for correct N-terminal dimerization. 
2.3.6 Discussion of the conformational dynamics of prokaryotic and 
eukaryotic Hsp90s 
 
Our analysis of the conformational dynamics of eukaryotic Hsp90 proteins and the 
comparison to the evolutionarily distant bacterial protein HtpG yielded the following novel 
insights into structure and function of Hsp90 proteins. (1) The conformational dynamics of 
the eukaryotic Hsp90s is much higher than the dynamics of prokaryotic HtpG. (2) Nucleotides 
induced small conformational changes that are not restricted to the NBD but observed 
throughout the Hsp90 proteins,. (3) The two nucleotide competitive inhibitors, GA and 
PU-H71, alter the conformational dynamics of Hsp90 in a way that is different from 
nucleotides and different from each other. 
 The dramatic increase in conformational flexibility in the eukaryotic Hsp90 proteins as 
compared to the prokaryotic HtpG could have several different reasons. The eukaryotic 
proteins evolved to bind to a large number of natively folded proteins, many of which are 
unrelated in sequence or structure. Such a large spectrum of clients may rely on a highly 
flexible structure to allow Hsp90 to quasi mold into different shapes to provide an optimal 
interface for client binding. Although it is currently unknown how many and what kind of 
clients are bound by E. coli HtpG, it is assumed that these are much lower in number and 
either not essential themselves or not stringently dependent on HtpG, since HtpG is not 
essential under any conditions tested so far and htpG deletion has no phenotype. Alternatively 
or in addition, the flexibility of the eukaryotic proteins could be linked to the interaction with 
the plethora of cochaperones (Picard, 2006). No cochaperones were identified for HtpG so 
far. While HtpG appears to work as a stand-alone machine, the eukaryotic Hsp90s may 
require the cochaperones not only to regulate progression through the ATPase cycle but also 
to stabilize certain parts of the eukaryotic Hsp90 proteins as required for the binding of 
specific clients. Mapping of the fast exchanging regions revealed that the differences in 
solvent accessibility between HtpG and the eukaryotic Hsp90 mainly reside in the MD and 
the DD, both of which are implicated in client binding (Meyer et al., 2003; Sato et al., 2000; 
Shiau et al., 2006). In addition, the ATPase stimulating cochaperone Aha1 contacts with its 
N-terminal domain the MD of Hsp90 over the entire length with interactions involving all 
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three subdomain of the MD (Meyer et al., 2004). It is conceivable that these interactions 
stabilize major parts of this domain. The C-terminus of all eukaryotic cytosolic Hsp90 
proteins ends in the MEEVD motif, which is bound by a large number of TPR-domain 
cochaperones, many of which are dimeric proteins like Hsp90 itself. Flexibility in the DD, 
especially influenced by binding of clients and cochaperones in other regions of the protein, 
could influence association and dissociation of the TPR-domain cochaperones and thereby 
coordinate progression through the chaperone cycle. Another important issue that might 
regulate the dynamics and stability of eukaryotic Hsp90 is posttranslational modification. 
Human Hsp90β was found in proteomics screens to be phosphorylated at various positions in 
the intrinsically unfolded linker (Ser226, Ser255, Ser261) and in the middle domain (Thr297) 
(Beausoleil et al., 2006; Matsuoka et al., 2007). Moreover, several acetylation sites (Lys294, 
Lys624) were reported in Hsp90 which play an important function in regulating the chaperone 
cycle (Kim et al., 2006; Scroggins et al., 2007). Certainly, the presence of these modifications 
can influence the conformational changes in the Hsp90 significantly. Flexibility in Hsp90 
could also facilitate the access of kinases/phosphatases and acetylases/deacetylases to those 
sites. 
ATP binding induced an overall protection in all three proteins. This protection was 
particularly prominent in the segments, which constitute the hinges of the ATP-lid (residues 
100-114 and 127-133 in hHsp90β, 91-105 and 118-124 in yHsc82), similar to the more 
drastic protection effects in these segments in HtpG. 
These nucleotide-dependent changes are in agreement with structural studies since these 
segments are found in different conformations in crystal structures of the apo NBD of Hsp90s 
(PDB ID code 1AH6, 1AH8, 1YES; (Prodromou et al., 1997b; Stebbins et al., 1997)) as 
compared to the full-length structures of yeast Hsp82 and E. coli HtpG in complex with 
AMPPNP and Sba1/p23 or ADP (PDB ID codes 2CG9 and 2IOP; (Ali et al., 2006; Shiau et 
al., 2006)). They are also consistent with an NMR study on the isolated NBD (Dehner et al., 
2003). In addition to the stabilization in the ATP-lid we found an ATP-induced stabilization 
in segment 395-415 in hHsp90β. The changes in solvent accessibility in this segment supports 
the currently favored mechanism of ATP hydrolysis, which assigns a crucial role to arginine 
380 in yeast Hsp82 (392 in hHsp90β)  (Ali et al., 2006; Meyer et al., 2003; Meyer et al., 
2004). A contact between nucleotide and Arg380 was recently shown in the crystal structure of 
full-length Hsp82 in complex with AMPPNP and Sba1/p23 (Ali et al., 2006). Our data now 
demonstrate that a communication between nucleotide and this arginine-containing loop also 
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occurs in human Hsp90β and in E. coli HtpG in the presence of ATP and the absence of the 
Sba1/p23 cochaperone.  
The full-length crystal structure of yeast Hsp82 also shows an N-terminal dimerization with 
an exchange of the first β-strand. In the structure this strand exchange is stabilized by 4 
hydrogen bonds. The stabilization observed in HX-MS in the first segments of hHsp90β and 
yHsc82 was only very small presumably because any N-terminal dimerization is very 
transient in the presence of ATP and the absence of stabilizing cochaperones like Sba1/p23 
like in the crystal structure. Indeed, our FRET experiments with mixed fluorescently labelled 
Hsp90 dimer revealed that only in presence of p23 and ATP, the N-termini of both NBD 
moved towards each other. In contrast, in HtpG we observed a very prominent protection of 
almost 8 amide hydrogens in this segment which together with crosslinking data is consistent 
with a stable N-terminal dimerization with strand exchange. The larger number of hydrogen 
bonds formed in HtpG as compared to yeast Hsp82 could be necessary for lack of stabilizing 
cochaperones.  
ADP binding also induced an overall protection in all three Hsp90 proteins. However, aside 
from the ATP-lid, ADP had quite different effects on the exchange behaviour of hHsp90β and 
HtpG as compared to ATP. While ATP induced a slight stabilization throughout the MD and 
DD of hHsp90β, ADP rather destabilized these parts of the protein. In HtpG a deprotection 
was also observed in many segments in the presence of ADP. In yHsc82, however, there was 
no such destabilization effect by ADP observed. It is tempting to speculate that progression 
through the ATPase cycle from ATP to ADP influence also the stability of the C-terminal 
dimerization and regulates subunit exchange of protomers differently in the species. 
Interestingly, a recent biochemical study showed that subunit exchange in human Hsp90β is 
much slower than in yeast Hsp90 and seems to be different in the human isoforms (Richter et 
al., 2008), thus pointing at an additional level of functional regulation in the dimeric Hsp90.  
Our data indicate that ATP and ADP induce different conformational states in all three Hsp90 
homologues and that these conformational changes are not restricted to the NBD but 
propagated throughout the entire proteins. In this context it was important to investigate how 
inhibitors of Hsp90 would affect the conformational flexibility. The two inhibitors affected 
the conformational dynamics of hHsp90β quite differently. While the overall conformational 
stability of Hsp90 in the presence of GA was similar to the state in the presence of ATP or 
ADP, the conformational flexibility of Hsp90 in the presence of PU-H71, which binds to the 
same site as nucleotides and GA, resembled rather the nucleotide-free state. However, the 
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overall changes in solvent accessibility in the presence of PU-H71 are misleading since in 
some segments of the NBD a protection was observed that is similar to a protection induced 
by ATP or GA, while in other parts a deprotection counterbalanced these effects. Our data 
clearly show that the two inhibitors cause changes in the conformational flexibility that are 
different from nucleotides and from each other. We believe that the conformation flexibility is 
important for client and cochaperone binding and consequently divergent effects on these 
dynamics should affect client and cochaperone binding differentially. Different inhibitors 
therefore might bias Hsp90 for binding of different subsets of clients or cochaperones and 
prevent binding of other clients and cochaperones. These data could explain the different in 
vivo effects of various types of drugs (Kasibhatla et al., 2007). 
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2.4 Conformational properties of the E3-ubiquitin ligase CHIP  
 
 
The dimeric U-box E3 ligase CHIP binds the C-terminus of Hsp90 and Hsp70 via its TPR-
domain. By ubiquitylating chaperone bound clients, CHIP links the chaperone machinery to 
the proteasomal degradation pathway. Two recently published crystal structures of mouse and 
zebrafish CHIP differ substantially, showing either asymmetric or symmetric homodimeric 
assemblies.  
In order to analyze the conformational properties of CHIP in solution, HX-MS with human 
CHIP was performed to monitor conformational changes upon binding of Hsp70 and Hsp90 
chaperones or their respective C-terminal EEVD peptides, and in complex with the E2 
ubiquitin-conjugating enzymes UbcH5a and Ubc13. 
 
2.4.1 Unliganded CHIP is a symmetric dimer in solution with highly 
flexible regions 
 
To analyze the conformational flexibility of human CHIP, we performed HX-MS experiments 
as described earlier (Rist et al., 2006). The purified protein was diluted into D2O buffer at 
physiological pH and incubated for different time intervals at 30°C. Subsequently, the 
exchange reaction was quenched by lowering the pH to 2.5 through the addition of ice-cold 
phosphate buffer. The sample was digested online by a pepsin column in the HPLC setup, 
desalted on a reversed phase trap column and eluted over an analytical reversed-phase column 
into an electrospray ionization hybrid quadrupol-time-of-flight mass spectrometer. The 
sequence coverage of identified CHIP peptic peptides was 95 %, allowing detection of 
deuteron incorporation in nearly all regions of the entire 35 kDa protein (Fig. 2.27 a).  
HX experiments with unliganded human CHIP revealed highly flexible and dynamic regions 
within in the protein (Fig. 2.27 b). Particularly, the very N-terminal peptides of the TPR 
domain, including residues 1-48 and 49-60 (forming the first TPR repeat in the crystal 
structure), seem to be largely unfolded, exchanging 99% and 73% of the accessible amide 
protons within 10 s, respectively.  
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Fig. 2.27 Conformational flexibility of human CHIP. (a) Amino acid sequence and peptic peptides of CHIP 
used for the HX analysis. Sequence coverage is 95 %. Secondary structure elements on top are derived from the 
crystal structure of mouse CHIP (PDB code 2C2L) (b) time-dependent deuteron incorporation shown on cartoon 
representation of the asymmetric mouse CHIP dimer structure in complex with MEEVD-peptide (residues 25-
304, PDB code 2C2L). The deuteration level of analyzed peptides after 10 s, 2 min and 30 min in D2O is shown 
in the color code as indicated for only one protomer in the dimeric structure. (c) original spectra of CHIP peptic 
peptides amino acids 152-161 and 162-169 in undeuterated, 30 s deuterated and fully deuterated state. The 
experiment was performed for comparison with hCHIP wildtype and hCHIP(128-303) lacking the TPR domain. 
The highly flexible character of unliganded hCHIP could also be monitored in additional HX 
experiments with longer deuteration intervals. After 2 min and 30 min incubation in D2O, 
almost all TPR domain peptides completely exchanged their amide protons (Fig. 2.27 b), 
suggesting a highly dynamic conformation in the helical repeat domain. Solvent accessibility 
of other regions is in good agreement with crystallographic data, as can be seen in the amide 
proton protection of helical parts within the hCHIP middle domain (peptide 162-169) and the 
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C-terminal U-box domain (Fig. 2.27 b, c) and rapidly exchanging loop regions.  The data also 
monitors the dimeric contacts in CHIP. Both segments in the helical middle domain, peptide 
160-169 and peptide 201-211 show a stable protection even after long exchange time intervals 
(Fig 1. b) which is consistent with the reported dimer interface of the CHIP crystal structure 
(Zhang et al., 2005). Also the second important hydrophobic dimerization interface in the U-
box domain, which is oriented around Asn284 (peptide 287-293) is highly protected from 
deuteron incorporation. 
Interestingly, the region including residues 153-161, which is the base of the helical hairpin of 
the charged middle domain, was found to be almost fully exchanged within 10 s. This 
indicates that this part is in solution either unfolded or alternating in the seconds time scale 
between the two conformations, helical and unfolded, as shown in the asymmetric crystal 
structure of mouse CHIP. No bimodal distribution could be observed in the deuterated peptide 
spectrum, suggesting CHIP being a symmetric dimer in solution with flexible regions in the 
helical coiled-coil domain. Since the crystal structure of Danio rerio CHIP lacking the TPR 
domains shows the protein as a symmetric dimer with the helical hairpin of the middle 
domain completely folded, we asked whether deletion of the TPR domain in hCHIP would 
also result in stabilization of this unfolded part into an elongated helix. Deuteron 
incorporation after 30 s HX into segment 153-161 of ΔTPR construct (hCHIP 128-303) was 
the same as in the full-length hCHIP (Fig. 2.27c), showing unchanged high flexibility in this 
part. However, deletion of the TPR domain led to a slightly increased protection of amide 
hydrogens in segments of the distal part of the middle domain and the U-box region (170-198, 
200-211, Fig. 2.27c), demonstrating a destabilizing effect of the unliganded TPR domain on 
other regions of the full-length protein. 
 
2.4.2 Chaperone binding results in large stabilization of the CHIP TPR 
domain 
 
CHIP has been shown to bind to the C-terminus of Hsp70 and Hsp90 chaperones with high 
affinity via its single TPR domain (Zhang et al., 2005). To analyze possible conformational 
changes induced by individual chaperone binding, we performed HX in the absence and 
presence of purified Hsp70 and Hsp90 chaperones and their respective octameric C-terminal 
peptides. CHIP was preincubated for 30 min with an excess of full-length chaperone or 
peptide to allow stable complex formation. After 30 s incubation in D2O, the samples were 
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analyzed in our HPLC-MS system including columns with immobilized pepsin. With the 
HPLC gradient used in this study, it was possible to separate almost all deuterated CHIP 
peptides from the majority of chaperone peptides for a detailed analysis of solvent 
accessibility. Overall, Hsp70/90 chaperone and peptide binding led to a significant decrease in 
deuteron incorporation in the TPR domain of CHIP.  
 
 
 
Fig. 2.28 Effects in deuteron incorporation of CHIP segments upon TPR-ligand binding 
(a)  Difference in number of deuterons incorporated of CHIP peptides in complex with Hsp90, Hsp70, Hsc70 or 
the octapeptides ASRMEEVD (Hsp90 C-terminus) and GPTIEEVD (Hsp70 C-terminus) minus the deuteron 
incorporation in absence of ligands after 30 s deuteration . (b) Secondary structure representation of mouse CHIP 
monomer visualizing the segments which show large (dark blue) and small (light blue) protection effects upon 
ligand binding. Unaffected regions are shown in grey. 
 
 
Especially the flexible N-terminus with the first helix-turn-helix repeat (segments 2-36, 38-48, 
50-60) and the third distal repeat (segment 119-139) in the TPR domain show a large 
stabilization in presence of peptides and full-length chaperones, having a total of almost 30 
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amide hydrogens protected in the complex compared to the apo form in a 30 s HX 
experiment. Another flexible region stabilized upon ligand binding is the proximal helix of 
the charged middle domain, segment 141-151, which shows a protection of 5 of 10 possible 
amide hydrogens in the formed complex. The adjacent flexible segment, 153-161, exchanged 
in presence of chaperones to the same high extent suggesting no influence on the symmetry of 
CHIP in this region upon ligand binding. No obvious difference in the deuteron incorporation 
was measured between CHIP-chaperone or CHIP-peptide complexes of both Hsp90 and 
Hsp70 type. This indicates that there is no additional contribution of the full-length chaperone 
binding to the conformation of CHIP, which is also reflected in similar binding affinities of 
CHIP to peptide and intact chaperones as measured by isothermal calorimetry or surface 
plasmon resonance spectroscopy (Zhang et al., 2005) (R. Nikolay, M. Stankiewicz, 
unpublished work). Binding of the human Hsc70 and Hsp90 had a slight protective effect on 
flexible U-box segments, but no significant differences between Hsp70 and Hsp90 were found 
that could point at differential ways of chaperone action on CHIP E3 ligase activity in terms 
of conformational changes. 
2.4.3 Effects of E2 ligase binding on the conformation of CHIP 
 
 
As an E3-ubiquitin ligase, CHIP cooperates with E2-ubiquitin-conjugating enzymes to 
transfer ubiquitin to target proteins. Recently, two different E2 ligases have been shown to 
interact with the U-box of CHIP, the canonical Lys48-ubiquitin chain linking enzyme UbcH5 
and the non-canonical Lys63-specific ubiquitin-conjugating enzyme Ubc13-Uev1a (Murata et 
al., 2001; Zhang et al., 2005). Structural information of this interaction, however, is only 
available for hCHIP U-box constructs in complex with Ubc13-Uev1 and the CHIP-U-box-
UbcH5 complex from Danio rerio (PDB code 2OXQ), showing a conserved binding interface 
for all E2 ligases. To analyze possible specific long-range effects of E2 binding on the CHIP 
conformation in solution, we performed HX experiments with CHIP-UbcH5a and CHIP-
Ubc13 complexes with large excess of E2s and measured the deuteron incorporation into 
CHIP peptides in comparison to unbound CHIP. 
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Fig. 2.29 Effects of E2 ligase binding on the deuteron incorporation of CHIP segments (a) Difference in 
deuteron incorporation into CHIP segments in presence of the E2 ligases UbcH5a and Ubc13 minus the deuteron 
incorporation into unbound CHIP after 30s deuteration. Peptides that could not be analyzed are marked with an 
asterisk (b) Secondary structure representation of the zebrafish CHIP-U-box-UbcH5 co-crystal structure (PDB 
code 2OXQ)  visualizing segments stabilized in HX-MS data upon UbcH5a binding (blue). 
 
 
In the CHIP-UbcH5a complex, subtle effects can be monitored on CHIP solvent accessibility 
caused by the E2 binding. One segment in the U-box domain, peptide 239-259, and two 
segments at the distal end of the helical middle domain, including residues 170-211, show a 
small but significant protection of 1-2 amide protons upon complex formation. The stabilized 
regions in the U-box resemble the reported interaction site of UbcH5 in the co-crystal 
structure and from NMR data (Xu et al., 2006), (PDB code 2OXQ). Interestingly, some 
segments in the TPR domain exhibit increased deuteron incorporation, though to a very low 
extent. In the CHIP-Ubc13 complex, there is also less exchange detected in the segments of 
the U-box, indicating the hydrophobic contacts of Ubc13 to this region as shown in the crystal 
structure (Zhang et al., 2005). Strikingly, there is a deprotection of amide protons detected in 
many segments of the TPR domain and the first part of the middle domain which is very 
dominant in peptide 141-151, a region that is highly stabilized in presence of Hsp70 and 
Hsp90 chaperones (Fig. 2.28). 
 
2.4.4 Discussion  
 
This study shows different novel aspects in understanding conformational properties of CHIP 
in solution. Unliganded CHIP is a highly dynamic protein that forms a symmetric dimer in 
solution. HX data can resolve the solvent accessibility of the dimeric 35 kDa protein with 
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complete sequence coverage including the very N-terminus which could not be crystallized 
due to high dynamics. Indeed, the N-terminus and the adjacent peptides up to residue 60, 
forming the first TPR helix-turn-helix, seem to be completely unfolded in unliganded CHIP, 
exchanging almost all accessible amide protons in 10 s. But all other segments in the TPR 
domain of unliganded CHIP exhibit high dynamics and exchange almost all their amide 
protons after 30 min exchange time, as well as distinct parts of the middle domain and the U-
box.  
We show here with HX-MS that human CHIP adopts a symmetrical dimer in solution with a 
highly flexible part at the beginning helical hairpin in the middle domain. This is in contrast to 
two recently published crystal structures of CHIP. The crystallization of a zebrafish CHIP 
construct that was missing the TPR domains but contained the helical linker and the U-box 
revealed a symmetric dimer with a folded helix at the N-terminus of the middle domain (helix 
α7 in the full-length protein) (Xu et al., 2006). When mouse CHIP was co-crystallized with a 
C-terminal Hsp90 peptide that contained an EEVD motif, CHIP was found to exist as an 
asymmetric homodimer, forming one protomer with an elongated helix α7 in the middle 
domain and the other protomer forming a “broken” helix α7. If this were the case for the 
human CHIP in solution, a bimodal distribution of the deuterated peptide indicating two 
different conformational states should be observed in this region. Our HX-MS data revealed 
that peptide 152-161 is highly flexible without bimodal conformational states and thus 
demonstrate a model of a symmetric homodimer that contains a “broken” helix 7 in each 
protomer. Due to the flexibility of this segment, it is still possible that this region in the 
middle domain is rapidly alternating between the helical and the unfolded which is trapped in 
the asymmetric conformation of mouse CHIP crystals. Under physiological conditions in 
solution though, the symmetric flexible dimer seems to be highly populated even in presence 
of ligands. This puts into question the speculated role of CHIP’s asymmetric assembly in 
connecting the “dimeric” chaperone binding function to the monomeric E2-ubiquitin-
conjugating function (Zhang et al., 2005).  
The highly dynamic character of CHIP TPR domain might also contribute to the recently 
discovered chaperone activity of CHIP. CHIP was shown to possess intrinsic chaperone 
activity that enables refolding of denatured luciferase and is enhanced under heat stress 
(Rosser et al., 2007). This study suggests that the chaperone activity resides in the TPR 
domain because deletion of the TPR domain is unable to refold luciferase. It is tempting to 
speculate that the flexible and unfolded regions in the TPR of ligand-free CHIP expose 
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hydrophobic patches that interact with nonnative polypeptides for disaggregation. Moreover, 
this would explain the heat-induced aggregation of wild-type CHIP which is absent in TPR 
deletion constructs (Rosser et al., 2007). In addition, the highly solvent-exposed N-terminal 
region of CHIPs TPR domain seems to be an important recognition site for posttranslational 
modifications. Several proteomic studies report two phosphorylation sites at Ser19 and Ser23 
(Beausoleil et al., 2006; Imami et al., 2008; Olsen et al., 2006) and an ubiquitination site at 
Lys22 that was identified upon auto-ubiquitination by the E2 ligase UbcH5a (Wang et al., 
2005). The flexibility and accessibility of this region might therefore have an important 
function for regulation and specificity of CHIP action.  
Data presented demonstrate that CHIP dynamics is extremely stabilized in the presence of 
Hsp70 and Hsp90 chaperones. Ligand binding induced a significant protection of amide 
hydrogens in the TPR domain which was strongest in both TPR repeats flanking the ligand 
binding site. The most conserved residues in the crystal structures of mouse CHIP and Hop-
TPR in complex with Hsp90 peptides were found to form a positively charged “clamp” that 
holds the two carboxylate groups of the final aspartate. In contrast to HOP-TPRs which show 
selective binding for the individual chaperones EEVD motifs (Scheufler et al., 2000), there is 
no specifity for Hsp70 or Hsp90 binding in view of the fact that the stabilization occurs to the 
same extend for both chaperones and the octameric C-terminal peptides. This demonstrates 
the promiscuity of the CHIP-TPR domain for all EEVD-containing ligands which is also 
reflected in similar binding affinities of full-length chaperones and peptides to CHIP (Zhang 
et al., 2005) (Marta Stankiewicz, Rainer Nikolay, unpublished results).  
The stabilization of the helical fold in the TPR domain by ligand binding was also observed in 
NMR and CD spectroscopic study of protein phosphatase 5 (PP5) that is targeted to Hsp90 via 
its N-terminal TPR domain (Cliff et al., 2006; Cliff et al., 2005). The isolated apo-TPR of 
PP5 was found to be not fully folded and could be stabilized significantly by addition of a 
pentapeptide MEEVD, increasing the helical content from 64% to 98 % as measured by CD 
spectroscopy (Cliff et al., 2005). The authors proposed that folding coupled to binding might 
be a common mechanism of ligand recognition by TPR domains although this idea has been 
debated (Cortajarena and Regan, 2006). Recently published data on the interaction of the TPR 
protein Ssn6 with Tup1 emphasize however the coupled folding-binding mechanism as a 
common principle in TPR mediated interactions (Palaiomylitou et al., 2008). 
Our data HX-MS clearly demonstrate that CHIP follows such a folding-binding mechanism as 
shown in PP5. However, the regions stabilized include mainly the outer TPR repeats 1 and 3 
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of the concave binding surface of CHIP TPR domain and the helix 7 which is part of the 
middle domain, an effect which is different in PP5 (Cliff et al., 2006). Interestingly, there is 
no significant effect upon complex formation on the conformational flexibility of other 
neighbouring regions of CHIP which might explain specifity differences of CHIP on the 
ubiquitylation of Hsp70 or Hsp90 substrates. Additional factors or modifications might thus 
be necessary for CHIP’s triage decision process in the protein quality control of chaperone-
bound client. 
Using HX-MS, we characterized the effect of E2 ligase binding on the CHIP dynamics. 
Complex formation with both E2 ligases, the canonical UbcH5a and the non-canonical Ubc13 
which bind both with micromolar affinity, led to a small stabilization in U-box peptides 
216-233 and 239-259 which resembles the interaction interface in the co-crystal structures of 
mouse CHIP-U-box-Ubc13 and zebrafish CHIP-U-box-UbcH5 (Xu et al., 2006; Zhang et al., 
2005).  As a common E2-E3 interface, the hydrophobic ridge of the E2 is bound in a 
hydrophobic groove of the CHIP U-box between the short helix α9 (residues 255-266) and the 
tips of two hairpin turns (235-240 and 270-274). The interaction is mainly based on 
hydrophobic interactions and polar contacts of side-chains where no amide hydrogens of 
CHIP are involved, explaining the small protection in hydrogen exchange in the complex. 
Furthermore, it was shown that also transient U-box E2 interactions are sufficient for 
substrate ubiquitination (Demand et al., 2001). In the CHIP-UbcH5a complex but not in the 
CHIP-Ubc13 complex, however, a second stabilization was observed localizing to the 
intrinsically unfolded loop region and the adjacent helix α8 of CHIP.  Interestingly, binding of 
a different E2 ligase resulted in differential effects on the dynamics CHIP’s TPR domain. 
While binding of the canonical UbcH5a had no significant effect on the HX kinetics in the 
TPR, complex formation with Ubc13 led to a measurable deprotection of numerous segments 
at the C-terminal end of TPR and the helix α7 of the middle domain. This finding could give 
insights into the different E2 specificity of the E3 ligase CHIP. UbcH5a was shown to be 
highly active in unspecific mono- and poly-ubiquitination of various substrates while Ubc13 
seems to play a more specific role in Lys63-linked poly-ubiquitination. Interestingly, truncated 
forms a CHIP lacking the TPR domain are as active in polyubiquitination as full-length CHIP 
when paired with Ubc13-Uev1a, but far less active with UbcH5a (Windheim et al., 2008). 
Unlike Ubc13, UbcH5a required the TPR domain of CHIP not only for ubiquitination activity 
but also for auto-ubiquitination on Lys22 of CHIP. Based on our HX data, it is intriguing to 
speculate that Ubc13 is a chaperone-independent E2 ligase. The Ubc13-CHIP complex shows 
significant destabilization in segments which are on the other hand highly stabilized by 
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chaperone binding, which argues for an displacement of TPR bound ligands when Ubc13 is 
bound. Indeed, the chaperone Hsp90 was not affecting CHIP-Ubc13 dependent 
polyubiquitination (Windheim et al., 2008) and no Hsp90/Hsp70 linked substrate is known so 
far that is ubiquitinated specifically via the Ubc13/Uev1a pathway. Furthermore, the helix α7 
which is affected upon Ubc13 binding seems to be critical for the stability of the whole TPR 
domain (Main et al., 2003). 
Altogether, this work set the basis for further interaction studies between TPR co-chaperones 
and Hsp70/Hsp90 chaperones by HX-MS.   
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3 Conclusions and Outlook 
 
This work provided important insights into the allosteric mechanism of the Hsp70 chaperones 
on the structural level. Up to now, this is the only study that provides local structural 
information on the conformation of the low-affinity ATP-state of a full-length Hsp70 and on 
the pathway of ATP signal communication through the protein.  
Certainly, more information on structure and dynamics is needed to fully understand the 
molecular mechanism of Hsp70 action. An open question of fundamental interest is the 
molecular mechanism of the synergistic stimulation of Hsp70 ATPase activity by J-domain 
proteins. New details on the rather transient interaction between a JDP and Hsc70 were shown 
in a co-crystal structure of a disulfide-crosslinked auxilin J-domain to the NBD of bovine 
Hsc70 (Jiang et al., 2007). The presented data implicate a role of the J-domain in directing the 
interdomain linker to a hydrophobic patch including Ile181 and Tyr371 in the NBD. How the J 
signal is finally transmitted to stimulate the ATPase activity remains unclear yet, as well as 
the function of J-protein as targeting factors for substrates.  
Another important question is how the ATP-driven conformational changes of Hsp70 affect 
the folding and refolding of substrates. In order to find Hsp70 binding sites within natively 
folded substrates, HX-MS of Hsp70-client complexes could be performed. Interaction sites 
between DnaK and the heat-shock transcription factor σ32 and the replication initiation factor 
RepE were already monitored using HX-MS methods and protease footprinting (Fernanda 
Rodriguez, unpublished results). Additionally, site-specific chemical crosslinking of modified 
Hsp70 to substrates and subsequent MS analysis of crosslinked peptides could be performed. 
Using heterotrifunctional crosslinkers containing a third biotin group, enrichment on affinity 
columns can be used to purify crosslinked peptides and to facilitate the mass spectrometric 
analysis. 
Furthermore, this work made significant contributions to the understanding of the dynamics of 
the Hsp90 chaperone machine. For the first time, the sequential order of ATP-dependent 
conformational changes within a Hsp90 could be kinetically and spatially resolved, thus 
leading to the full description of the HtpG ATPase cycle. While the bacterial HtpG showed 
drastic conformational stabilization upon ATP binding, eukaryotic Hsp90 chaperones seem to 
require highly dynamic conformational states to allow productive binding and activation of 
client proteins, regulated by a plethora of co-chaperones. By characterizing the ATP-driven 
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conformational changes within the Hsp90 chaperone family by HX-MS, this work set the 
basis for studying the interplay of Hsp90 with its co-factors and substrates. 
Hence, it would be now of keen interest to investigate the effect of co-chaperone binding on 
the Hsp90 dynamics by HX-MS. While this work has investigated the chaperone interaction 
to the TPR co-chaperone CHIP in detail, it would be interesting to compare the effects on the 
Hsp90 site. This should also include other TPR proteins like the co-chaperone Hop/Sti1 that 
interacts with the C-terminus of Hsp70/Hsp90 chaperones, but exhibits also long-range effects 
on their ATPase activities, resulting in stimulation of the Hsp70 and inhibition of the Hsp90 
ATP turnover. Further interaction studies should focus on the regulatory effects of other TPR 
co-chaperones on Hsp90 including FKBP51, FKBP52 and other immunophilins whose 
functions in the chaperone cycle are poorly understood yet. One major problem when 
investigating large protein-protein complexes by HX-MS is, however, the complexity of 
peptides resulting after peptic digestion in the HPLC setup. This problem can be tackled by 
developing new separation strategies (e.g. immobilization one protein partner on a column), 
establishing sophisticated HPLC gradients or using new mass spectrometers with higher mass 
accuracy and resolution. One important task is the automation and acceleration of the HX-MS 
data analysis which still is very time-consuming and rate-limiting for the studies. 
The main issue in the Hsp90 chaperone field remains the identification of Hsp90 binding sites 
within client proteins and the characteristics of substrate turnover in substrate-co-chaperone-
Hsp90 complexes. In vitro studies of Hsp90-client complexes are difficult because client 
proteins are usually unstable and hard to purify, and it is hard to form stable Hsp90-substrate 
complexes in vitro. A minimal system of five proteins (Hsp70, Hsp90, p23, Hop, Hsp40) was 
shown to assemble an active chaperone complex that drives activation of antibody-bound 
glucocortoid receptor upon hormone binding (Morishima et al., 2003), however there are no 
reports for the stable reconstitution of other native Hsp90-client complexes in vitro. One 
strategy would be to purify native Hsp90-client complexes after overexpression in insect cells 
(as described for a Cdk4-Cdc37-Hsp90 complex (Vaughan et al., 2006)) and to analyze the 
binding interface by HX-MS. Another approach would be the investigation of stable client 
subdomains that interact with Hsp90, e.g. the DNA-binding domain of p53 or the ligand-
binding domain of estrogen receptor. These proteins could be stably expressed in E. coli and 
purified during this work and their interaction to Hsp90 can be analyzed in future.  
 
 
Conclusions and Outlook 
 96
 
 
 
 
 
 
Materials and Methods 
 97
4 Materials and Methods 
4.1 Materials 
 
4.1.1 Software and Equipment 
 
Computer Software: 
Office 2003       Microsoft Corp. 
EndNote 8.0       ISI ResearchSoft 
Photoshop CS2      Adobe 
Illustrator CS2      Adobe 
Acrobat Professional      Adobe 
Analyst QS 1.1 with BioAnalyst extensions   Applied Biosystems/MDS Sciex 
GPMAW       Lighthouse Data 
MagTran       Z. Zhang 
HXPep       Z. Zhang 
VB script “isotope-centroid.dll”    developed in-house 
Origin 6.1       OriginLab Corp. 
PyMOL       DeLano Scientific LLC 
Clone Manager 5.0      Sci Ed Central  
 
 
Mass spectrometers: 
QSTAR Pulsar i Hybrid MS/MS System   Applied Biosystems/MDS SCIEX 
UltraFlex MALDI-TOF/TOF    Bruker Daltonics 
 
HPLC pumps: 
1100 Series Capillary Pump     Agilent 
1100 Series Binary HPLC Pump    Agilent 
LC-10 ADVP HPLC       Shimadzu 
Rheos 2000 Micro HPLV     Flux Instruments 
Ultimate HPLC with Switchos and Famos   LC Packings 
 
Other equipment: 
 
Speed-Vac       Bachofer 
UV lamp B-100AP      Ultraviolet Products 
French Press       SLM-Amin.co 
Microfluidizer EmulsiFlex-C5? ?   Avestin 
ÄKTA FPLC and columns     GE Healthcare (Amersham) 
Spektrometer UV-1601     Shimadzu 
Sonifier 450       Branson 
PCR cycler T-Gradient     Biometra 
Fluorescence Spectrometer LS50B    Perkin Elmer / Applied Biosystems 
 
UV/VIS spectrophotometer NanoDrop ND-1000  Thermo Scientific 
Centrifuges       Sorvall, Eppendorf, Heraeus 
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4.1.2 Chemicals 
 
If not otherwise stated, all chemicals were analytical grade and obtained from Roth, Sigma or 
Merck. Only high purity solvents (HPLC grade) were used.  
4.1.3 Bacterial Strains 
 
Name Genotype Source 
BB1553 F- araDΔ139Δ (argF-lac)U169 rpsL150 relA1 deoC1 pts 
F25 rpsR flbB5301 
Lab collection
BB1994 BB1553, pDMI.1 Lab collection
DH5α SupE44 ΔlacU169 deoR (f80lacZAM15)hsdR17 recA1 endA1 
gyrA96 thi-1 relA1 
Lab collection
DH5αZ1 DH5α lacIq Tetr Specr ((Lutz and Bujard, 1997)) Lab collection
CJ236 dut1, ung1, thi-1, relA1/pCJ105(F’camr) (Kunkel et al., 
1987) 
Lab collection
BL21 (DE3) 
pLys 
E. coli B, F-, dcm, ompT, hsdS(rB-mB-), gal(DE3) [pLysS 
(Camr)] 
Invitrogen 
BL21(DE3)star 
pCodonPlus 
F- ompT hsdSB (rB- mB-) gal dcm rne131 (DE3) [pCodonPlus 
(Camr)] 
Invitrogen 
Fi8202  
pCodonPlus 
ΔntrBC fadAB101::TN10 lacIq lacL8/D202  [pCodonPlus 
(Camr)] 
Lab collection
 
4.1.4 Plasmids 
 
Name Description Source 
pCA528 (= pSUMO) pET24 based with N-terminal His6-
Smt3-Ulp1 site(SUMO)-tag, T7 
promotor, KanR 
Dr. C. Andreasson 
pSUMO-hHsp90beta His6-SUMO-hHsp90β,  KanR This work 
pSUMO-hHsp90beta-Cys--E20C His6-SUMO-hHsp90β-Cys--E20C, 
KanR 
M. Stankiewicz 
pSUMO-Hsc70-human His6-SUMO-hHsc70, KanR This work 
pSUMO-Hsc82-yeast His6-SUMO-Hsc82-Sc,  KanR This work 
pSUMO-Hsp70-human His6-SUMO-hHsp70, KanR This work 
pET15b-p23 His6-p23, AmpR M. Stankiewicz 
pSUMO-Ubc13-human His6-SUMO-Ubc13 human, KanR This work 
pSUMO-Uev1a-human His6-SUMO-Uev1a human, KanR This work 
pET15b bacterial expression vector, T7 
promotor, N-terminal His6-thrombin 
site fusion, AmpR 
Novagen 
pMPM201-Rn-Hsc70 Hsc70-R.norvegicus, arabinose-
inducible, AmpR 
Dr. C. Gässler 
pET15b-hHsp90beta-MC His6-hHsp90β-285-723, AmpR This work 
pET15b-hHsp90beta-N His6-hHsp90β-1-222, AmpR This work 
pET15b-hHsp90beta-NM His6-hHsp90β-1-545, AmpR This work 
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pSUMO-hHsp90beta-E42A His6-SUMO-hHsp90β-E42A, KanR This work 
pSUMO-p53core(94-312) His6-SUMO-p53 human core 
domain (94-312),  KanR 
This work 
pET15b-ER-LBD(302-552) His6-human ER-LBD-302-552, 
AmpR 
This work 
pSUMO-Hsc82-yeast-E11C His6-SUMO-Hsc82-Sc-E11C, KanR This work 
 
4.1.5 Oligonucleotides 
 
All primers were obtained from Thermo Electron or Operon. Mutagenesis primer were 
phosphorylated at the 5’end (p). 
 
Name Sequence (5’? 3’) 
5-Ubc13-BsaI CCAGTGGGTCTCAGGTGGTATGGCCGGGCTGCC 
5-Uev1a-BsaI CCAGTGGGTCTCAGGTGGTATGCCAGGAGAGGTTCAAGC 
hHsp70-BsaI-5' CCAGTGGGTCTCAGGTGGTATGGCCAAAGCCGCGGCGAT 
hHsc70-BsaI-5' CCAGTGGGTCTCAGGTGGTATGTCCAAGGGACCTGCAGTTG 
5'-BsaI-hHsp90beta CCAGTGGGTCTCAGGTGGTATGCCTGAGGAAGTGCACCATG 
3'-EcoRI-SalI-hHsp90b GAATTCGTCGACCTAATCGACTTCTTCCATGCGA 
5’-BsmBI-Hsc82 CCAGTGCGTCTCAGGTGGTATGGCTGGTGAAACTTTTGAATT 
3'-Hsc82-XhoI GGGGTACCTCGAGCACTAGTTAATCAACTTCTTCCATCTCGGT 
Hsp90b-XbaI-NdeI-5' GCTCTAGACATATGCCTGAGGAAGTGCACC 
Hsp90b-285-XbaI-NdeI-5' GCTCTAGACATATGACCAAGCCTATTTGGACCAG 
Hsp90b-220-BamH1-3' CGCGGATCCTTATTCCTTCTCCAAATAAAGGGTG 
Hsp90b-545-BamH1-3' CGCGGATCCTTACTCAGGCAGCTCCAGACCCTC 
Hsp90b-723-BglII-3' TTTGGAAGATCTTAATCGACTTCTTCCATGCGAG 
90B_E42A pCATTAGAGATCAACGCGCGCAGGAAAATCTCC 
hsc82-E11C pCAACTGAGTGATGCATGCTTGAAATTC 
3'-p53core312-XhoI GGGGTACCTCGAGCACTAGTTAGGTGTTGTTGGGCAGTGCTC 
5'-BsmBI-p53core-94 CCAGTGCGTCTCAGGTGGTTCATCTTCTGTCCCTTCCCAGAAA 
5'-ER-302-EcoRI-NdeI CGGAATTCATATGAAGAAGAACAGCCTGGCCTTG 
3'-ER-552-BamHI CGGGATCCTTAGGGCGCATGTAGGCGGTGGG 
4.1.6 Standards and kits 
 
QIAprep Spin Miniprep Kit  Qiagen (Hilden) 
QIAGEN Plasmid Midi Kit  Qiagen (Hilden) 
QIAquick PCR Purification Kit Qiagen (Hilden) 
QIAquick Gel Extraction Kit  Qiagen (Hilden) 
apo-Myoglobin   Sigma 
GeneRuler™ 1kb DNA Ladder Fermentas 
Prestained Protein Ladder (SM0441) Fermentas 
Protein Ladder (SM0431)  Fermentas 
Prestained Protein Ladder (SM0671) Fermentas 
Gel filtration standard  BioRad 
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4.1.7 Proteins 
 
DnaK (2-637) wildtype  Bukau lab collection 
DnaK R151A    Bukau lab collection (Dr. Vogel) 
DnaK T199A    Bukau lab collection (Klaus Paal) 
DnaK(2-385)    Bukau lab collection (Klaus Paal) 
DnaK(393-637)   Bukau lab collection (Klaus Paal) 
 
HtpG-His10    Dr. Kramer 
HtpG-E34A-His10   Dr. Kramer 
HtpG-E12C-His10   Dr. Kramer 
HptG-E12C-E34C-His10  Dr. Kramer 
 
CHIP wildtype   Bukau lab collection (Dr. Nikolay) 
CHIP delta TPR (128-203)  Bukau lab collection (Dr. Nikolay) 
UbcH5a    Bukau lab collection (Dr. Nikolay) 
 
Ulp1 (SUMO protease)  Bukau lab collection 
 
Restriction enzymes, other enzymes New England Biolabs, Fermentas, Roche 
Poroszyme Immobilized Pepsin Applied Biosystems 
 
4.1.8 Peptides 
 
Pep65 (σ32-M195-N207) MAPVLYLQDKSSN Peptide Technology Laboratories 
Hsp70-C terminus  GPTIEEVD   Thermo Hybaid 
Hsp90β-C terminus  ASRMEEVD   Thermo Hybaid 
NR-peptide   NRLLLTGC   lab collection 
 
 
4.1.9 Media 
 
LB (Luria-Bertani) medium     10 g/l tryptone 
        5 g/L yeast extract 
        5 g/l NaCl 
 
2 x YT medium      16 g/l tryptone 
        10 g/l yeast extract 
        5 g/l NaCl 
 
(for plates, medium was supplemented with 15 g/l agar and antibiotics) 
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4.1.10 Buffers 
 
 
HKM        25 mM HEPES/KOH pH 7.6 
        50 mM KCl 
        5 mM MgCl2   
 
PBS        137 mM NaCl 
        2.7 mM KCl 
        10 mM Na2HPO4 
        2 mM NaH2PO4 
        adjust to pH 7.4 with HCl 
4.1.11 Antibiotics 
 
All concentration are final concentrations, stock solutions are filter-sterilized 
 
Ampicillin (Na-salt)      100 µg/ml 
Kanamycin       50 µg/ml 
Chloramphenicol      25 µg/ml (in ethanol) 
 
 
4.2 Methods 
 
4.2.1 Molecular Biology Techniques 
 
If not stated otherwise, standard method protocols were performed according to “Molecular 
Cloning” (Maniatis et al., 1989). 
4.2.1.1 Agarose gel electrophoresis 
 
Agarose flat-bed gels in various concentrations (0.6 – 2% agarose in 1x TAE buffer) and sizes 
were run to separate DNA-fragments in an electrical field (10 – 20 V/cm) for analytical or 
preperative use. The desired amount of agarose was boiled in 1x TAE buffer until completely 
molten. After it cooled down to ca. 60°C, ethidium bromide solution (5 µl per 100ml agarose) 
was mixed into the liquid agarose, and then poured in a flat-bed tray with combs. As soon as 
the agarose solidified, the DNA in DNA-loading buffer was loaded into the slots and 
separated electrophoretically. The DNA was detected on a UV-light tray (265 nm). For 
preparative gels, a less strong UV-light source was used (365 nm) to avoid irradiation damage 
to the DNA. 
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10x TAE buffer 
400 mM Tris/acetate, pH 8.0 
10 mM EDTA 
 
6x DNA loading buffer 
30% glycerol  
0.25% bromophenol blue 
0.25% xylene cyanol FF 
 
4.2.1.2 Purification of DNA fragments 
 
Fragments of DNA generated by restriction digest were separated using standard agarose gel 
electrophoresis (Maniatis et al., 1989). DNA bands corresponding to desired products were 
identified using a UV transilluminator and bands were excised from ethidium bromide stained 
gels using a scalpel. Separation of DNA from the gel was achieved using the QIAquick Gel 
Extraction Kit (Qiagen). 
4.2.1.3 Restriction digest of DNA 
 
Restriction enzymes (type II exonucleases) cut double strand DNA site-specifically. 
Restriction digests were used for analysis as well as cloning. The enzymes (NEB, Roche, 
Fermentas) were used in a concentration of 0.2 – 1 U with the recommended buffer in a total 
volume of 20 – 50 µl. The digests were incubated at the enzyme-specific temperature for at 
least two hours to a maximum of overnight. For partial digests, a serial dilution of the 
restriction enzyme was prepared and the DNA was cut for 30 min at optimum temperature 
and buffer conditions. 
4.2.1.4 Ligation of DNA fragments 
 
Ligases link DNA ends by catalyzing the phosphodiester-bonding. DNA fragments with 
matching digested ends were incubated in no more than 10 µl total volume with 40 U 
T4-DNA-ligase and the recommended ligation buffer. The optimal ratio of vector to insert 
DNA was 1:3 for “sticky end” ligations. Different conditions for incubation were used: over 
night at 16°C, 2 h at room temperature or 30 min at 30°C. 
4.2.1.5 Production of chemical competent cells 
  
Protocol according to (Nishimura et al., 1990): A 50 ml culture was inoculated with 0.5 ml of 
an overnight culture and grown in medium A (LB broth with 10 mM MgSO4·7H2O and 0.2% 
glucose) to mid-logarithmic phase. The cells were kept 10 minutes on ice, pelleted at 1500g 
for 10 minutes at 4°C and resuspended gently on ice in 0.5 ml medium A. 2.5 ml ice cold 
storage solution (LB broth with 36% glycerol, 12% PEG-7500 and  12 mM MgSO4·7H2O) 
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were added and the suspension was mixed without vortexing. The cells were aliquoted in 100 
µl portions, frozen in liquid nitrogen and stored at -80°C. 
4.2.1.6 Transformation  
 
For transformation, 1-5 µl DNA were incubated with 50 µl competent cells for 30 min on ice, 
then heat-shocked for 90 seconds at 42°C (40°C for ΔdnaK strains) and 2 minutes on ice. 
500 µl of LB medium was added and the mixture was shaken for 45 min at 37°C (30°C) to 
allow bacterial recovery and expression of the antibiotic resistance gene. 100 µl of 
transformed cells were streaked onto LB agar plates containing the appropriate antibiotics. 
4.2.1.7 Purification of plasmid DNA 
 
Plasmid DNA isolation was performed using either the small-scale QIAGEN® Quick Spin 
method or the large-scale QIAGEN® Plasmid Midi Kit according to the protocol provided by 
the manufacturer. 
4.2.1.8 Polymerase chain reaction (PCR)  
 
The Polymerase Chain Reaction (PCR) was used to clone genes from plasmid or genomic 
DNA as well as to probe DNA samples for the presence or absence of a specific sequence. 
Generally, the reaction was performed in 50 µl total volume with 50 pmol of each primer and 
with a final concentration of 250 µM of a dNTP mix. Various polymerases with the 
recommended buffer systems were used, depending on the purpose: OptiTaq ™ (Roboklon) 
was used for cloning because of its productivity and proof-reading capability, and the Taq 
polymerase for analytical PCRs. The PCR reaction was performed in a cycler, using the 
following basic protocol: 3 min at 94°C, then 30 – 35 cycles of 1 min at 94°C, 30 sec – 1 min 
at optimum annealing temperature (between 52° and 62°C) 1 – 5 min at 72°C (depending on 
the length of the amplified fragment) and a final 10 min incubation at 72°C to allow the 
polymerase to fill up incomplete fragments. Conditions varied, and were optimized for every 
amplification. The PCR products were analyzed on an agarose gel and, if necessary purified 
with the Qiagen MiniElute PCR purification kit. 
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4.2.1.9 PCR cloning into pSUMO vector 
 
The respective gene (hsp70, hsc70, hsp90, hsc82, Ubc13, Uev1a) was amplified by PCR from 
plasmid DNA or genomic yeast DNA that was provided by the lab collection. The 5’- and 3’-
primers were designed such that they were complementary to the beginning and end of the 
gene and contained extended restriction sites for BsaI (or alternatively BsmBI) and XhoI 
(SalI), respectively. The obtained PCR product was cut with BsaI (BsmBI) and XhoI and 
inserted by ligation into linearized pCA528 which was also cut with BsaI and XhoI. The 
resulting plasmid was transformed into the E. coli strain DH5αZ1 and after DNA isolation 
confirmed by sequencing at GATC Biotech AG (Konstanz). 
4.2.1.10 Site-directed mutagenesis (Kunkel Method) 
 
The mutant genes were created by in vitro mutagenesis according to Kunkel (Kunkel et al., 
1987). Single-stranded DNA (ssDNA) of the desired vector construct was prepared using the 
E. coli host strain CJ236 and helper phage M13KO7. CJ236 is dut
–
and ung
– and therefore 
deficient for the enzymes dUTPase (Dut) and uracil-N glycosylase (Ung). A deficiency of 
dUTPase leads to the production of elevated levels of dUTP which in turn leads to the 
misincorporation of deoxyuridine into DNA in place of thymidine. A deficiency of uracil-N 
glycosylase makes the bacteria unable to remove the uracil residues from the DNA. The 
infection of these cells with M13 helper phages lead to formation of phages which contained 
ssDNA of the vector. Phages were harvested and ssDNA was extracted by phenol-chloroform 
extraction and ethanol precipitation. 
The mutagenic 5’-phosphorylated oligonucleotide was annealed to the deoxyuridine-
containing ssDNA, and was extended and ligated using T7 DNA polymerase and T4 DNA 
ligase, respectively. The DNA was transformed into E. coli DH5αZ1, which is ung
+
, thereby 
degrading the original uridine-containing strand. The newly synthesized strand which 
contained the mutated bases was replicated to produce intact mutated plasmid which was 
confirmed by sequencing at GATC Biotech AG. 
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10x Annealing buffer 10x Polymerase buffer (Polmix) 
200 mM Tris/HCl pH 7.5 
20 mM MgCl2 
500 mM NaCl 
 
200 mM Tris/HCl pH 7.5 
20 mM DTT 
100 mM MgCl2 
4 mM ATP 
5 mM dNTP 
0.5 mg/ml BSA 
 
Annealing  
1 μL phosphorylated primer , 1 μl ssDNA, 1 μl 10x annealing buffer, and 7 μl H2O were 
heated to 70°C for 2 min in a thermomixer, slowly cooled to 30°C, and then placed on ice.   
Elongation reaction (extension and ligation)  
To the annealed template-primer 10 μl 10x Polmix buffer, 0.125 μl T7 DNA polymerase (5 
units), 0.5 μl T4 DNA ligase (200 units), and 80 μl H2O were added, incubated on ice for 
5 min, at room temperature for 5 min, and at 37°C for 2 h. Then, 5 μl were used for 
transformation into DH5αZ1. 
 
4.2.2 Biochemical Methods 
 
4.2.2.1 SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
 
4x SDS stacking gel buffer 
0.5 M Tris/HCl, pH 6.8 
0.4% SDS 
 
4x SDS separation gel buffer 
1.5 M Tris/HCl, pH 8.8 
0.4% SDS 
1x SDS gel running buffer 
25 mM Tris, pH 8.0 
200 mM glycine 
0.1% (w/v) SDS 
4x SDS gel loading buffer 
500 mM Tris/HCl, pH 6.8 
8% (w/v) SDS 
40% (v/v) glycerol 
20% (v/v) β-mercaptoethanol 
0.6% (w/v) bromophenol blue 
 
Proteins of different sizes can be separated by discontinuous SDS-Polyacrylamide gel 
electrophoresis (SDS-PAGE) under denaturing conditions (Laemmli, 1970). The gels used for 
this are bipartite: A lower separation gel, with polyacrylamide concentrations from 8 to 15% 
depending on the size of the proteins to be separated, and a stacking gel with 4% 
polyacrylamide to focus all proteins before they enter the lower part.  
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Typically, the following concentrations were used for the separating part of one midi or maxi 
gel or four mini gels: 
 
 8% 10% 12% 14% 15% 
Acrylamide (30%) in ml 8 10 12 14 15 
4x SDS separation buffer in ml 7.5 7.5 7.5 7.5 7.5 
Water in ml 14.5 12.5 10.5 8.5 7.5 
10% APS in µl 240 240 240 240 240 
TEMED in µl 40 40 40 40 40 
 
 
For the stacking gel, a fixed concentration of 4% polyacrylamide was used: 
 
Acrylamide (30%) in ml 3 
4x SDS stacking buffer in ml 5 
Water in ml 12 
10% APS in µl 90 
TEMED in µl 40 
 
The samples were prepared by mixing with protein loading buffer and boiling for 5 minutes at 
95°C. Then, the samples were loaded into the rinsed slots of the gel with a Hamilton syringe. 
All gels were run with 120 V in 1x SDS gel running buffer until the samples entered the 
separating gels, and then the current was raised to 200 or 300 V, depending on the gel size. 
The gel was run till the bromphenol blue marker reached the bottom to guarantee optimal 
partitioning of the proteins. 
4.2.2.2 Coomassie blue staining 
 
Proteins can be visualized in SDS gels by coomassie blue staining. The dye complexes with 
basic and aromatic side chains, resulting in a blue colour of the protein bands. 
Coomassie staining solution 
0.2% (w/v) Coom. Brilliant Blue R250 
50% (v/v) methanol 
5% (v/v) acetic acid 
-> filter before use 
 
Coomassie destaining solution 
50% (v/v) methanol 
5% (v/v) acetic acid 
 
Before staining, the gel was fixed with destaining solution for 15 to 30 minutes to wash out 
the SDS, which results in less background staining. Then, the gel was incubated on a shaker in 
staining solution for at least one hour or overnight. Finally, the coomassie solution was 
removed and the stained gel was again incubated in destaining solution until the background 
was clear and the protein bands were clearly visible. 
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4.2.2.3 Silver staining 
 
The silver stain method is a sensitive staining method to visualize protein bands that cannot be 
detected with Coomassie staining. All steps are carried out at room temperature on a shaker.  
Fixing solution 
50% (v/v) ethanol 
40% ddH2O 
10% acetic acid 
0.05% formaldehyde (37%) 
 
Washing solution 
50% ethanol 
50% ddH2O 
 
Prestaining solution  
0.02% (w/v) Na2S2O3·5H2O 
in ddH2O 
 
Staining solution 
0.2% (w/v) AgNO3 
0.075% (v/v) formaldehyde (37%) 
in ddH2O 
 
Developing solution 
6% (w/v) Na2CO3 
0.0004% (w/v) Na2S2O3/5H2O 
0.05% (v/v) formaldehyde (37%) 
in ddH2O 
 
Stop solutiom 
44% (v/v) ethanol 
44% ddH2O 
12% acetic acid 
 
SDS was washed out of the gel by incubation in an excess of fixing solution for at least 2 
hours, or optimally, overnight. The gel should always be covered by the solutions added. 
After a wash step of 2 times 25 minutes in washing solution, the prestaining solution was 
applied for 1 minute, followed by 20 minutes incubation in the silver nitrate staining solution. 
To wash away the remains of the staining solution, the gel was rinsed with deionised water 
three times. Immediately afterwards, the gel was incubated in developing solution until the 
bands became clearly visible. Depending on the amount of the protein, this step took from 10 
to 30 minutes. The complete reaction was stopped with stop solution. 
4.2.2.4 Determination of protein concentration  
 
Protein concentrations were determined spectrophotometrically at λ=595 nm using Bradford 
reagent (BioRad) and BSA calibration curves (Bradford, 1976).  
Additionally, protein concentrations were determined by measuring absorption at a 
wavelength of λ=280 nm using a ND-1000 spectrophotometer (Nanodrop, Thermo Scientific). 
Buffer without protein was used as reference. Protein concentrations were calculated on the 
basis of the Lambert-Beer law and their theoretical extinction coefficients at λ=280 nm (Gill 
and von Hippel, 1989), as calculated by the ProtParam tool at the ExPASy proteomics server 
(http://www.expasy.ch). 
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4.2.2.5 Purification of Hsc70  
 
Hsc70 was purified according to a DnaK purification protocol (Buchberger et al., 1994). Each 
step was analyzed by SDS-PAGE and Coomassie blue staining. 
Buffer A 
25 mM HEPES/KOH  pH 7.6 
10 mM KCl  
5 mM MgCl2 
10 mM β-Mercaptoethanol  
1 mM EDTA 
5% Glycerol 
 
Buffer B 
Buffer A  
+ 1 M KCl 
 
Buffer C 
50 mM Tris/HCl pH 7.6 
10% Sucrose 
 
Buffer D 
1 mg DNaseI  
1 M (NH4)2SO4 
50 mM EDTA 
50 mM DTT (freshly added) 
ATP buffer 
Buffer A  
+ 10 mM ATP 
+ 10 mM MgCl2 
(check pH = 7.6 !) 
 
 
  
Cell growth and overproduction 
Usually 9 l of 2x YT complemented with 100 µg/ml ampicillin were inoculated with an 
overnight culture of the ∆dnaK52 strain BB1994 carrying the plasmid pMPM201-Hsc70-Rn. 
The culture was grown under vigorous shaking at 30°C to an OD600 of ~0.6. For induction L-
arabinose was added to a final concentration of 0.01% and the culture was incubated for at 
least 5 h or overnight at 30°C.  
Cell lysis and ammonium sulfate precipitation 
Cells were harvested by centrifugation at 4500 rpm for 20 min (Sorvall F7 rotor), and cell 
pellets (for every ~16 g of pellet) were resuspended in 60 ml Buffer C, 7 ml Buffer D and 
1.4 ml PMSF (50 mM). All steps were carried out at 4°C or on ice. Cells were lysed by 
French press at a pressure of 1000 psi. Cell debris was separated from lysates by 
centrifugation for 30 min at 10000 rpm and additional 1 h at 40000 rpm. The cleared 
supernatant was precipitated with 0.33 g/ml (NH4)2SO4 by stepwise addition on ice and then 
centrifuged for 20 min at 10 000 rpm in a Sorvall F14 rotor. Supernatant was discarded and 
the protein pellet was resuspended in 40 ml Buffer A and dialyzed against 3 l Buffer A 
overnight in the cold room. 
Anion exchange chromatography (DEAE-Sepharose) 
The dialyzed protein solution was cleared from particles by centrifugation for 15 min at 
10000 rpm. After filtration through a 0.45 µm filter, the solution was loaded onto a 250 ml 
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DEAE-Sepharose column which was equilibrated with Buffer A. The column was washed 
with 300 ml Buffer A and eluted with a 700 ml gradient of 0 to 50% Buffer B into 10 ml 
fractions. Afterwards, the column was washed with 300 ml 100% Buffer B. The Hsc70 
containing fractions were pooled . 
ATP-agarose affinity chromatography 
2.5 ml bed volume of ATP-agarose (Jena Bioscience, kept in 20% ethanol) for every 100 mL 
protein solution was first equilibrated with 10 ml Buffer A, then washed with 10 ml Buffer B 
and re-equilibrated with 10 ml Buffer A. The pooled fractions from DEAE-chromatography 
were added to the equilibrated ATP-agarose and incubated at 4°C in a 50 ml falcon tube 
shaking end-over-end for at least 30 min. The agarose was packed into a disposable column 
(BioRad) and washed with 20 ml Buffer A and 20 ml Buffer B. The washed ATP-agarose was 
resuspended in the column with ATP-Buffer (20 ml) and incubated for 45 min at 4°C. After 
incubation, agarose was repacked into the column and the eluate was collected. 
Anion exchange chromatography (Resource Q) 
The Hsc70-containing eluate of the ATP-agarose was loaded onto a 6 ml ResourceQ (GE 
Healthcare) strong anion exchange column. The column was washed with 40 ml Buffer A  
and Hsc70 was eluted with a linear gradient of 0 to 50 % Buffer B. Fractions of 1.3 ml size 
were collected. Hsc70 containing fractions were pooled, aliquots frozen in liquid nitrogen and 
stored at -80°C. 
4.2.2.6 Purification of proteins with His6-SUMO-tag strategy 
 
All proteins overexpressed from the vector pCA528 (pSUMO) (Andreasson et al., 2008) were 
purified and processed according to the following protocol. The proteins are expressed with 
an N-terminal His6-SUMO fusion tag which increases solubility of the proteins and can be 
removed by the specific SUMO protease Ulp1 without any remaining amino acids (Malakhov 
et al., 2004). 
The purification protocol is described exemplary for the purification of human Hsp90β and 
was used likewise for purification of Hsc82, hHsp90β-E20C, hHsp70, hHsc70, Ubc13, 
Uev1a. The co-chaperone p23 was purified accordingly, but without His6-tag removal step 
with Ulp1. 
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Lysis buffer 
20 mM HEPES/KOH pH 7.6 
100 mM KCl 
5 mM MgCl2 
5% glycerol 
1 mM β-mercaptoethanol 
1 mM PMSF 
1 mg DNaseI/100ml 
10 µg/ml Aprotinin ,  
5 µg/ml Leupeptin  
8 µg/ml Pepstatin A 
 
Buffer A 
20 mM HEPES/KOH pH 7.6 
100 mM KCl 
5 mM MgCl2 
5% glycerol 
1 mM β-mercaptoethanol 
 
Buffer B 
20 mM HEPES/KOH pH 7.6 
10 mM KCl 
5 mM MgCl2 
5% glycerol 
1 mM β-mercaptoethanol 
 
Buffer C 
20 mM HEPES/KOH pH 7.6 
1 M KCl 
5 mM MgCl2 
5% glycerol 
1 mM β-mercaptoethanol 
 
Gel filtration buffer 
20 mM HEPES/KOH pH 7.6 
300 mM KCl 
5%glycerol 
1mM DTT 
 
Storage buffer 
20 mM HEPES, pH 7.6 
20 mM KCl  
5 mM MgCl2  
5% glycerol  
1 mM DTT 
Cell growth and lysis 
Human Hsp90 was overexpressed from the vector pSUMO-hHsp90beta in the E. coli strain 
BL21(DE3)Star/pCodonPlus. The culture was grown in 5 l 2xYT medium supplemented with 
kanamycin to OD600 = 0.8 and expression was induced with 0.5 mM IPTG for 5 h at 30°C. 
After harvesting by centrifugation at 4500 rpm using a Sorvall F7 rotor for 20 min at 4°C, 
cells were resupended in 100 ml lysis buffer and lysed by a microfluidizer .  
Nickel-affinity chromatography 
The lysate was clarified by ultracentrifugation (40,000 rpm for 30 min) and incubated with 5 
g Ni-IDA-matrix (Protino, Macherey-Nagel) for 30 min. After incubation, the matrix was 
transferred to a disposable column and washed with 5 x 10 ml buffer A and bound protein 
eluted with buffer A containing 250 mM imidazole. The used Ni-IDA matrix was cleaned and 
regenerated with cleaning solution (6 M guadinium hydrochloride, 0.4 M acetic acid), washed 
with water and equilibrated with buffer B. 
SUMO-tag cleavage and removal 
The eluted fusion protein was supplemented with Ulp1 protease (10µl/10mg eluted protein), 
which cleaved the His6-Smt3 tag and the mixture was dialyzed overnight at 4°C against 
buffer B. Cleaved Hsp90 was recovered in the flow-through fractions after a second 
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incubation with the regenerated Ni-IDA matrix whereas the N-terminal His6-Smt3 tag and 
Ulp1 remained on the column.  
Anion-exchange chromatography 
The dialyzed and tag-depleted Hsp90 solution was then loaded on an anion exchange 
chromatography column (ReSourceQ 6 ml, GE Healthcare). The column was washed with 30 
ml buffer B and the Hsp90 was eluted with a linear gradient of 0-100% buffer C over 120 ml.  
Size exclusion chromatography 
Pooled Hsp90 fractions were further purified by Superdex 200 (GE Healthcare) size exclusion 
chromatography in gel filtration buffer and finally dialyzed against storage buffer. After 
concentration of the protein fraction with VIVASPIN ultracentrifugation spin columns, 
aliquots were frozen in liquid nitrogen and stored at -80°C. 
4.2.2.7 Determination of nucleotide content  
 
100 µl of a 10 µM protein solution were incubated for 10 minutes at 99°C and denaturated 
protein was then centrifuged for 10 minutes at 13000 rpm in a table top centrifuge. The 
nucleotide content of the supernatant was analyzed by analytical anion exchange 
chromatography (ResourceQ 1ml) with a linear gradient in 25 mM HEPES/KOH pH 6.5, 0 to 
1.5 M KCl. 
4.2.2.8 ATPase activity assays 
 
Single turnover assays were performed with 50 µM HtpG, 40 µM ATP and 0.1 µCi 
[α-32P]ATP. At different time points the reaction was quenched in 10% acetic acid 400 mM 
LiCl, ATP was separated from ADP by thin layer chromatography and quantified by 
phosphoimaging as described (Laufen et al., 1999).  
Steady state ATPase activity was measured in an enzyme-coupled colorimetric assay using 
pyruvate kinase/lactate dehydrogenase (PK/LDH) as described (Ali et al., 1993). The assay 
mixture contained HKM buffer (25 mM HEPES pH 7.4, 50 mM KCl, 5 mM MgCl2), DTT (5 
mM), PK/LDH mix (Sigma; 100-fold diluted), NADH (250 μM), phosphoenolpyruvate (1 
mM), ATP (2 mM or as indicated), and HtpG or mutant HtpG proteins (3 μM). All assays 
were performed at 30°C. All reported ATPase values are the differences between the values 
measured in the absence and presence of 150 µM Geldanamycin. 
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Steady-state ATPase assays for hHsp90β and Hsc82 were performed in same way with 5 mM 
ATP.  
4.2.3 Chemical crosslinking and modification of proteins 
4.2.3.1 Disulfide crosslinking 
 
100 pmol HtpG-E12C were reduced with 5 mM TECEP for 30 min at 30°C and then 
incubated with large excess of nucleotides ATP (120 mM), ADP (60 mM), AMPPNP 
(60 mM) for at least 10 min. Oxidation of the cysteines was performed with 10 mM aqueous 
diamide solution for 10 min at 30°C, free sulfhydryl groups were then blocked with 10 mM 
iodoacetamide. Crosslink products were analyzed on a non-reducing 12% SDS 
polyacrylamide gel. 
4.2.3.2 Bis-maleimide crosslinking 
 
5 µM HtpG-E12C were reduced with 10 mM TECEP for 30 min at 30°C and then incubated 
with an excess of nucleotides (ATP, ADP, AMPPNP, same concentrations as in 4.2.3.1) or 
HKM buffer as control for at least 10 min at 30°C. Dimer-crosslinking was then performed by 
incubation of the protein with 5 µM of the crosslinker bis(maleimido)ethane (BMOE) or 
bis(maleimido)hexane (BMH) (Thermo Scientific) dissolved in HKM buffer for one hour at 
30°C. The reaction mixture was quenched by adding 20 mM DTT and analyzed on a 12% 
SDS polyacrylamide gel. 
4.2.3.3 Fluorescent labelling of proteins 
 
Protein solutions of HtpG-E12C and HtpG-E12C-E34A were reduced with 10 mM TECEP 
and then incubated with either Hilyte Fluor™ 488-C2-maleimide (AnaSpec. Inc.), 
QXL-520-C2-maleimide (AnaSpec Inc.) (dissolved in 100% dimethylformamide) at room 
temperature for 1 hour. Unreacted label was then blocked by addition of 10 mM β-
mercaptoethanol and removed by desalting with a self-packed Sephadex-G-75 column (GE 
Healthcare) equilibrated in HKM buffer. The labeling efficiency was checked to be 100 % by 
MS and final concentration of labelled protein was determined by measuring UV/VIS 
absorption with a NanoDrop Spectrophotometer (Thermo Scientific). 
Same procedure was used for labelling hHsp90β-E20C with either Cy3-maleimide or Cy5-
maleimide (CyDye™, GE Healthcare). 
Extinction coefficients:   
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ε(HiLyte Fluor™ 488)503nm = 80000 M-1cm-1; ε(QXL™ 520)514nm = 26300 M-1cm-1; 
ε(Cy3)550nm = 150000 M-1cm-1; ε(Cy5)670nm = 250000 M-1cm-1 
 
4.2.4 Fluorescence spectroscopy 
 
4.2.4.1 Fluorescence resonance energy transfer (FRET) 
 
FRET, also named Förster resonance energy transfer, is based on the dipolar coupling 
between the emission dipole of a fluorescent donor (D) and the absorption dipole of a 
fluorescent acceptor (A). FRET occurs as a non-radiative transfer of energy from the excited 
donor to the acceptor, resulting in a quenching of the donor emission and sensitized emission 
from the acceptor. The donor molecules typically emit at shorter wavelengths that overlap 
with the absorption of acceptors. The FRET efficiency (EFRET) is highly dependent on the 
distance between the two fluorophores and varies with the sixth power of distance r0 between 
donor and acceptor: 
6
0
6
0
6
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REFRET +=  
The Förster radius R0 is the characteristic distance between fluorophores where the FRET 
efficiency is 50%, which can be calculated for any pair of fluorescent molecules. FRET can 
thus be used as a spectroscopic ruler for distance measurements in proteins (Stryer, 1978) and 
for the detection of conformational changes (Jares-Erijman and Jovin, 2003). FRET is 
detected either by the appearance of sensitized fluorescence of the acceptor or by the intensity 
ratio change of donor/acceptor (if the acceptor is fluorescent), or the fluorescence decrease of 
the donor.  
The Förster radius for the classical used FRET pair Cy3/ Cy5 is 53 Å. The second FRET pair 
HiLyte Fluor™ 488 /QXL-520 uses a quantum dot as a non-fluorescent acceptor (dark 
quencher).  
For FRET experiments with hHsp90β, 100 nM fluorescent hHsp90β-E20C-Cy3 and 200 nM 
hHsp90β-E20C-Cy5 were mixed in HKM buffer and incubated for 30 min at 30 °C to ensure 
formation of mixed dimers. Fluorescence emission spectra were recorded in absence or 
presence of ATP (3 mM final concentration) or p23 (6 µM final concentration) or in presence 
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of both from 540-700 nm at an excitation wavelength of 520 nm on a Perkin Elmer LS-55 
Luminescence Spectrometer at 30°C. 
 
For fluorescence measurements of HtpG, labeled proteins HtpG-E12C-Hilyte Fluor™ 488 
(HtpGFL) and HtpG-E12C-QXL-520 (HtpGQ) were mixed in a ratio 300 nM:600 nM in HKM 
buffer and incubated for 30 min at 30°C to ensure formation of mixed dimers. As a control 
HtpGFL was incubated with unlabeled HtpG in the same ratio of concentrations. Donor 
fluorescence emission spectra were recorded in absence or presence of nucleotides (20 mM 
final concentration) from 500-700 nm at an excitation wavelength of 475 nm on a Perkin 
Elmer LS-55 Luminescence Spectrometer at 30°C. The donor fluorescence at 525 nm was 
measured after addition of nucleotides in a time-course experiment over 20 min and 60 min 
for HtpGFL or the HtpG-E34AFL, respectively. The data were fitted using GraphPad Prism 
software. 
 
4.2.4.2 Stopped-flow analysis 
 
Using a stopped-flow device (SX-18M Applied Photophysics, Surrey, UK) HtpGFL (300 nM) 
in HKM buffer was rapidly mixed 1:1 with a solution of 0.003 to 30 mM ATP or ADP.  
Fluorescence (excitation 488 nm; cut-off filter at 530 nm) was measured for 0.1 to 10 s at 
30 °C. An exponential function was fitted to the time-dependent fluorescence increase using 
GraphPad Prism software. 
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4.2.5 Mass spectrometry 
 
4.2.5.1 Molecular Weight Determination of Proteins by On-line LC/MS 
 
In order to analyze the exact molecular mass of proteins by ESI-MS, the samples must be 
desalted from buffer before they can be eluted into the mass spectrometer. Protein molecular 
weights were determined by online LC/MS using a QSTAR Pulsar equipped with the 
electrospray ion source (Applied Biosystems/MDS SCIEX), two HPLC pumps (Agilent 1100 
Series), a Rheodyne injection valve (Model 7725) with a 200 µl stainless steel sample loop, 
and a 2-position/10-port valve with microelectric actuator (Valco C2-1000EP6) as described 
in (Rist et al., 2005a). The protein samples (50-100 pmol) were injected and pushed onto a 
reversed-phase trap column with a high flow rate of 0.05 % TFA (400 µl/min) provided by 
pump A. As a trap column, either a micro-trap column (0.8 x 3 mm) (Rist et al., 2005a) or a 
micro-guard column (1 x 20 mm, Upchurch) packed with POROS 10 R1 or R2 material 
(PerSeptive Biosystems) was used. After 90 s, the 10-port valve was switched to elute the 
desalted protein with 80% buffer B (90% acetonitrile, 0.05% TFA) at 20 µl/min directly into 
the electrospray source of the Q-TOF-mass spectrometer. The timing and sequence of 
operation of the valves was controlled by the Agilent 1100 Series Capillary Pump, while each 
run was started by the electrical switch injection valve. 
Mass spectra were acquired in positive ion mode with an ionspray voltage of 5000 V. 
Average molecular weights of proteins were deconvoluted from the ESI spectra using the 
Bayesian Reconstruct tool of the BioAnalyst software. All spectra were re-calibrated using 
myoglobin as standard. 
 
4.2.5.2 Protein Identification by static nanoESI-MS or nanoLC ESI-MS 
 
Peptides prepared from peptic or tryptic digestion were desalted using self-packed 
microcolumns. These were GELloader tips (Eppendorf) filled with a piece of fused silica (20 
µm ID, 280 µm OD, LC Packings) and a small bedvolume of POROS 20 R2 bulk material 
(PerSeptive Biosystems). The column was first activated with 60% MeOH, followed by 10 µl 
1%  formic acid (FA). The acidified peptide mixture sample was loaded on the tip, washed 
twice with 10 µl 1% FA and then directly eluted in 2 µl of 60% MeOH, 1% FA into a 
gold/palladium coated boro-silicate nano-electrospray needle (Proxeon Biosystems). 
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Peptide sequencing by static nano ESI-MS was performed by tandem mass spectrometry 
using a QSTAR Pulsar instrument (Applied Biosystems/MDS SCIEX) equipped with a 
nanoelectrospray ion source (Proxeon Biosystems). Mass spectra were acquired in positive 
ion mode. The ionspray voltage IS (700-1000 V) applied to the nanoelectrospray needle was 
adjusted to produce a stable spray with a flow rate of ~20 nl/min, thereby allowing a long 
analysis time (~50 min on a sample of 1 μl). For MS/MS-spectra the precursor ion was 
selected in the first quadrupole (Q1) and fragmented in the collision cell. Nitrogen was used 
as the collision gas. The collision energy setting was increased until fragment ion signals were 
as abundant as the parent ion signal. Before the end of the measurement, the collision energy 
was further increased by 5-10 V to generate more small immonium ions which might be 
useful for data interpretation. The quadrupole time-of-flight mass spectrometer provided a 
resolution of >7000 FWHM and a mass accuracy of <50 ppm in both MS and MS/MS mode. 
For fast MS/MS data acquisition, information dependent data aquisition (IDA) experiments 
were performed with 1 s MS survey scan and 10 s product ion scan of the most abundant 
peptide signals. 
 
For MS/MS analysis of samples by nanoLC-MS, peptides were concentrated nearly to dry-
ness in a speedVac vacuum centrifuge, and diluted to a total volume of 30 µL with 0.1% TFA. 
Of each sample, 25 µL was analyzed using a nanoHPLC system (UltiMate: Dionex, 
Amsterdam, The Netherlands), equipped with a FAMOS auto-sampler (Dionex), coupled to 
an ESI Q-TOF hybrid mass spectrometer (Applied Biosystems, Foster City, CA). Samples 
were loaded on an Inertsil C18-trapping column (LC Packings, Amsterdam, The Netherlands) 
using 0.1% TFA and a flow rate of 20 µL/min. Peptides were eluted and separated on an 
analytical column (75 µm x 150mm) packed with Inertsil 3-µm C18 material (LC Packings) 
using a flow rate of 200 nL/min and applying a gradient of buffer A (0.1% formic acid/5% 
ACN) and buffer B (0.1% formic acid/80% ACN). The elution profile was as follows: 0–2 
min, 5% B; 2–50 min, 5–40% B; 50–60 min, 40–60% B; and 60–63 min, 60–90% B. The 
column was connected to a nano-ESI emitter (New Objectives, Woburn, MA) and 2000 V 
were applied via liquid junction. The Q-TOF operated in positive ion mode. One MS survey 
scan (0.7 s) was followed by one information dependent (IDA experiment) product ion scan 
(3 s). Only double and triple charged ions were selected for fragmentation (MS/MS). 
Proteins and peptides were identified by sending the MS/MS data to the MASCOT search 
engine or by peptide sequence tags, derived from fragment ion spectra of selected peptides, 
against the nonredundant protein database maintained and updated regularly by the European 
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Bioinformatics Institute (EBI) or the Swiss-Prot database using the program PepSea (MDS 
Proteomics) (Boeckmann et al., 2003). Every protein hit was confirmed by comparing the 
expected fragment ions with all the ions observed in the product ion spectrum. 
4.2.6 Amide hydrogen exchange (HX-MS) experiments and data analysis 
4.2.6.1 Materials and Buffers 
 
D2O buffer: 25 mM HEPES, pD 7.6, 50 mM KCl, 5 mM MgCl2 (deuterated HKM buffer) 
was prepared using 99.85% D2O (Euriso-top, Gif-sur-Yvette, France), lyophilized, and re-
dissolved five times in fresh D2O volumes. Usually 10x stock solutions were prepared and  
were diluted 1:10 in D2O before use. 
Quench buffer: 400 mM KH2PO4/H3PO4, pH 2.2.  
For HX experiments with DnaK, 2 M guadinium hydrochloride was added to the quench 
buffer to facilitate proteolytic digest. 
Immobilization of pepsin /protease XIII on POROS 20-AL beads (Wang et al., 2002): 
160 mg protease powder (pepsin from Roche or protease XIII Aspergillus saitoi from Sigma) 
was dissolved in 4 ml 50 mM sodium-citrate buffer (pH 4.4). 0.5 g of POROS-20AL (Applied 
Biosystems) and 30.2 mg sodium-cyanoborohydride (NaBH3CN) was added to the solution 
and mixed by gentle over top shaking. Immediately, 4 ml of 2 M Na2SO4 solution was added 
dropwise to increase surface concentration by salting out procedure. The suspension was then 
incubated overnight at 4°C by over top shaking and then quenched by addition of 10 µl 16.7 
M ethanolamine for 2 hours. The mixture was then washed several times with 0.05% TFA 
solution.. Finally, the slurry was stored in 0.05% TFA solution with addition of 0.05% sodium 
azide. The immoblized protease was then packed into 2 x 20 mm microguard columns 
(Upchurch). 
Fully deuterated protein controls 
The protein solution of interest was unfolded in 6 M guanidinium hydrochloride, lyophilized 
and at least 3 times diluted in D2O and lyophilized again. 
4.2.6.2 Amide hydrogen exchange experiments 
 
Continuous or pulse HX-MS experiments were carried out off-line and analyzed by a special 
HPLC-MS setup described below (Rist et al., 2003; Rist et al., 2005b) .  
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For the individual experiments with different chaperones, usually 100-200 pmol of the 
proteins of interest were preincubated in HKM buffer in absence or presence of excess ligands 
(nucleotides, inhibitors, peptides) or proteins at 30°C in a final volume of 5 µl. 
DnaK/DnaK mutants: 40 µM DnaK was incubated with 60 mM ATP for 1 min and then 
subjected to HX. For the study of peptide binding to DnaK, 40 µM DnaK was incubated with 
60 mM peptide Pep65 for 1 h before deuteration.  
Hsp90/HtpG/HtpG mutants: Nucleotide-free Hsp90 proteins (40 μM) were pre-incubated 
with a large excess of buffered ATP (120 mM), ADP (60 mM), AMPPNP (60 mM), or PU-
H71 (60 μM) for 10 min at 30°C to ensure complete binding. Geldanamycin was dissolved in 
DMSO, freshly diluted 1:100 in HKM buffer and then incubated with Hsp90β (40 μM) at a 
final concentration of 600 μM overnight on ice under light-protection. In all cases the ligand 
occupancy of Hsp90 as calculated from the published dissociation equilibrium constants using 
the quadratic solution of the binding equilibrium was more than 99% during pre-incubation 
and more than 95% during incubation in D2O. For pulsed HX experiments, HtpG was pre-
incubated with ATP for certain time intervals between 10 s-90min before 10s deuteration. 
CHIP: 20 µM of ligand free human CHIP was incubated with 100 µM hHsp70, hHsc70 or 
hHsp90β, respectively for 30 min at 30°C. For complex formation with octapeptides, 40 µM 
CHIP was pre-incubated with 600 µM Hsp90 peptide (ASRMEEVD) or Hsp70 peptide 
(GPTIEEVD) for 30 min at 30°C. For complex formation with E2 ligases, 20 µM CHIP was 
pre-incubated with 100 µM of either Ubc13 or UbcH5a for 60 min at 30°C. 
The amide hydrogen exchange reactions were initiated by a 20-fold dilution of the protein 
into D2O buffer and incubated at 30°C. After various time intervals (10 s-90 min), the 
exchange reaction was quenched by decreasing the temperature to 0°C and the pH to 2.2 with 
100 µl ice-cold quench buffer. Quenched samples were loaded with a prechilled Hamilton-
syringe into the injection valve of the rapid desalting HPLC setup connected to the 
electrospray ion source of the quadrupole-TOF instrument. The deuterated mass of the full-
length proteins was then measured as in the experimental setup in 4.2.5.1 with a desalting 
time of 90 s; however the whole system was immersed in an ice bath to minimize back-
exchange.  
For the on-line generation and analysis of peptic peptides, the setup contained an additional 
column (2 x 20 mm, Upchurch) packed with immobilized pepsin or protease XIII (or a 
combination of both) which was mounted after the injection valve (Fig 4.1). The resulting 
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peptides from online-digestion were than trapped on the reversed-phase column (POROS 50 
R2 material) and desalted. After 3 min, the desalted peptides were eluted from the trap 
column over a 0.75 mm ID x 6 cm analytical reversed-phase colum packed with ZORBAX 
300-SB-C8 (3.5 µm particles) directly into the electrospray source. The solvent for elution 
was delivered by Pump B with a flow rate of 17.5 µl/min using the following short gradient: 
buffer A (0.05 % TFA) to buffer B (90% acetonitrile, 0.05% TFA), having the profile: %B: 
15-55 (0-10 min), %B: 55-100 (10-11 min), %B: 100-15% (11-12 min). The last eluted 
peptides were detected 13 minutes after sample injection. The whole system was immersed in 
an ice bath to minimize back-exchange. In all experiments, control samples with undeuterated 
and fully deuterated proteins were measured. 
 
Fig. 4.1 Schematic drawing of the in-line peptic digestion/rapid-desalting HPLC setup used for HX-MS 
experiments. (a) Injected samples were pushed trough the pepsin column, trapped on a reversed phase column 
and desalted via Pump A (b) after a certain time, the 10-port valve was switched to elute the desalted peptides 
into the ESI-source of the MS via Pump B. All parts are immersed in an ice-bath to minimize back-exchange. 
For analysis of full-length proteins, the pepsin column was removed. (Figure modified from (Rist et al., 2005b)) 
4.2.6.3 HX-MS data analysis 
 
Peptic peptides were identified either by static nanoESI-MS/MS or by on-line 
nanoLC/MS/MS as described in 4.2.5.2 on the basis of their fragment spectra. After internal 
calibration, the mass error was below 10 ppm and hence more peptides could be identified on 
the basis of their exact mass. Peptide identification lists are found in the appendix. 
Data analysis of continuous HX labelling experiments  
In order to analyze deuteron incorporation into full-length proteins, mass spectra of deuterated 
proteins were analyzed by the Protein Reconstruct tool of the BioAnalyst software. The 
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number of deuterons incorporated was determined by substracting the determined mass of the 
undeuterated protein. 
The deuterium content of the peptides was calculated by using the average mass difference 
between the isotopic envelopes (centroids) of the deuterated and the undeuterated peptides.  
The centroid <m> is calculated is by the following equation: 
∑
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where Ii is the intensity of the peak at m/z = mi 
This data analysis was usually done with the MagTran software (Zhang and Marshall, 1998), 
which needed time-consuming steps of data export and import between different programs. 
During this work, a Visual Basic script was developed which could be implemented into the 
Analyst QS 1.1 software for fast isotopic centroid determination of an exchanged peptide. In 
this script, named “isotope-centroid.dll”, an isotopic peak cluster can be selected and the 
resulting centroid m/z value is displayed and stored directly in an Excel data sheet for easy 
data processing. The script enabled extensive data analysis of large peptide data sets and even 
the distinguished analysis of overlapping species. 
For the calculation of the deuteron incorporation into peptides, adjustments were made for 
deuterium losses due to back-exchange during analysis based on appropriate controls, a 0% 
deuterium control (undeuterated protein) and a 100% totally deuterated control  according to 
following formula (Zhang and Smith, 1993): 
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where D is the number of deuterons incorporated present in a particular peptic peptide after 
incubation of the protein in D2O, N is the total number of exchangeable amide hydrogens in 
the peptide sequence (substracted by proline residues), and <m> is the experimentally 
observed average mass. <m0%> is the undeuterated control and <m100%> the fully deuterated 
control. 
Experimental data were fit by nonlinear least squares to a sum of three exponential terms 
resulting in three exchange rates with the amplitudes corresponding to the number of 
exchanging amide hydrogens according to  
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where D is the deuterium content of a peptide with N peptide amide hydrogens and ki is the 
rate constant for exchange for the peptide hydrogens. 
The average chemical exchange rate was determined by simulating deuteron incorporation for 
different time intervals and back-exchange during the desalting step using the exchange rates 
for pD 7.6 and pH 2.4 calculated with the HXPep program (courtesy Z. Zhang) and fitting a 
single exponential equation to the values. Protection factors were calculated according to the 
equation for the EX2 exchange regime, p = 1/Kunf = kch/kobs (where Kunf indicates the 
unfolding equilibrium constant; kch indicates the average chemical exchange rate; kobs 
indicates the observed exchange rate (Hvidt and Nielsen, 1966). The lower limit of ΔG for the 
unfolding reaction was estimated according to ΔG= -RT ln(Kunf)=-RT ln(kobs/kch) setting for 
the non-exchanging amide hydrogens the lowest exchange rates (0.0001 s-1) detectable in our 
experiment. 
Data analysis of pulsed HX labelling experiments (HtpG) 
For the kinetic analysis of the transition of I- to T-state in HX experiments, full length protein 
mass spectra of 10 time points of three independent measurements were deconvoluted using 
MagTran software (Zhang and Smith, 1993) and the abundance of the two deuterated mass 
species was calculated by fitting two Gaussian peaks into the deconvoluted spectra using the 
following equation: 
y = A1σ 2π e
− 1
2
x−x 1
σ
⎛ 
⎝ ⎜ 
⎞ 
⎠ ⎟ 
2
+ A2σ 2π e
− 1
2
x−x 2
σ
⎛ 
⎝ ⎜ 
⎞ 
⎠ ⎟ 
2
 
with A1, A2, x1 and x2 being area and mean of the first and second peak and σ the standard 
deviation of the Gaussian peaks. The ration of A1 to the sum of A1 and A2 represented the 
relative amount of the T state. The increasing amount of the T-state in dependence of time 
was fitted using a first order rate equation. 
For the analysis of the transition kinetics in deuterated peptides, peptide MS spectra of three 
independent experiments (8 time points) were extracted, smoothed, normalized to the highest 
peak of the isotope cluster and the intensity of two peaks determined: the peak, which is 
highest at 10 s preincubation with ATP (I state), and the peak, which is highest at 300 s 
preincubation with ATP (T state). We plotted the T state peak intensity divided by the sum of 
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the intensities of the two peaks versus time (T/(T+I)). This ratio followed first order rate 
kinetics. 
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6 Abbreviations 
 
σ32 Sigma32, heat shock transcription factor in E. coli 
µM micromolar 
17-AAG 17-allylaminogeldanamycin 
17-DMAG 17-dimethylaminoethylamino-demethoxygeldanamycin 
Å Ångström 
aa amino acids 
ADP adenosine diphosphate 
AMPPNP adenylyl imido diphosphate 
apo ligand free state 
APS ammonium persulfate 
ATP adenosine triphosphate 
BMH bis(maleimido)hexane 
BMOE bis(maleimido)ethane 
bp base pairs 
BSA bovine serum albumine 
CD circular dichroism 
CFTR cystic fibrosis transmembrane regulator 
CHIP C-terminus of Hsc70 interacting protein 
CID collision induced dissociation 
D = 2H deuterium 
Da Dalton (atomic mass unit) 
DC direct current 
DD dimerization domain 
DEAE diethylaminoethyl 
DMF dimethylformamide 
DMSO dimethylsulfoxide 
DNA desoxyribonucleic acid 
DnaJ Hsp40 co-chaperone in E. coli 
DnaK Hsp70 chaperone in  E. coli 
DTT 1,4-dithiothreitol 
E. coli Escherichia coli 
E2 ubiquitin-conjugating enzyme 
E3 ubiquitin-ligase 
EDTA ethylenediamine-N,N,N',N'-tetraacetic acid  
ESI electrospray ionization 
FA formic acid 
FRET fluorescence resonance energy transfer 
GA geldanamycin 
GHKL GyraseB/Hsp90/Histidine Kinase/MutL ATPase superfamily 
GroEL Hsp60 chaperone in E. coli 
GroES Hsp10 chaperone in E. coli 
GrpE nucleotide exchange factor for DnaK 
HCCA 4-hydroxy-α-cyanocinnamic acid 
HECT homologous to E6-AP carboxy terminus 
HEPES 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid 
Hop Hsp70-Hsp90-organizing protein 
HPLC high-performance liquid chromatography 
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Hsc constitutively expressed heat shock protein (cognate) 
Hsp heat shock protein 
Hsp90β constitutively expressed isoform of Hsp90 
HtpG high temperature protein G in E. coli 
HX amide hydrogen exchange 
ID inner diameter 
IPTG isopropyl-β-D-thiogalactopyranoside 
J Joule 
JDP J-domain protein 
kDa kilodalton 
LC  liquid chromatography 
m/z mass-to-charge ratio 
MALDI matrix assisted laser desorption/ionization 
MD middle domain 
MeOH methanol 
mRNA messenger ribonucleic acid 
MS mass spectrometry 
MS/MS tandem mass spectrometry 
NBD nucleotide binding domain 
NEF nucleotide exchange factor 
nM nanomolar 
NMR nuclear magnetic resonance 
OD optical density 
PAGE polyacrylamide gel electrophoresis 
PCR polymerase chain reaction 
PDB protein data bank 
Pi inorganic phosphate 
PMSF phenylmethanesulfonyl fluoride 
PP5 protein phosphatase 5 
ppm parts per million 
PU-H71 purine scaffold inhibitor H71 
RF radio frequency 
RING really interesting new gene 
RNA ribonucleic acid 
RP reversed-phase 
SAXS small angle X-ray scattering  
SBD substrate binding domain 
SDS sodium dodecyl sulphate 
SHR steroid hormone receptor 
TCEP tris(2-carboxyethyl) phosphine 
TEMED N,N,N',N'-tetramethylethylendiamine 
TFA trifluoroacetic acid 
TOF time-of-flight 
TPR tetratricopeptide repeat 
Tris 2-amino-2-(hydroxymethyl)-1,3-propanediol 
wt wildtype 
z number of charges on an ion 
 
The 1-letter code or the 3-letter code for amino acids was used
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7 Appendix  
 
Peptic peptide identification lists 
 
DnaK 
first 
residue 
last 
residue 
mass 
(theo.) 
m/z 
(theo.) charge sequence 
2 9 827.5117 414.7637 2 GKIIGIDL 
2 15 1390.7126 696.3641 2 GKIIGIDLGTTNSC 
16 41 2726.3909 909.8048 3 VAIMDGTTPRVLENAEGDRTTPSIIA 
17 41 2627.3225 876.7820 3 AIMDGTTPRVLENAEGDRTTPSIIA 
17 49 3534.7148 1179.2461 3 AIMDGTTPRVLENAEGDRTTPSIIAYTQDGETL 
18 41 2556.2854 853.1029 3 IMDGTTPRVLENAEGDRTTPSIIA 
18 49 3463.6777 1155.5670 3 IMDGTTPRVLENAEGDRTTPSIIAYTQDGETL 
41 49 996.4400 499.2278 2 AYTQDGETL 
42 49 925.4029 463.7093 2 YTQDGETL 
42 66 2728.378 910.4671 3 IAYTQDGETLVGQPAKRQAVTNPQNTLFA 
50 66 1820.9857 608.0030 3 VGQPAKRQAVTNPQNTL 
50 66 1820.9857 911.5007 2 VGQPAKRQAVTNPQNTL 
50 67 1968.0541 657.0258 3 VGQPAKRQAVTNPQNTLF 
67 80 1747.9846 583.6693 3 FAIKRLIGRRFQDE 
67 81 1877.0272 470.2646 4 FAIKRLIGRRFQDEE 
67 81 1877.0272 626.6835 3 FAIKRLIGRRFQDEE 
67 85 2375.2822 594.8284 4 FAIKRLIGRRFQDEEVQRD 
82 101 2159.1045 720.7093 3 VQRDVSIMPFKIIAADNGDA 
82 101 2159.1045 1080.5601 2 VQRDVSIMPFKIIAADNGDA 
86 97 1303.7210 652.8683 2 VSIMPFKIIAAD 
86 101 1660.8494 831.4325 2 VSIMPFKIIAADNGDA 
102 117 1767.9342 590.3192 3 WVEVKGQKMAPPQISA 
102 117 1767.9342 884.9749 2 WVEVKGQKMAPPQISA 
102 118 1896.9768 633.3334 3 WVEVKGQKMAPPQISAE 
102 118 1896.9768 949.4962 2 WVEVKGQKMAPPQISAE 
103 118 1710.8975 571.3070 3 VEVKGQKMAPPQISAE 
119 129 1289.7377 645.8767 2 VLKKMKKTAED 
119 137 2178.1606 727.0613 3 VLKKMKKTAEDYLGEPVTE 
119 137 2178.1606 1090.0881 2 VLKKMKKTAEDYLGEPVTE 
119 138 2249.1977 750.7404 3 VLKKMKKTAEDYLGEPVTEA 
119 139 2384.2873 795.7702 3 VLKKMKKTAEDYLGEPVTEAV 
138 163 2745.4562 687.3719 4 AVITVPAYFNDAQRQATKDAGRIAGL 
138 163 2745.4562 916.1599 3 AVITVPAYFNDAQRQATKDAGRIAGL 
146 163 1930.9973 644.6736 3 FNDAQRQATKDAGRIAGL 
147 163 1783.9289 595.6508 3 NDAQRQATKDAGRIAGL 
164 174 1268.7088 635.3622 2 EVKRIINEPTA 
164 176 1410.7831 706.3994 2 EVKRIINEPTAAA 
164 177 1523.8671 508.9635 3 EVKRIINEPTAAAL 
164 177 1523.8671 762.9414 2 EVKRIINEPTAAAL 
166 177 1295.7561 648.8859 2 KRIINEPTAAAL 
173 191 1862.985 622.0028 3 TAAALAYGLDKGTGNRTIA 
177 192 1647.8944 550.3059 3 LAYGLDKGTGNRTIAV 
177 192 1647.8944 824.9550 2 LAYGLDKGTGNRTIAV 
178 192 1534.8104 512.6113 3 AYGLDKGTGNRTIAV 
178 192 1534.8104 512.6113 3 AYGLDKGTGNRTIAV 
178 192 1534.8104 768.4130 2 AYGLDKGTGNRTIAV 
188 203 1683.8468 562.2901 3 RTIAVYDLGGGTFDIS 
205 217 1522.7039 762.3598 2 IEIDEVDGEKTFE 
207 216 1151.5346 576.7751 2 IDEVDGEKTF 
207 219 1492.7297 747.3727 2 IDEVDGEKTFEVL 
218 231 1397.6423 699.8290 2 VLATNGDTHLGGED 
220 231 1185.4898 593.7527 2 ATNGDTHLGGED 
220 232 1332.5582 667.2869 2 ATNGDTHLGGEDF 
220 236 1803.8024 602.2753 3 ATNGDTHLGGEDFDSRL 
220 236 1803.8024 902.9090 2 ATNGDTHLGGEDFDSRL 
231 252 2656.3384 886.4539 3 DFDSRLINYLVEEFKKDQGIDL 
244 259 1859.9564 620.9933 3 FKKDQGIDLRNDPLAM 
244 273 3467.8922 694.5862 5 FKKDQGIDLRNDPLAMQRLKEAAEKAKIEL 
260 273 1625.9465 542.9900 3 QRLKEAAEKAKIEL 
260 283 2669.4348 890.8194 3 QRLKEAAEKAKIELSSAQQTDVNL 
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274 283 1061.4989 531.7573 2 SSAQQTDVNL 
281 289 1004.5179 503.2668 2 VNLPYITAD 
284 305 2424.3311 607.0906 4 PYITADATGPKHMNIKVTRAKL 
284 305 2424.3311 809.1182 3 PYITADATGPKHMNIKVTRAKL 
289 305 1879.0462 470.7694 4 DATGPKHMNIKVTRAKL 
289 305 1879.0462 627.3565 3 DATGPKHMNIKVTRAKL 
289 308 2208.2049 553.0590 4 DATGPKHMNIKVTRAKLESL 
309 329 2278.2533 760.4256 3 VEDLVNRSIEPLKVALQDAGL 
309 329 2278.2533 1140.1345 2 VEDLVNRSIEPLKVALQDAGL 
311 329 2050.1422 684.3885 3 DLVNRSIEPLKVALQDAGL 
311 329 2050.1422 1026.0789 2 DLVNRSIEPLKVALQDAGL 
312 329 1935.1153 646.0462 3 LVNRSIEPLKVALQDAGL 
312 329 1935.1153 968.5655 2 LVNRSIEPLKVALQDAGL 
313 329 1822.0312 608.3515 3 VNRSIEPLKVALQDAGL 
337 356 2230.2330 558.5661 4 VILVGGQTRMPMVQKKVAEF 
337 356 2230.2330 744.4188 3 VILVGGQTRMPMVQKKVAEF 
340 356 1904.9965 477.2569 4 VGGQTRMPMVQKKVAEF 
340 356 1904.9965 636.0066 3 VGGQTRMPMVQKKVAEF 
340 356 1904.9965 953.5061 2 VGGQTRMPMVQKKVAEF 
357 369 1529.7474 510.9236 3 FGKEPRKDVNPDE 
357 369 1529.7474 765.8815 2 FGKEPRKDVNPDE 
357 370 1600.7845 534.6026 3 FGKEPRKDVNPDEA 
357 370 1600.7845 801.4001 2 FGKEPRKDVNPDEA 
357 370 1600.7845 801.4001 2 FGKEPRKDVNPDEA 
357 372 1770.8901 591.3045 3 FGKEPRKDVNPDEAVA 
370 391 2065.1783 689.4006 3 AVAIGAAVQGGVLTGDVKDVLL 
370 391 2065.1783 1033.5970 2 AVAIGAAVQGGVLTGDVKDVLL 
371 382 1053.6182 527.8169 2 VAIGAAVQGGVL 
371 391 1994.1412 665.7215 3 VAIGAAVQGGVLTGDVKDVLL 
371 391 1994.1412 998.0784 2 VAIGAAVQGGVLTGDVKDVLL 
371 392 2107.2252 703.4162 3 VAIGAAVQGGVLTGDVKDVLLL 
383 391 958.5335 480.2746 2 TGDVKDVLL 
389 392 456.3312 457.3390 1 VLLL 
392 399 856.4906 429.2531 2 LLDVTPLSL 
392 399 856.4906 857.4984 1 LLDVTPLSL 
400 408 893.3987 447.7072 2 GIETMGGVM 
400 408 893.3987 894.4065 1 GIETMGGVM 
412 425 1536.8624 513.2953 3 IAKNTTIPTKHSQV 
412 430 2072.0902 691.7045 3 IAKNTTIPTKHSQVFSTAE 
412 435 2587.2878 863.4371 3 IAKNTTIPTKHSQVFSTAEDNQSA 
412 437 2787.4039 930.1424 3 IAKNTTIPTKHSQVFSTAEDNQSAVT 
436 457 2466.3455 617.5942 4 VTIHVLQGERKRAADNKSLGQF 
438 457 2266.2294 567.5652 4 IHVLQGERKRAADNKSLGQF 
438 457 2266.2294 756.4176 3 IHVLQGERKRAADNKSLGQF 
438 457 2266.2294 1134.1225 2 IHVLQGERKRAADNKSLGQF 
458 473 1720.8567 861.4362 2 NLDGINPAPRGMPQIE 
472 484 1419.7176 710.8666 2 IEVTFDIDADGIL 
512 532 2462.2224 821.7486 3 IQKMVRDAEANAEADRKFEEL 
531 564 3798.925 950.7391 4 ELVQTRNQGDHLLHSTRKQVEEAGDKLPADDKTA 
541 552 1475.7845 738.9001 2 HLLHSTRKQVEE 
553 568 1600.7944 534.6059 3 AGDKLPADDKTAIESA 
591 600 1145.6114 573.8135 2 LAQVSQKLME 
601 625 2595.1546 866.0593 3 IAQQQHAQQQTAGADASANNAKDDD 
601 628 2908.3183 970.4472 3 IAQQQHAQQQTAGADASANNAKDDDVVD 
601 630 3108.3980 1037.1405 3 IAQQQHAQQQTAGADASANNAKDDDVVDAE 
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HtpG  
first 
residue 
last 
residue 
mass 
(theo) 
m/z 
(theo) charge sequence 
1 19 2228.1735 743.7323 3 MKGQETRGFQSEVKQLLHL 
20 31 1480.7384 494.5873 3 MIHSLYSNKEIF 
32 48 1918.0272 640.3502 3 LRELISNASDAADKLRF 
35 56 2386.2600 796.4278 3 LISNASDAADKLRFRALSNPDL 
64 88 2865.4900 717.3803 4 RVRVSFDKDKRTLTISDNGVGMTRD 
70 88 2121.0484 708.0239 3 DKDKRTLTISDNGVGMTRD 
78 88 1163.5240 582.7698 2 ISDNGVGMTRD 
86 106 2287.2171 763.4135 3 TRDEVIDHLGTIAKSGTKSFL 
89 98 1066.5658 534.2907 2 EVIDHLGTIA 
89 106 1915.0414 639.3549 3 EVIDHLGTIAKSGTKSFL 
99 106 866.4900 434.2528 2 KSGTKSFL 
107 119 1376.6419 689.3288 2 ESLGSDQAKDSQL 
120 127 823.4228 824.4306 1 IGQFGVGF 
132 153 2356.2862 786.4365 3 IVADKVTVRTRAAGEKPENGVF 
154 165 1297.5462 649.7809 2 WESAGEGEYTVA 
162 175 1596.7631 533.2622 3 YTVADITKEDRGTE 
179 187 1130.4992 566.2574 2 HLREGEDEF 
191 202 1508.8099 503.9444 3 WRVRSIISKYSD 
191 206 1943.1045 648.7093 3 WRVRSIISKYSDHIAL 
200 206 817.3970 409.7063 2 YSDHIAL 
207 219 1557.7682 520.2639 3 PVEIEKREEKDGE 
220 233 1599.8984 534.3073 3 TVISWEKINKAQAL 
234 244 1377.6500 460.2245 3 WTRNKSEITDE 
246 277 3951.8969 988.9820 4 EEYKEFYKHIAHDFNDPLTWSHNRVEGKQEYTSLLY 
278 299 2704.3696 902.4643 3 SLLYIPSQAPWDMWNRDHKHGLKLYV 
300 305 810.4388 406.2272 2 YVQRVF 
300 308 1169.5903 585.8030 2 YVQRVFIMD 
309 317 1113.3637 557.6897 2 DAEQFMPNY 
318 334 1913.0492 638.6909 3 LRFVRGLIDSSDLPLNV 
319 334 1799.9894 601.0043 3 RFVRGLIDSSDLPLNV 
335 359 2941.6243 981.5492 3 NVSREILQDSTVTRNLRNALTKRVLQMLE 
361 374 1684.8308 562.6181 3 EKLAKDDAEKYQTF 
375 382 989.5334 495.7745 2 WQQFGLVL 
383 393 1204.5360 603.2758 2 KEGPAEDFANQ 
400 416 1819.9064 607.6433 3 LRFASTHTDSSAQTVSL 
417 435 2322.1201 775.0478 3 EDYVSRMKEGQEKIYYITA 
438 449 1285.6666 429.5633 3 YAAAKSSPHLEL 
450 458 1054.6862 528.3509 2 LRKKGIEVL 
459 466 959.4924 480.7540 2 LLSDRIDE 
472 490 2125.0570 709.3601 3 LTEFDGKPFQSVSKVDESL 
475 490 1781.8835 594.9690 3 FDGKPFQSVSKVDESL 
500 521 2385.3267 796.1167 3 SAKEAEKALTPFIDRVKALLGE 
522 541 2277.2917 760.1050 3 RVKDVRLTHRLTDTPAIVST 
526 545 2209.1339 737.3858 3 VRLTHRLTDTPAIVSTDADE 
554 566 1406.7557 469.9264 3 FAAAGQKVPEVKY 
567 576 1195.6237 598.8197 2 IFELNPDHVL 
570 585 1791.9115 598.3116 3 LNPDHVLVKRAADTED 
585 599 1820.8800 911.4478 2 DEAKFSEWVELLLDQ 
602 613 1326.6779 664.3468 2 LAERGTLEDPNL 
615 621 929.5229 465.7693 2 IRRMNQL 
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hHsp90β  
first 
residue 
last 
residue 
mass 
(theo) 
m/z 
(theo) charge sequence modification
1 10 1192.48 597.24 2 MPEEVHHGEE  
2 14 1519.64 507.55 3 PEEVHHGEEEVET  
15 20 712.32 713.32 1 FAFQAE  
15 24 1136.59 569.30 2 FAFQAEIAQL  
28 39 1487.77 744.89 2 IINTFYSNKEIF  
32 39 1046.51 524.26 2 FYSNKEIF  
40 51 1300.7 651.35 2 LRELISNASDAL  
41 51 1187.61 594.81 2 RELISNASDAL  
52 65 1663.88 555.63 3 DKIRYESLTDPSKL  
57 65 988.51 495.26 2 ESLTDPSKL  
57 70 1504.73 502.58 3 ESLTDPSKLDSGKE  
66 81 1794.94 599.31 3 DSGKELKIDIIPNPQE  
66 83 2052.09 685.03 3 DSGKELKIDIIPNPQERT  
71 81 1278.72 640.36 2 LKIDIIPNPQE  
71 83 1535.87 512.96 3 LKIDIIPNPQERT  
71 86 1863.08 622.03 3 LKIDIIPNPQERTLTL  
87 98 1219.61 610.81 2 VDTGIGMTKADL  
87 98 1235.61 618.81 2 VDTGIGMTKADL Oxidation (M) 
99 114 1664.89 555.96 3 INNLGTIAKSGTKAFM  
99 114 1680.89 561.30 3 INNLGTIAKSGTKAFM Oxidation (M) 
105 114 1052.57 527.29 2 IAKSGTKAFM  
105 114 1068.56 535.28 2 IAKSGTKAFM Oxidation (M) 
113 126 1495.71 748.85 2 FMEALQAGADISMI  
126 133 823.42 824.42 1 IGQFGVGF  
139 154 1822.94 608.65 3 VAEKVVVITKHNDDEQ  
141 154 1652.84 551.95 3 EKVVVITKHNDDEQ  
142 154 1523.79 508.93 3 KVVVITKHNDDEQ  
155 165 1160.48 581.24 2 YAWESSAGGSF  
166 183 1918.07 640.36 3 TVRADHGEPIGRGTKVIL  
184 192 1161.53 581.77 2 HLKEDQTEY  
194 208 1898.05 633.68 3 EERRVKEVVKKHSQF  
196 208 1639.96 547.65 3 RRVKEVVKKHSQF  
209 214 775.45 776.45 1 IGYPITL  
216 229 1781.83 594.94 3 YLEKEREKEISDDE  
216 231 1981.91 661.64 3 YLEKEREKEISDDEAE  
216 256 4869.18 974.84 5 YLEKEREK……..DEEKPKIEDVGSD  
257 282 3151.66 788.92 4 EEDDSGKDKKKKTKKIKEKYIDQEEL  
283 300 2184.08 729.03 3 NKTKPIWTRNPDDITQEE  
290 300 1316.58 659.29 2 TRNPDDITQEE  
301 304 515.21 516.21 1 YGEF  
305 316 1519.69 507.56 3 YKSLTNDWEDHL  
317 324 915.48 458.74 2 AVKHFSVE  
317 327 1213.65 607.83 2 AVKHFSVEGQL  
317 328 1342.69 672.35 2 AVKHFSVEGQLE  
317 329 1489.76 745.88 2 AVKHFSVEGQLEF  
333 342 1230.69 616.35 2 LFIPRRAPFD  
344 355 1502.89 501.96 3 FENKKKKNNIKL  
356 363 1082.61 542.31 2 YVRRVFIM  
367 376 1251.60 626.80 2 DELIPEYLNF  
368 376 1136.58 569.29 2 ELIPEYLNF  
377 390 1538.83 770.42 2 IRGVVDSEDLPLNI  
383 390 899.46 450.73 2 SEDLPLNI  
384 393 1184.6 593.30 2 EDLPLNISRE  
386 393 940.53 471.27 2 LPLNISRE  
394 403 1202.71 401.90 3 MLQQSKILKV Oxidation (M) 
394 415 2624.60 875.87 3 REMLQQSKILKVIRKNIVKKCLELFS  
416 419 495.25 496.25 1 FSEL  
420 429 1270.62 424.54 3 AEDKENYKKF  
433 443 1284.72 429.24 3 FSKNLKLGIHE  
437 443 808.48 405.24 2 LKLGIHE  
437 454 2136.18 713.06 3 LKLGIHEDSTNRRRLSEL  
455 465 1291.58 646.79 2 LRYHTSQSGDE  
455 466 1438.61 480.54 3 LRYHTSQSGDEM Oxidation (M) 
470 484 1863.90 622.30 3 SEYVSRMKETQKSIY Oxidation (M) 
472 484 1647.83 550.28 3 YVSRMKETQKSIY Oxidation (M) 
473 484 1484.77 495.92 3 VSRMKETQKSIY Oxidation (M) 
485 498 1495.72 748.86 2 YITGESKEQVANSA  
485 499 1642.78 822.39 2 YITGESKEQVANSAF  
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500 512 1635.92 546.31 3 VERVRKRGFEVVY  
526 535 1108.58 555.29 2 KEFDGKSLVS  
536 547 1357.66 679.83 2 VTKEGLELPEDE  
567 584 2159.23 720.74 3 MKEILDKKVEKVTISNRL Oxidation (M) 
572 584 1528.89 510.63 3 DKKVEKVTISNRL  
591 602 1342.62 672.31 2 IVTSTYGWTANM  
596 602 841.34 421.67 2 YGWTANM  
603 611 1058.59 530.30 2 ERIMKAQAL  
603 613 1329.72 444.24 3 ERIMKAQALRD  
603 613 1345.71 449.57 3 ERIMKAQALRD Oxidation (M) 
603 617 1794.87 599.29 3 ERIMKAQALRDNSTM 2 Oxidation (M) 
621 636 1885.97 629.66 3 MAKKHLEINPDHPIVE Oxidation (M) 
621 638 2100.10 701.03 3 MAKKHLEINPDHPIVETL Oxidation (M) 
622 636 1738.94 580.65 3 AKKHLEINPDHPIVE  
637 653 1929.03 644.01 3 TLRQKAEADKNDKAVKD  
637 654 2042.11 681.70 3 TLRQKAEADKNDKAVKDL  
638 653 1827.98 610.33 3 LRQKAEADKNDKAVKD  
638 654 1941.06 648.02 3 LRQKAEADKNDKAVKDL  
639 654 1827.98 610.33 3 RQKAEADKNDKAVKDL  
655 658 443.32 444.32 1 VVLL  
659 663 579.29 580.29 1 FETAL  
664 683 2337.12 780.04 3 LSSGFSLEDPQTHSNRIYRM  
668 680 1542.74 515.25 3 FSLEDPQTHSNRI  
669 680 1395.67 466.22 3 SLEDPQTHSNRI  
669 683 1845.88 616.29 3 SLEDPQTHSNRIYRM  
684 692 956.55 479.28 2 IKLGLGIDE  
684 693 1071.58 536.79 2 IKLGLGIDED  
684 694 1200.62 601.31 2 IKLGLGIDEDE  
697 713 1746.83 874.42 2 AEEPNAAVPDEIPPLEG  
697 715 1990.90 664.63 3 AEEPNAAVPDEIPPLEGDE  
697 716 2105.93 702.98 3 AEEPNAAVPDEIPPLEGDED  
697 717 2176.96 726.65 3 AEEPNAAVPDEIPPLEGDEDA  
697 720 2551.14 851.38 3 AEEPNAAVPDEIPPLEGDEDASRM  
 
 
 
 
Hsc82  
 
1st 
residue 
last 
residue 
mass 
(theo) 
m/z 
(theo) charge sequence modification
1 7 783.31 784.31 1 MAGETFE  
6 15 1224.6 613.30 2 FEFQAEITQL  
8 15 948.49 475.25 2 FQAEITQL  
19 30 1439.77 720.89 2 IINTVYSNKEIF  
31 42 1300.7 651.35 2 LRELISNASDAL  
31 47 1976.07 659.69 3 LRELISNASDALDKIRY  
34 47 1577.84 526.95 3 LISNASDALDKIRY  
34 49 1776.94 593.31 3 LISNASDALDKIRYQA  
34 55 2445.29 816.10 3 LISNASDALDKIRYQALSDPKQ  
43 55 1560.83 521.28 3 DKIRYQALSDPKQ  
43 62 2358.21 787.07 3 DKIRYQALSDPKQLETEPDL  
48 63 1829.9 915.95 2 QALSDPKQLETEPDLF  
50 62 1483.74 742.87 2 LSDPKQLETEPDL  
50 63 1630.81 816.41 2 LSDPKQLETEPDLF  
53 62 1168.6 585.30 2 PKQLETEPDL  
63 75 1568.93 523.98 3 FIRITPKPEEKVL  
63 76 1697.97 566.99 3 FIRITPKPEEKVLE  
64 76 1550.9 517.97 3 IRITPKPEEKVLE  
73 89 1859.02 620.67 3 KVLEIRDSGIGMTKAEL  
75 89 1631.86 544.95 3 LEIRDSGIGMTKAEL  
76 89 1518.77 507.26 3 EIRDSGIGMTKAEL  
77 89 1389.73 695.87 2 IRDSGIGMTKAEL  
77 89 1405.72 469.57 3 IRDSGIGMTKAEL Oxidation (M) 
90 105 1664.89 555.96 3 INNLGTIAKSGTKAFM  
90 105 1680.89 561.30 3 INNLGTIAKSGTKAFM Oxidation (M) 
90 107 1864.97 622.66 3 INNLGTIAKSGTKAFMEA  
114 124 1140.56 571.28 2 VSMIGQFGVGF  
117 124 823.42 412.71 2 IGQFGVGF  
129 145 1955.99 653.00 3 LVADRVQVISKNNEDEQ  
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132 145 1672.8 558.60 3 DRVQVISKNNEDEQ  
132 146 1835.86 612.95 3 DRVQVISKNNEDEQY  
133 145 1557.77 520.26 3 RVQVISKNNEDEQ  
133 146 1720.84 574.61 3 RVQVISKNNEDEQY  
146 156 1229.54 615.77 2 YIWESNAGGSF  
157 175 2140.2 714.40 3 TVTLDEVNERIGRGTVLRL  
183 200 2332.25 778.42 3 EYLEEKRIKEVIKRHSEF  
184 200 2203.21 735.40 3 YLEEKRIKEVIKRHSEF  
185 200 2040.15 681.05 3 LEEKRIKEVIKRHSEF  
186 200 1927.06 643.35 3 EEKRIKEVIKRHSEF  
188 200 1668.98 557.33 3 KRIKEVIKRHSEF  
201 207 802.46 402.23 2 VAYPIQL  
201 208 915.54 458.77 2 VAYPIQLL  
245 263 2327.26 776.75 3 EEEEKKPKTKKVKEEVQEL  
263 279 2040.06 681.02 3 LEELNKTKPLWTRNPSD  
263 282 2382.25 795.08 3 LEELNKTKPLWTRNPSDITQ  
264 279 1926.98 643.33 3 EELNKTKPLWTRNPSD  
289 300 1465.67 733.84 2 YKSISNDWEDPL  
301 311 1305.67 653.84 2 YVKHFSVEGQL  
301 312 1434.71 718.36 2 YVKHFSVEGQLE  
301 313 1581.78 791.89 2 YVKHFSVEGQLEF  
314 327 1655.99 553.00 3 RAILFIPKRAPFDL  
318 328 1349.75 675.88 2 FIPKRAPFDLF  
328 339 1475.88 492.96 3 FESKKKKNNIKL  
340 349 1296.68 649.34 2 YVRRVFITDE  
349 357 1100.5 551.25 2 EAEDLIPEW  
349 359 1300.62 651.31 2 EAEDLIPEWLS  
350 357 971.46 486.73 2 AEDLIPEW  
350 358 1084.54 543.27 2 AEDLIPEWL  
350 359 1171.58 586.79 2 AEDLIPEWLS  
359 374 1730.91 866.46 2 SFVKGVVDSEDLPLNL  
360 374 1643.88 822.94 2 FVKGVVDSEDLPLNL  
361 374 1496.81 749.41 2 VKGVVDSEDLPLNL  
364 374 1212.62 607.31 2 VVDSEDLPLNL  
367 374 899.46 450.73 2 SEDLPLNL  
382 399 2137.35 713.45 3 NKIMKVIRKNIVKKLIEA  
388 400 1570.99 524.66 3 IRKNIVKKLIEAF  
417 427 1254.71 419.24 3 FAKNIKLGVHE  
417 435 2124.14 709.05 3 FAKNIKLGVHEDTQNRAAL  
418 435 1977.08 660.03 3 AKNIKLGVHEDTQNRAAL  
421 431 1252.64 627.32 2 IKLGVHEDTQN  
421 435 1663.9 555.63 3 IKLGVHEDTQNRAAL  
424 435 1309.64 655.82 2 GVHEDTQNRAAL  
439 450 1423.73 712.87 2 LRYNSTKSVDEL  
456 468 1677.83 560.28 3 YVTRMPEHQKNIY  
456 468 1693.82 565.61 3 YVTRMPEHQKNIY Oxidation (M) 
456 469 1840.89 614.63 3 YVTRMPEHQKNIYY  
457 468 1514.77 505.92 3 VTRMPEHQKNIY  
476 492 1905.07 636.02 3 KAVEKSPFLDALKAKNF  
478 484 818.45 410.23 2 VEKSPFL  
504 519 1887.96 630.32 3 YAFTQLKEFEGKTLVD  
506 519 1653.86 552.29 3 FTQLKEFEGKTLVD  
507 519 1506.79 503.26 3 TQLKEFEGKTLVD  
510 519 1164.6 583.30 2 KEFEGKTLVD  
527 542 1990.93 664.64 3 EETDEEKAEREKEIKE  
540 554 1773.03 592.01 3 IKEYEPLTKALKDIL  
540 556 1945.08 649.36 3 IKEYEPLTKALKDILGD  
540 557 2073.14 692.05 3 IKEYEPLTKALKDILGDQ  
543 556 1574.86 525.95 3 YEPLTKALKDILGD  
543 556 1574.86 525.95 3 YEPLTKALKDILGD  
543 559 1931.03 966.52 2 YEPLTKALKDILGDQVE  
560 567 934.59 468.30 2 KVVVSYKL  
560 573 1472.86 737.43 2 KVVVSYKLLDAPAA  
574 584 1235.6 618.80 2 IRTGQFGWSAN  
574 585 1366.65 684.33 2 IRTGQFGWSANM  
574 585 1382.64 692.32 2 IRTGQFGWSANM Oxidation (M) 
586 599 1634.82 545.94 3 ERIMKAQALRDSSM  
586 601 1808.89 603.96 3 ERIMKAQALRDSSMSS  
602 620 2212.18 738.39 3 YMSSKKTFEISPKSPIIKE  
603 620 2049.12 684.04 3 MSSKKTFEISPKSPIIKE  
604 620 1918.08 640.36 3 SSKKTFEISPKSPIIKE  
621 641 2327.28 776.76 3 LKKRVDEGGAQDKTVKDLTNL  
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621 642 2440.36 814.45 3 LKKRVDEGGAQDKTVKDLTNLL  
648 652 523.26 524.26 1 LTSGF  
648 660 1413.67 707.84 2 LTSGFSLEEPTSF  
652 660 1055.48 528.74 2 FSLEEPTSF  
668 672 501.62 502.62 1 ISLGL  
677 701 2676.11 893.04 3 DEETETAPEASTEAPVEEVPADTEM  
 
 
 
 
CHIP wt 
 
first 
residue 
last 
residue 
mass 
(theo) m/z (theo) charge sequence 
1 28 2771.35 924.78 3 MKGKEEKEGGARLGAGGGSPEKSPSAQE 
1 36 3709.88 928.47 4 MKGKEEKEGGARLGAGGGSPEKSPSAQELKEQGNRL 
37 45 1065.56 533.78 2 FVGRKYPEA 
37 48 1310.64 656.32 2 FVGRKYPEAAAC 
49 60 1329.75 444.25 3 YGRAITRNPLVA 
49 60 1329.75 665.88 2 YGRAITRNPLVA 
49 61 1428.82 477.27 3 YGRAITRNPLVAV 
49 62 1591.88 531.63 3 YGRAITRNPLVAVY 
53 60 882.53 442.27 2 ITRNPLVA 
53 61 981.6 491.80 2 ITRNPLVAV 
53 62 1144.66 573.33 2 ITRNPLVAVY 
61 68 998.52 500.26 2 VYYTNRAL 
61 69 1101.53 551.77 2 VYYTNRALC 
61 70 1264.59 633.30 2 VYYTNRALCY 
62 69 1002.46 502.23 2 YYTNRALC 
62 70 1165.52 583.76 2 YYTNRALCY 
63 70 1002.46 502.23 2 YTNRALCY 
70 82 1573.76 787.88 2 YLKMQQHEQALAD 
70 83 1676.77 559.92 3 YLKMQQHEQALADC 
71 80 1224.63 613.32 2 LKMQQHEQAL 
71 82 1410.69 706.35 2 LKMQQHEQALAD 
71 83 1513.7 505.57 3 LKMQQHEQALADC 
84 98 1725.93 576.31 3 RRALELDGQSVKAHF 
89 98 1100.56 551.28 2 LDGQSVKAHF 
90 98 987.48 494.74 2 DGQSVKAHF 
90 105 1776.86 593.29 3 DGQSVKAHFFLGQCQL 
99 105 807.39 404.70 2 FLGQCQL 
99 106 936.44 469.22 2 FLGQCQLE 
107 117 1254.54 628.27 2 MESYDEAIANL 
118 131 1722.92 575.31 3 QRAYSLAKEQRLNF 
118 139 2491.28 831.43 3 QRAYSLAKEQRLNFGDDIPSAL 
121 131 1367.72 456.91 3 YSLAKEQRLNF 
121 138 2023 675.33 3 YSLAKEQRLNFGDDIPSA 
121 139 2136.09 713.03 3 YSLAKEQRLNFGDDIPSAL 
124 131 1004.54 503.27 2 AKEQRLNF 
124 139 1772.91 591.97 3 AKEQRLNFGDDIPSAL 
125 139 1701.87 568.29 3 KEQRLNFGDDIPSAL 
127 138 1331.65 666.83 2 QRLNFGDDIPSA 
130 138 934.4 468.20 2 NFGDDIPSA 
139 151 1640.98 547.99 3 LRIAKKKRWNSIE 
140 151 1527.90 510.30 3 RIAKKKRWNSIE 
152 161 1295.66 648.83 2 ERRIHQESEL 
162 168 874.47 438.24 2 HSYLSRL 
169 179 1343.67 672.83 2 IAAERERELEE 
169 198 3519.58 880.89 4 IAAERERELEECQRNHEGDEDDSHVRAQQA 
180 197 2122.88 708.63 3 CQRNHEGDEDDSHVRAQQ 
180 198 2193.92 732.31 3 CQRNHEGDEDDSHVRAQQA 
199 211 1553.67 518.89 3 CIEAKHDKYMADM 
200 210 1319.62 440.87 3 IEAKHDKYMAD 
202 211 1208.53 605.27 2 AKHDKYMADM 
215 233 2296.16 766.39 3 FSQVDEKRKKRDIPDYLCG 
215 238 2900.49 967.83 3 FSQVDEKRKKRDIPDYLCGKISFE 
238 246 1090.52 546.26 2 ELMREPCIT 
238 252 1708.82 855.41 2 ELMREPCITPSGITY 
238 259 2594.24 865.75 3 ELMREPCITPSGITYDRKDIEE 
239 246 961.47 481.74 2 LMREPCIT 
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239 249 1202.58 602.29 2 LMREPCITPSG 
239 252 1579.77 790.89 2 LMREPCITPSGITY 
240 246 848.39 425.20 2 MREPCIT 
240 252 1466.69 734.35 2 MREPCITPSGITY 
240 259 2352.11 785.04 3 MREPCITPSGITYDRKDIEE 
243 252 1050.51 526.26 2 PCITPSGITY 
243 259 1935.92 646.31 3 PCITPSGITYDRKDIEE 
247 259 1521.73 508.24 3 PSGITYDRKDIEE 
253 261 1153.57 577.79 2 DRKDIEEHL 
260 277 2087.1 696.70 3 HLQRVGHFDPVTRSPLTQ 
260 278 2216.15 739.72 3 HLQRVGHFDPVTRSPLTQE 
260 284 2894.55 724.64 4 HLQRVGHFDPVTRSPLTQEQLIPNL 
262 277 1836.96 613.32 3 QRVGHFDPVTRSPLTQ 
262 278 1966 656.33 3 QRVGHFDPVTRSPLTQE 
262 284 2644.41 662.10 4 QRVGHFDPVTRSPLTQEQLIPNL 
279 286 898.49 450.25 2 QLIPNLAM 
285 293 1022.51 512.26 2 AMKEVIDAF 
287 293 820.43 411.22 2 KEVIDAF 
294 303 1210.52 606.26 2 ISENGWVEDY 
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